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Abstract 
The type III secretion system (T3SS) is a macromolecular structure assembled by many 
Gram-negative bacteria in order to invade target host cells.  A functional T3SS contains a 
syringe-like structural component known as the needle apparatus, which works in concert with 
an export apparatus that recognizes the cargo and an ATPase complex that energizes the 
transport of bacterial effector proteins.  Effectors transported directly into the host cell cytoplasm 
modulate host cellular functions such as cytoskeletal dynamics and cellular signaling in order to 
enable the pathogens to invade, survive, and multiply within the host environment. 
Gram-negative bacteria harboring the T3SS include Salmonella, Shigella, enteropathogenic 
E. coli, Yersinia, Burkholderia, Pseudomonas, as well as Chlamydia.  These organisms are 
responsible for infectious diseases in humans and pose a threat to human health worldwide.  
Inactivation of the T3SS, by knocking out structural or functional proteins, renders pathogens 
incapable of causing infection.  Salmonella and Shigella are responsible for millions of cases of 
food-borne diarrhea annually throughout the world.  In addition, large-scale food recalls due to 
frequent outbreaks of food poisoning has a negative impact on the food industry in the United 
States.  No preventive vaccines are available against Salmonella and Shigella.  Study of the 
T3SS thus has a scope for the development of strategies to combat these pathogens. 
The T3SS among different bacterial species share common features but also show unique 
structural and functional characteristics.  Therefore, the T3SS provides a suitable target for the 
development of specific anti-infectives.  The needle apparatus of the T3SS consists of a base 
followed by an extracellular needle.  The needle is attached to a tip complex and a translocon.  
The tip complex serves as a platform for the assembly of the translocon that punctures a 
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translocation pore within the host cell membrane.  The tip complex is assembled from several 
copies of a hydrophilic tip protein and the translocon is assembled from two hydrophobic 
translocon proteins.  This dissertation describes structural and functional studies, as well as 
characterization of the protein-protein interactions that are important in the assembly of the tip 
complex and the translocon of Salmonella and Shigella.   
In Salmonella, the tip complex is formed by the tip protein SipD.  A translocon made up of 
the translocon proteins SipB and SipC is attached on the tip complex.  A combination of X-ray 
crystallography, Nuclear magnetic resonance (NMR) spectroscopy, site-directed mutagenesis, as 
well as functional assays were applied to determine the structure of the Salmonella tip protein 
SipD and show that the C-terminus is crucial for the function and an antiparallel β-sheet is 
important for the tertiary structure of SipD.  The function of the T3SS can be regulated by small 
molecules such as bile salts.  The T3SS of Salmonella is down regulated by bile salts.  The tip 
protein SipD directly binds to the bile salt deoxycholate using an unknown mechanism.  The 
crystal structures of SipD bound to bile salts reported herein show that the interaction between 
bile salts and SipD is predominantly hydrophobic.  Further, deoxycholate induced the 
degradation of the Salmonella translocon protein SipB.  These observations have led to the 
hypothesis that deoxycholate might interfere with the interaction between SipD and SipB leading 
to a down regulation of the T3SS in Salmonella.  The structure of the translocon and how it is 
attached to the tip complex is not clear.  Preliminary structural characterization of a folded, 
hydrophilic domain at the N-terminus of SipB was undertaken to locate two fragments of SipB 
within residues 82-240 and 82-226, which produced well-dispersed 2D-NMR spectra.  
Paramagnetic relaxation enhancement (PRE) was employed to define the interaction between 
SipD and the N-terminal hydrophilic domain of SipB.  A region within residues Asp207-Asn283 
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of SipB bound to a mixed α/β region of SipD.  PRE was also used to study how the Shigella tip 
protein IpaD binds to its needle protein MxiH in order to assemble the tip complex in Shigella.  
MxiH was shown to bind to the lower portion of a coiled coil region in IpaD.    
Secretion through the T3SS is enabled by extensive cross-talk within its components.  The 
assembly of the needle apparatus requires polymerization of multiple copies of several different 
proteins.  Regulation of secretion is most probably an outcome of conformational changes 
relayed in sequence through the needle apparatus.  Work described in this dissertation shows that 
weak protein-protein interactions are a common theme in the assembly of the needle apparatus.  
Further, T3SS proteins contain discreet functional domains.  For example, the coiled coil of the 
tip protein allows the assembly of the tip complex while the mixed α/β region attaches to the 
translocon.  The structure of theT3SS proteins varies depending upon the role it plays.  For 
example, the extracellular needle is assembled from a small polar protein but the translocon 
proteins contain both hydrophilic and hydrophobic domains.  Nevertheless, further studies are 
required to fully appreciate certain aspects of the T3SS such as how large proteins are 
transported through the needle, how the T3SS switches between active and inactive states of 
secretion, how substrate specificity is controlled, and how effector secretion is energized.  
Complete understanding of theT3SS requires the determination of high resolution structures of 
the needle apparatus, direct binding studies analyzing how isolated components of the needle 
apparatus interact with each other and behave in vitro, computational modeling of larger 
substructures, and functional assays to test the physiological implications of these in vitro 
studies.               
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CHAPTER 1:  Introduction 
1.1.  Introduction to the type III secretion system 
Secretion of proteins across the cell membrane is a fundamental characteristic of all bacteria 
(1).  The secreted proteins perform a multitude of functions including extraction of nutrients 
from the surroundings, motility, intercellular communication, and formation of the cell 
membrane (1).  Secretion of proteins in Gram-positive bacteria occurs through the general 
secretory pathway (1, 2).  However, additional specialized secretory mechanisms are required to 
transport proteins across the outer membrane of Gram-negative bacteria (1, 2).  Secretion 
machineries in Gram-negative bacteria are classified into seven groups (types I through VII) 
based on their structure, regulation, and substrate specificities (3, 4).  The type III secretion 
system (T3SS) was initially discovered as a set of gene clusters required for virulence of several 
pathogenic Gram-negative bacteria (2).   
The T3SS can be differentiated from other secretion systems by the following characteristics: 
the substrates are secreted through both the inner and outer bacterial membranes, several 
accessory proteins are required for the secretion process, the T3SS substrates lack a cleavable 
sec-dependent signal sequence, and several extracellular signals are required for the full 
activation of the T3SS(2).  A functional T3SS includes a needle apparatus, which works in 
concert with an export apparatus and an ATPase complex that are associated with the needle 
apparatus at the bacterial inner membrane (5).  The needle apparatus spans the bacterial cell 
membranes, the extracellular space, and the host cell membrane (6).  The needle apparatus is 
essentially a hollow channel through which substrates or bacterial effectors are transported from 
the bacterial cytoplasm to the cytoplasm of the target host cell (6).  The export apparatus controls 
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substrate specificity and the order of secretion through the needle apparatus and the ATPase 
complex energizes the unidirectional transport of effectors through the needle apparatus (5, 6).  
Prior to secretion through the needle apparatus, effectors remain bound to chaperones, which 
maintain them in a secretion-competent state within the bacterial cytoplasm (7).  Upon delivery 
into the host cytoplasm the effectors modulate several host cellular processes such as 
cytoskeletal dynamics, progression of cell cycle, apoptosis, endocytic trafficking, and gene 
expression (8).  The membrane bound components of the needle apparatus, export apparatus, and 
the ATPase complex are well conserved among several Gram-negative bacteria pathogenic to 
both animals (Salmonella, Shigella, Yersinia) and plants (Xanthomonas, P. syringae, Erwinia, 
etc.) (4).  Additionally, genes coding for a T3SS were also found in several symbiotic and non-
pathogenic bacteria (4).  These core components also bear structural and functional resemblance 
to the flagellar export apparatus (4).  The conserved nature of the T3SS is thought to be due to 
horizontal gene transfer because the G+C content of T3SS genes is distinct from the rest of the 
bacterial genome (2). 
T3SS are classified into seven families based on sequence conservation (9) [Table 1].  Out of 
the seven, three families of T3SS most commonly occur among bacteria that are pathogenic to 
human beings (9).  These are the Ysc family, the Inv-Mxi-Spa family, and the Esc family.  These 
names also denote the T3SS gene clusters in Yersinia, Shigella, and E. coli respectively (9).  The 
Ysc family includes the T3SS of Yersinia, Pseudomonas, and Aeromonas (9).  Salmonella 
contains two sets of T3SS genes located within Salmonella pathogenecity islands 1 and 2 (SPI-1 
& SPI-2).  The SPI-1 T3SS belongs to the Inv-Mxi-Spa family along with that of Shigella and 
Burkholderia (9).  The SPI-2 T3SS from Salmonella belongs to the  
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Table 1:  Classification of the T3SS.   
T3SS family Bacterial species Diseases caused 
Salmonella typhimurium (SPI-1) Salmonellosis 
Shigella flexneri Shigellosis 
 
Inv-Mxi-Spa 
Burkholderia pseudomallei Melioidosis 
Salmonella typhimurium (SPI-2) Salmonellosis 
Enteropathogenic E. coli (EPEC) Diarrhea 
 
Esc 
Enterohaemorrhagic E. coli (EHEC) Hemolytic-uremic syndrome 
Yersinia pestis Bubonic plague 
Pseudomonas aeruginosa Infection in immunocompromised 
Ysc 
Aeromonas salmonicida Furunculosis in fish 
Chlamydia trachomatis Trachoma, genital infections Chlamydiales 
Chlamydia pneumoniae Acute respiratory disease 
Rhizobium Rhizobium sp. Plant symbiont 
Hrp1 Pseudomonas syringae Infections in plants 
Hrp2 Xanthomonas campestris Infections in plant 
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Esc family along with those from enteropathogenic E. coli (EPEC) and enterohaemorrhagic E. 
coli (EHEC) (9).  These T3SS-harboring bacterial species are the causative agents of a         
variety of diseases ranging from Bubonic plague (caused by Yersinia pestis), food-poisoning 
(caused by Salmonella, Shigella, and E. coli), hospital-acquired secondary infections (caused by 
Pseudomonas aeruginosa), and sexually transmitted diseases (caused by Chlamydia) (6).  The 
T3SS is a key player in the development of these illnesses, which together pose a major threat to 
human health.   
1.2. The structural components of the T3SS  
1.2.1.  The basal body - The needle apparatus forms the structural component of the T3SS 
and has been visualized in detail using three-dimensional electron microscopy [Figure 1-1] (10). 
The needle apparatus of several bacteria including Salmonella (11), Shigella (12), Yersinia (13), 
Escherichia (14), and Pseudomonas (15) show a common syringe-like appearance and is thus 
called an injectisome.  Over 20 different proteins assemble the needle apparatus, which is 
divided into a basal body, a needle, a tip complex, and a translocon (9).  The structure of a 
prototypical needle apparatus is depicted in Figure 1-2.  The basal body contains two radially 
symmetrical multimeric rings that span the bacterial inner membrane (IM ring), and the outer 
membrane (OM ring) (9) [Figure 1-2].  A tubular structure called the inner rod connects the IM 
ring to the OM ring through the periplasmic space (10).  The basal body measures approximately 
250 Å × 300 Å and encloses an inner channel about 20-30 Å in diameter (10).  The basal body 
forms the core secretory unit and secretes structural proteins into the extracellular space, which 
then assemble the rest of the needle apparatus.   
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Figure 1-1:  An electron micrograph image of purified Salmonella T3SS needle complexes 
that consist of the basal body and the needle (16).  This research was originally published in 
Journal of Biological Chemistry. Zhong,D., Lefebre, M., Kaur, K., McDowell, M. A., Gdowski, C., 
Jo, S., Wang, Y., Benedict, S. H., Lea, S. M., Galan, J. E., De Guzman, R. N. The Salmonella Type 
III Secretion System Inner Rod Protein PrgJ Is Partially Folded, J. Biol.Chem., 2012; 287: 25303-
11.  © The American Society for Biochemistry and Molecular Biology.  It is the policy of the 
American Society for Biochemistry and Molecular Biology to allow reuse of any material published 
in its journals (the Journal of Biological Chemistry, Molecular & Cellular Proteomics and the 
Journal of Lipid Research) in a thesis or dissertation at no cost and with no explicit permission 
needed.   
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 1.2.2.  The needle - A characteristic feature of the needle apparatus is a hollow cylindrical 
needle that connects the basal body within the bacterial membrane to the translocon within the 
host cell membrane [Figures 1-1 & 1-2].  The needle is approximately 400-800 Å in length with 
an outer diameter of 70-80 Å and an inner lumen of 20-30 Å (17).  The diameter of the inner 
lumen is only sufficient to hold two well-folded α-helices.  This implies that larger protein 
components of the T3SS have to be transported through the lumen in an unfolded or partially 
folded state.  However, the process of transport of proteins through the needle is poorly 
understood.  The needle is assembled by the helical polymerization of the needle protein (9).  
Needle proteins are around 6-9 kD in size and contain two α-helices connected by a P-X-X-P 
motif, where X is any amino acid (18, 19).  The N-terminus and the C-terminus of the needle 
proteins is highly flexible and can adopt several conformations (19).  The C-terminus of the 
needle proteins is important for the assembly of the needle as removal of only five residues from 
the C-terminus is sufficient to abrogate polymerization of the needle (20).  Although, the three-
dimensional structure of the needle has been studied extensively (18, 21-23), much less is known 
about the mechanism and regulation of transport of effectors through the needle.  The transport 
of effector proteins through the needle lumen is activated only after the translocon attaches to the 
host cell membrane (24).  This means that activation signals are relayed from the host cell 
membrane and across the needle to the export apparatus at the bacterial cell membrane.  How the 
needle relays information to the export apparatus is poorly understood.  Certain point mutations 
within the needle proteins can give rise to needles which constitutively secrete effectors in the 
absence of an activation signal (20).  This has led to the hypothesis that contact with the host cell 
membrane might trigger conformational changes throughout the length of the needle and   
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Figure 1-2:  Cartoon of the T3SS showing the needle apparatus.  The needle apparatus is divided 
into a basal body, a needle, a tip complex, and a translocon.  The basal body contains an OM ring 
that spans the bacterial inner membrane and an IM ring that spans the bacterial outer membrane.  
An extension of the OM ring called the neck reaches into the periplasmic space.  The IM and 
OM rings are connected by an inner rod.  An export apparatus and ATPase complex are 
associated with the basal body.  The needle bridges the extracellular space and is capped by a tip 
complex and a translocon.  The translocon forms a translocation pore within the host cell 
membrane.  The needle apparatus transports bacterial effectors directly into the host cytoplasm.  
Effectors remain bound to chaperones in the bacterial cytoplasm prior to transport through the 
needle. 
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the mutant needle proteins might assemble a needle that mimics the activated conformation of 
the WT needle.  The flexible termini of the needle protein are thought to allow the WT needle to 
adopt different conformations.  The active and inactive needle conformations however, are not 
known.  
1.2.3.  The tip complex - An oligomeric tip complex plugs the opening of the needle until 
contact with host cell is established (25) [Figure 1-2].  Following contact with the host cell 
membrane the tip complex is thought to undergo a conformational change, which triggers the 
assembly of the translocon.  The translocon sits on the tip complex and integrates into the host 
cell membrane to form the translocation pore that allows the delivery of effectors into the host 
cell cytoplasm.  Thus, the tip complex regulates the secretion of effectors and also acts as a 
platform for the formation of the translocon.  The tip complex is composed of multiple copies of 
the tip protein (26, 27).  The atomic structures of tip proteins from several bacterial species have 
been determined by X-ray crystallography (28-30).  Tip proteins are highly α-helical and roughly 
30-40 kD in size with an overall elliptical shape.  The sequence identity among the tip proteins 
ranges from 30-40 % with a higher degree of sequence conservation at the C-terminus.  A long 
central coiled coil is conserved among all tip proteins (28).  On either side of the coiled coil there 
is an N-terminal domain and a C-terminal domain that vary to a higher degree (28).  Tip protein 
Yersinia LcrV and Pseudomonas PcrV are known to have cognate chaperones LcrG and PcrG 
respectively (31).  However, no tip chaperones have been identified for the tip proteins of 
Salmonella and Shigella. The assembled tip complexes of Yersinia (26) and Shigella (27) have 
been visualized using electron microscopy.  These pathogens assemble a pentameric tip complex 
formed by five tip proteins that are polymerized along their coiled coil domains.  Nevertheless, 
the low resolution of these structures prevented detailed analysis of the molecular interactions 
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between the tip proteins and between the tip proteins and the needle proteins necessary for the 
assembly of the tip complex.  In addition, how the tip complex senses the host cell membrane 
and triggers the assembly of the translocon is also poorly understood.  
  1.2.4.  The translocon - The translocon is a membrane-embedded structure that sits on top 
of the tip complex and forms a pore in the host cell membrane [Figure 1-2].  The translocon 
proteins, which are responsible for assembling the translocon, were identified within the T3SS 
loci as genes encoding two membrane proteins and were adjacent to the genes for the tip protein 
(32).  The translocon proteins colocalize with the tip protein on the bacterial surface (33).  
Studies using osmoprotectants of different sizes showed that translocons form 30-50 Å wide 
pores within the eukaryotic cell membrane (12, 34).  Intact translocons formed by EPEC were 
visualized by electron microscopy and were found to contain 6-8 lobe-like structures (35) 
[Figure 1-3].  This strongly suggests that the translocon is polymerized from multiple protein 
units.  The crystal structures of small fragments from the translocon proteins Salmonella SipB 
and Shigella IpaB showed that these proteins contain trimeric coiled coils (36).  However, the 
structure, stoichiometry, and the mechanism of assembly of the translocon are currently 
unknown.   
1.3.  The functional components of the T3SS 
1.3.1. The export apparatus - The assembly of the needle apparatus begins with the 
formation of the IM and OM rings of the basal body (5).  The inner rod and the needle are 
assembled soon after.  The tip protein and the translocon proteins are secreted following the 
assembly of the needle and the effectors are secreted last (24).  Based on their order of secretion, 
the T3SS components are sometimes classified as early (inner rod and needle protein), middle  
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Figure 1-3:  Structure of the translocation pore from EPEC (A) Electron micrograph image 
of translocation pores formed by EPEC within the cell membrane of a red blood cell.  
Translocation pores show a segmented appearance  (35).  (B) A three-dimensional image of 
a translocation pore from EPEC determined by atomic force microscopy (35).  The 
translocation pore had a doughnut-like shape and contained 6-8 lobes.  This figure was 
reproduced with permission from John Wiley and Sons.  © 2001 Blackwell Science Ltd, Cellular 
Microbiology, 3, 669-679 
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(tip protein), and late (translocon and effector proteins) effectors (24).  The export apparatus 
is responsible for switching the substrate specificity from early to middle to late effectors and 
controlling the hierarchy of secretion through the basal body (37-39).  Five highly conserved 
integral membrane proteins assemble the export apparatus, which is associated with the basal 
body within the bacterial inner membrane (5, 40).  Although the structures of the cytosolic 
portions of some of the export apparatus proteins have been determined (37, 39, 41, 42), little is 
known about the molecular interactions between these proteins or the specific roles they play in 
the function of the export apparatus.  One export apparatus protein belonging to the Yersinia 
YscU family (SpaS in Salmonella and Spa40 in Shigella, Table 2) contains a conserved NPTH 
motif that can undergo autocatalytic cleavage, which results in a conformational change (37-39).  
This phenomenon is thought to be important for switching of substrate specificity.  The largest 
member of the export apparatus, which belongs to the Yersinia YscV family (InvA in Salmonella 
and MxiA in Shigella, Table 2), forms a multimeric ring below the base (42).  Although the 
exact function of this ring is unknown, mutation of the residues lining the inner surface of this 
ring had a negative impact on effector secretion (42).    
1.3.2.  The ATPase complex - The ATPase complex couples hydrolysis of ATP with the 
secretion of effectors through the needle apparatus (7).  The major component of the ATPase 
complex is a cytoplasmic ATPase belonging to the Yersinia YscN family (InvC in Salmonella 
and Spa47 in Shigella, Table 2) (43).  The T3SS ATPase shares a high degree of sequence 
similarity with the β-subunit of the Fo-F1-ATPases and forms a double-hexameric ring below the 
export apparatus (43).  Prior to secretion through the needle apparatus effectors are bound to 
their cognate chaperones (7).  The ATPase recognizes and binds to the chaperone-effector  
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Table 2:  Protein components of the T3SSs of Salmonella and Shigella 
Role Salmonella Shigella 
Translocon SipB, SipC IpaB, IpaC 
Tip complex SipD IpaD 
Needle PrgI MxiH 
Base InvG, PrgJ 
PrgK, PrgH 
MxiD, MxiI, 
MxiJ, MxiG 
Export 
apparatus 
SpaP, SpaQ, 
SpaS, SpaR,  
InvA 
Spa9, Spa24, 
Spa29, Spa40, 
MxiA 
ATPase InvC Spa47 
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complex and catalyzes the release of the chaperones (7).  The release of the chaperone from its 
cognate effector requires the hydrolysis of ATP (7).  Studies with the flagellar apparatus suggest 
that the ATPase forms a complex with other proteins, which might regulate the hydrolysis of 
ATP and secretion of effectors (44).  The Shigella ATPase Spa47 was also found to form 
complexes with cytoplasmic proteins MxiN, MxiK, and Spa33 (45, 46).  The identities and 
functional roles of these proteins are poorly understood. 
1.3.3.  T3SS chaperones - T3SS chaperones are cytoplasmic proteins that bind to T3SS 
substrates and play several roles (9).  T3SS chaperones are segregated into three classes based on 
the specific substrates they bind to (9).  Class I chaperones bind to T3SS effectors and maintain 
them in a secretion-competent state within the bacterial cytoplasm.  Class II chaperones bind to 
the two hydrophobic translocon proteins and partition them within the bacterial cytoplasm 
thereby preventing their premature degradation.  Moreover, translocon proteins are toxic to the 
bacterial cell and the class II chaperones neutralize their toxicity.  All class II chaperones contain 
34-amino acid α-helical repeats called tetratricopeptide repeats (TPRs) (9).  TPR motifs are also 
found in eukaryotic chaperones and promote protein-protein interactions.  Class III chaperones 
bind to needle proteins and prevent their premature polymerization.  The extracellular helical 
components of the flagellum and the needle proteins from Yersinia, Pseudomonas, and EPEC are 
recognized by specific class III chaperones (9).  In contrast, no chaperones were identified for 
the needle proteins from Salmonella, Shigella, and Burkholderia (28).     
T3SS chaperones bind to the chaperone-binding domain (CBD) present at the disordered N-
terminus of their binding partners and allow them to be recognized by the export apparatus and 
the ATPase complex (7, 47).  This might lead to an increase in the local concentration of the 
substrates at the basal body, which will promote their secretion through the needle apparatus (4).  
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T3SS chaperones are also thought to impose a secretion hierarchy by interacting with the export 
apparatus or ATPase complex with varying affinities.  In the absence of their binding partners, 
the free chaperone might even inhibit transport through the T3SS.  Some T3SS chaperones can 
stimulate or inhibit the membrane localization of their binding partners (4).  There is also 
evidence suggesting that T3SS chaperones might act as transcriptional regulators (4). 
1.3.4.  T3SS effectors - Gram-negative animal pathogens use the T3SS to deliver six to 
twenty different effector proteins into the target cell (9).  T3SS effectors perform two overall 
goals: host cytoskeletal rearrangements and modulation of the host immune response (48).  
Rearrangements in the host actin cytoskeleton can be caused by direct interaction of effectors 
with the cytoskeletal components leading to actin polymerization, bundling, and initiation of 
focal adhesion points (48).  Effectors can also have enzymatic activity that promotes GDP/GTP 
nucleotide exchange in small GTPases like Rac1 and Cdc42 (48).  In many cases, manipulation 
of the host cytoskeleton enables the pathogen to gain entry into nonphagocytotic host cells.   
Effectors can further influence cellular motility by targeting tubulin, kinesin, and vinculin (48).  
Depending upon the pathogen, host inflammatory responses can be stimulated or inhibited by 
T3SS effectors (48).  For example, some T3SS effectors from Salmonella and Shigella (like SipB 
and IpaB respectively) are Interleukin-1ß-converting enzyme (ICE) cysteine proteases, which 
activate interleukins (49).  These pathogens also activate NF-κB, which releases 
proinflammatory cytokines like IL-8 (50, 51).  In contrast, effectors delivered by Yersinia down 
regulate the host inflammatory response.  For example, YopP blocks the release of tumor 
necrosis factor-α (TNF-α) by macrophages (52).  T3SS effectors can also lead to a disturbance in 
the host immune system by triggering apoptosis of macrophages and through regulation of 
transcription (48).  The list of effectors delivered by the T3SS is long and still incomplete (53).   
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1.4.  The T3SSs of Salmonella & Shigella 
1.4.1.  Pathogenesis of Salmonella and Shigella - Salmonella and Shigella are rod-shaped 
Gram-negative bacteria belonging to the enterobacteriaceae family.  All four species of Shigella, 
which include S. flexneri, S. dysenteriae, S. boydii, and S. sonnei, are responsible for Shigellosis 
(54).  Salmonella has a more complicated classification and nomenclature.  Salmonella enterica 
includes six subspecies, out of which Salmonella enterica subspecies enterica is further divided 
into serotypes Enteritidis, Typhimurium, Typhi, and Cholerasesuis (54).  Salmonella enterica 
subspecies enterica serotype Typhimurium is referred to as Salmonella typhimurium or simply 
Salmonella throughout this dissertation.  Salmonella typhimurium is the causative agent of 
Salmonellosis.   
Salmonella and Shigella are transmitted through the oral-fecal route.  They enter the human 
body by means of contaminated food or water.  Acid tolerance response (ATR) mechanisms 
allow the pathogens to survive the low pH inside the stomach and travel through the 
gastrointestinal tract (55, 56).  Salmonella invades the small intestine (55), while Shigella 
invades the large intestine (56).  The T3SS allows the uptake of bacteria by M cells of the host 
intestinal epithelium and also ensures the survival of bacteria within intracellular vacuoles.  M 
cells are modified epithelial cells that sample the microenvironment of the host intestinal lumen.  
The M cells transcytose the bacteria to the basolateral side of the intestinal epithelium where 
they are taken up by macrophages (56).  The two pathogens have slightly different fates upon 
phagocytosis.  Salmonella takes up residence in Salmonella-containing vacuoles or SCVs within 
circulating macrophages and colonizes other organs such as the spleen and the liver (55).  
Shigella, on the other hand rapidly induces apoptosis in macrophages to ensure their survival  
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Figure 1-4:  Pathogenesis of Salmonella (55) and Shigella (56).  Salmonella and Shigella invade 
intestinal epithelial cells with the help of effectors that are injected into the host cell by a T3SS.  
The bacterium travels to the macrophage cells and induces apoptosis.  Salmonella can travel to 
other organs like the spleen and kidneys through circulating macrophages.  Bacteria within 
macrophages can induce apoptosis of macrophage which ultimately activates the host immune 
system.     
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(56).  In both cases, induction of an acute and massive inflammatory response leads to the 
destruction of the intestinal epithelial tissue and causes symptoms characteristic of food-
poisoning.  The pathogenesis of Salmonella and Shigella is described in Figure 1-4.  Symptoms 
for Salmonellosis and Shigellosis include severe diarrhea, fever, nausea, vomiting, abdominal 
cramps, and headaches.  Shigellosis is further accompanied by rectal bleeding.   
Salmonella are zoonotic parasites and infect humans and other non human animals.  In 
contrast, Shigella infects primates and is more prevalent in developing countries.  Together, 
Salmonella and Shigella are responsible for ~ 70,000 cases of food poisoning annually in the 
United States (57) and pose a major public health problem.  In a healthy individual, the 
symptoms are usually resolved without medication in about 3-4 days.  Severe cases can occur in 
children below 5 years of age, elderly, and immunocompromised individuals and are managed 
by oral rehydration and non specific antibiotics.  No protective vaccines are available against 
Salmonella typhimurium and Shigella sp. and species resistant to the commonly used antibiotics 
are frequently encountered.   
1.4.2.  Genetic organization of the T3SSs in Salmonella and Shigella - Virulence-associated 
genes (like the T3SS) in bacteria are often placed in highly mobile clusters, which are subject to 
rapid horizontal transfer.  These clusters are also known as pathogenicity islands and are 
characterized by unique nucleotide composition and codon usage as well as a high deletion 
frequency and the presence of insertion sequences (56).  
 Salmonella is known to contain up to five Salmonella pathogenicity islands (SPIs) 
containing genes for several different virulence determinants including T3SSs, flagella, adhesins, 
and genes for biofilm formation (55).  SPI-1 and SPI-2 contain genes for two T3SSs named  
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Figure 1-5:  Genetic organization of the T3SSs in Salmonella (55) and Shigella (56).  The T3SS 
is organized as clusters of genes according to the functional role played by their protein products.    
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T3SS-1 and T3SS-2 respectively.  SPI-1 is positioned at centisome 63 in the chromosome of 
Salmonella where contiguous open reading frames code for proteins that form the structural and 
functional components of the T3SS (prg/org and inv/spa operons), T3SS effectors and translocon 
proteins (sic/sip operon) and also chaperones and other regulatory proteins.  T3SS-1 secretes up 
to 13 different effector proteins which mediate actin cytoskeletal rearrangements in the host cell 
leading to the uptake of bacterial cells by intestinal M cells (55, 58).  T3SS-1 effectors also 
signal the production of proinflammatory cytokines like IL-8 and TNF-α, which aids in 
propagation of infection by triggering the transmigration of neutrophils (55) .  Genes for the 
T3SS-2 are located at centisome 30 of the Salmonella chromosome and are arranged within four 
operons that code for regulatory proteins, structural proteins, effectors, and chaperones (59).  
T3SS-2 is activated by the low pH of the vacuolar environment inside the M cells (60).  The 
primary goal of the effectors secreted through the T3SS-2 is to ensure the intracellular survival 
of the bacteria.  In order to achieve this goal T3SS-2 effectors manipulate the host cytoskeleton 
and vesicular transport and prevent the action of antimicrobial host factors and enable the 
pathogen to acquire nourishment for growth and multiplication within the SCVs (60).  The 
genetic loci coding for the T3SSs in Salmonella are depicted in figure 1-5.  The coordination of 
T3SS-1 and T3SS-2 is complicated and has been reviewed elsewhere (61).   
Genes for the T3SS in Shigella are located within a large virulence plasmid that is about 200 
kb in size (56).  The essential genes are located within a conserved 31-kb region called “entry 
region” whose products are required for entry into host cells and for macrophage cell death (56).  
T3SS genes in Shigella are also divided into four groups based on their function [Figure 1-5].  
The first group codes for the ipa antigens, which are T3SS effectors and some components of the 
needle apparatus (tip complex and translocon).  The second group contains genes for membrane 
20	  
	  
expression of ipa (mxi) and surface presentation of ipa (spa) antigens.  These gene products 
assemble the T3SS (56).  The plasmid also codes T3SS chaperones and transcriptional activators 
(regulators) for T3SS genes.  
1.4.3.  The needle apparatus of Salmonella and Shigella - The needle apparatus of 
Salmonella and Shigella retain the substructures that are conserved across all T3SS families.  
The basal body is composed of an IM ring, an OM ring, and an inner rod.  In Salmonella, the 
proteins PrgH and PrgK form the IM ring, InvG forms the OM ring, and PrgJ forms the inner rod 
(10).  The Shigella counterparts of these proteins are MxiJ and MxiG (IM ring), MxiD (OM 
ring), and MxiI (inner rod) (62).  The proteins forming the needle apparatus of Salmonella and 
Shigella are listed in Table 2.  The OM ring is estimated to have 12-15 fold symmetry and is 
assembled by InvG in Salmonella and MxiD in Shigella (10, 63).  These proteins belong to the 
secretin family of membrane proteins, which are highly conserved not only across T3SSs but 
also in flagella, T2SS, and type IV pili (63).  These proteins have a conserved protease-resistant 
C-terminal domain with a β-barrel structure known as the secretin fold (64).  This domain forms 
the membrane-embedded portion of the OM ring while, the N-terminal periplasmic domain 
forms the neck region of the OM ring (10, 63).  The neck region reaches deep into the periplasm 
and might help attach the OM ring to the IM ring (10) [Figure 1-2].  Secretins require a small 
lipidated protein called a pilotin which assists in the assembly of the OM ring (64).  The IM ring 
has a 24-fold symmetry and consists of two concentric rings called the outer-IM ring and the 
inner-IM ring (10, 62).  PrgK and MxiJ are periplasmic lipoproteins that form the inner-IM rings 
in Salmonella and Shigella respectively (6).  The structure of EscJ from EPEC, which is a 
homolog of PrgK and MxiJ, shows that these proteins contain two mixed α/β domains connected 
by a flexible linker (65).  Salmonella PrgH and Shigella MxiG form the outer IM ring and 
21	  
	  
contain an N-terminal cytoplasmic domain and a C-terminal periplasmic domain (63).  The C-
terminal periplasmic domain of PrgH is boot-shaped with three α/β domains connected by 
flexible linkers (63).  The structure of the N-terminal cytoplasmic domain of MxiG is also known 
and was shown to bear resemblance to the forkhead-associated (FHA) domains, which are 
known to bind phosphothreonine and function in cell signaling pathways (66).  However, the 
FHA-like domain of MxiG lacks conserved residues and does not bind phosphothreonine (66).  
All the proteins forming the basal body rings contain α/β domains connected by flexible linkers 
(63).  These α/β domain contain two α-helices folded against a β-sheet and are a conserved 
structural motif in the proteins forming the basal body.  It is possible that symmetrical ring 
structures are assembled using the α/β domain as a common ring-forming unit while, the 
variation in sequence allows for rings with varying sizes, stoichiometry, and unique surface 
features adapted to the specific physiology of the bacterial species (63).  In contrast to the well 
folded globular domains present in the ring forming proteins, Salmonella PrgJ, which forms the 
inner rod in Salmonella, adopts a partially folded α-helical conformation (16).  
The needles from Salmonella and Shigella have been subjected to extensive structural 
analysis (17, 18, 21, 22, 67).  The Salmonella needle is polymerized from the Salmonella needle 
protein PrgI and the Shigella needle is polymerized from the Shigella needle protein MxiH.  PrgI 
and MxiH are small α-helical hairpins with flexible termini (18, 19, 68).  The tendency of the full 
length recombinant needle proteins to polymerize in vitro initially prevented their structure 
determination.  However, it was found that deletion of five residues from the extreme C-terminus 
rendered these proteins unable to polymerize into needles both in vitro and inside the bacterial 
cell (20).  The structures of PrgICΔ5(19) and MxiH CΔ5 (18) were then determined using NMR 
spectroscopy and X-ray crystallography respectively.  Several different methods have been used  
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to generate needle models with both common and divergent features.  Initially, three-dimensional 
reconstructions of the Shigella (69) and Salmonella (21)  needles were reported using a                  
combination of X-ray fiber diffraction and electron microscopy for Shigella and cryo-electron 
microscopy (cryo-EM) for Salmonella.  The crystal structures of MxiHCΔ5 and PrgICΔ5 were 
fitted into the Shigella (18) and Salmonella needle models respectively.  The Shigella needle had 
an outer diameter of 70 Å and had an inner channel that was ~ 20 Å wide (17).  The Salmonella 
needle was slightly wider with an outer diameter of 85 Å and an inner channel of 25 Å (21).  
However, the major difference between the two needles was that while, the Shigella needle had 
5.6 subunits/turn the Salmonella needle was reported to have 6.3 subunits/turn (21).  Higher 
resolution atomic models of the Shigella needle using cryo-EM (22) and the Salmonella needle 
using solid state NMR (ssNMR) (23) have been reported recently [Figure 1-6].  These models 
have major differences.  The Shigella needle was polymerized from overexpression of 
recombinant full length MxiH, which formed an N-terminal α-helix facing the needle lumen, a 
loop facing the outer surface, and two short C-terminal α-helices with a β-hairpin in between 
lining the outer surface of the needle (22).  The β-hairpin was formed by residues 51-64 and was 
suggested to act as a linchpin to stabilize the needle protein monomers within the polymerized 
needle (22).  The Salmonella needle was also polymerized from full length recombinant needle 
protein PrgI, but in complete contrast to MxiH, the N-terminal helix of PrgI formed the outer 
surface of the needle with the extreme N-terminus adopting an extended conformation, while the 
C-terminal helix lined the needle lumen (23).  It is uncertain why the needles of Salmonella and 
Shigella, which have homologous T3SSs, would assemble needles with completely contradictory 
features.  Nonetheless, these observations imply that the other components of the Shigella and 
Salmonella needle apparatus, particularly the tip complex and the translocon, might also  
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Figure 1-6:  Models of the Shigella and Salmonella needles.  (A) Three-dimensional 
reconstruction of the Shigella needle solved by cryo-EM (22).  One monomer of MxiH is 
highlighted in pink.  (B) The conformation of MxiH within the assembled needle.  The N-
terminus of MxiH faces the needle lumen and the C-terminus forms a β-turn.  (A) and (B) From 
Fujii T., Cheung M., Blanco A., Kato T., Blocker A., Namba K., Structure of a type III secretion needle at 
7 Å resolution provides insights into its assembly and signaling mechanisms, Proc Natl Acad Sci., 2012 
Mar 20; 109:4461-6.  PNAS permits the use of original figures or tables published in PNAS for 
noncommercial and educational use.   (C)  A model of the Salmonella needle determined using solid state 
NMR, electron microcsopy, and computational modeling (23).  The N-terminus of PrgI faces the exterior 
of the needle.  Reprinted by permission from Macmillan Publishers Ltd: Nature May 20; 486: 276-9, © 
copyright 2012 Nature. 
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assemble with different structural features and using different mechanisms.  The tip complex and 
the translocon are the major foci of this dissertation and are discussed in the following sections.       
1.5.  Studies on the tip complex of Salmonella and Shigella 
1.5.1.  Crystal structure of the Salmonella tip protein SipD - The tip complex is formed by 
the tip protein SipD (23) in Salmonella and IpaD in Shigella (28).  The ipaD gene was 
discovered within the ipa locus along with the genes for the translocon proteins ipaB and ipaC, 
their chaperone ipgC, and the effector protein ipaA (70, 71).  These proteins were termed ipa for 
invasion plasmid antigens because their gene products elicited a strong immune response during 
Shigellosis (72).  Nonpolar deletion of ipaD rendered Shigella entry-deficient but secretion-
competent (71).  This meant that IpaD was required for entry into intestinal epithelial cells but 
not for the secretion of effectors.  Further, deletion of ipaD led to an increase in the secretion of 
effectors suggesting that IpaD is involved in blocking the secretion of effectors (71).  The sipD 
gene was discovered in Salmonella soon after and was found to bear high sequence identity with 
ipaD (73).  Deletion of sipD showed a similar phenotype where Salmonella was entry-deficient 
but showed increased secretion of effectors (73).  Transmission electron microscopy of immuno-
gold labeled IpaD showed that it docks at the tip of the Shigella needles (25).  Extensive 
mutagenesis revealed that IpaD has at least two roles (74).  Loss of function mutations of IpaD 
lead to constitutive secretion of effectors in the absence of an inducer and Shigella was unable to 
form translocation pores and was thus non-invasive (74).  However, these two roles were found 
to be independent of each other suggesting that IpaD has distinct functional domains (74).  
Biophysical characterization revealed that IpaD was highly soluble and predominantly α-helical 
with a biphasic thermal denaturation profile further confirming the presence of discreet domains 
that folded independently (75).  The crystal structure of IpaD showed that the tip protein had an 
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N-terminal α-helical hairpin domain, a central coiled coil and a C-terminal domain containing 
both α-helices and β-sheets (28).  A comparison with the structures of the homologous tip protein 
BipD (29) from Burkholderia and the Yersinia tip protein LcrV (30) showed that the coiled coil 
is conserved in other tip proteins while the N-terminal α-helical hairpin was unique to IpaD and 
BipD (28).  The tip proteins assemble the tip complex on the needle and are thus exposed on the 
bacterial surface.  Preliminary evidence shows that tip proteins have the potential to be adapted 
into T3SS-based protective vaccines (76-79).  Therefore, structural and functional studies on the 
tip proteins provide a scope for the development of protective vaccines to combat pathogens that 
harbor a T3SS.  Salmonella SipD is ~35% identical and ~50% similar to IpaD.  Despite having 
close sequence similarity, SipD is unable to substitute for IpaD in the T3SS of Shigella (74).  
Therefore, the atomic structure of SipD was required in order to investigate the functional roles 
of SipD and analyze its molecular interactions with other components of the needle apparatus of 
Salmonella and thereby gain insight into the function of the tip complex.  The determination of 
the atomic structure of SipD is described herein.  Further, the functional significance of the 
different domains within SipD was probed by making short deletions and testing their effect on 
the ability of Salmonella to invade human intestinal epithelial cells.  Structural and functional 
studies on SipD are described in chapter 3. 
1.5.2.  The interaction between SipD and bile salts - One of the roles of the tip complex is 
that of a negative regulator of effector secretion.  This logically implies that the tip is also 
involved in receiving and translating the activation signal in order to trigger effector secretion.  
As the tip complex is exposed to the bacterial surface it is well suited to act as an environmental 
sensor.  One way in which the tip complex could sample the microenvironment within the host is 
by sensing or responding to small molecules.  In fact, small molecules are known to affect the 
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T3SS.  For example, the presence of calcium in Yersinia blocks secretion through the needle 
(80).  In another example, the presence of the small dye Congo red in Shigella mimics contact 
with host cells and induces the secretion of effectors through the T3SS needle (81).  However, 
the mechanism by which the T3SS in these bacteria are regulated in response to small molecules 
is poorly understood.  Several studies have demonstrated how small molecule could be utilized 
to inhibit the secretion of effectors through the T3SS of Salmonella (82), Shigella (83), Yersinia 
(84, 85), and Chlamydia (86).  Hence, investigation of the interaction between small molecules 
and components of the T3SS could produce valuable information about T3SS function that can 
then be exploited for the development of therapeutics. 
Bile salts are known to influence the physiology of non-pathogenic and pathogenic intestinal 
bacteria (87).  Bile salts suppress the invasiveness of Salmonella but stimulate that of Shigella 
(88, 89).  Further, the tip proteins SipD and IpaD can directly bind to the bile salt deoxycholate 
(90).  However, the mechanism of interaction between bile salts and the tip proteins was 
unknown.  SipD was thus crystallized in complex with the bile salts deoxycholate and 
chenodeoxycholate.  The crystal structures of SipD bound to deoxycholate and 
chenodeoxycholate were the first to describe the interaction between any T3SS tip protein and a 
small molecule such as bile salt.  Further, the effect of deoxycholate on the invasiveness of 
Salmonella and the secretion of the translocon protein SipB were analyzed.  The interaction 
between SipD and deoxycholate is discussed in chapter 4. 
1.5.3. The interaction between the Shigella tip protein and the needle protein - A 20 Å 
resolution three-dimensional reconstruction of the Shigella tip complex shows five IpaD 
molecules assembled at the tip of the Shigella needle (27).  Similar structures of the Yersinia tip 
complex were also reported (26).  The tip complex of Yersinia showed a distinct division into 
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head, neck, and base substructures (26).  This characteristic helped in the orientation of the tip 
proteins within the Yersinia tip complex where the N-terminal domain of Yersinia LcrV formed 
the base while the C-terminal domain formed the head substructure (91).  However, such a 
distinct division was absent in the tip complex of Shigella possibly because the N- and C-
terminal domains in Shigella IpaD adopt are elongated as opposed to the globular domains in 
LcrV (28).  Therefore, the exact orientation of IpaD within the tip complex is unclear.  Deletion 
of residues at the extreme C-terminus of IpaD prevents the formation of the tip complex in 
Shigella (74).  However, it is not known if the C-terminus is required for tip-tip interaction or 
needle-tip interaction.  Further, how the IpaD tip complex blocks the secretion of effectors prior 
to contact with the host cell and the mechanism by which this negative regulation is relieved are 
unknown.  It was suggested that contact with the host cell membrane triggers a conformational 
change within the tip complex (28).  This conformational change is then relayed down the needle 
apparatus and leads to secretion of effectors.  Detailed knowledge about the binding interfaces 
between the tip and needle proteins is required to understand the mechanism that regulates the 
secretion of effectors.  However, attachment and entry of Shigella into host cells is rapid process 
and the tip complex and translocon are thus transient structural features.  Therefore, it is 
challenging to obtain atomic resolution models of the tip complex using electron microscopy.  
We have therefore employed NMR spectroscopy to study the direct interaction between the tip 
protein IpaD and the needle protein MxiH.  NMR spectroscopy was previously used to identify 
the binding site of the Salmonella needle protein PrgI on the tip protein SipD (92).  However, 
Salmonella PrgI and Shigella MxiH were reported to form needles with drastic structural 
contrasts (22, 23).  MxiH assembled needles with its N-terminal helix lining the needle lumen 
while, PrgI needles were assembled with the C-terminal helix towards the needle lumen [Figure 
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1-6].  Further, unlike PrgI the C-terminus of MxiH within the polymerized needle folded into 
three structural features: a short α-helix followed by a β-hairpin and a bent α-helix (22).  These 
differences suggest that the tip proteins Salmonella SipD and Shigella IpaD might bind 
differently to their respective needle proteins.  The PRE technique was used in order to locate the 
binding site of MxiH on IpaD.  The studies on the interaction between IpaD and MxiH are 
described in chapter 7.        
1.6.  Studies on the Salmonella translocon protein SipB  
The translocon is one of the least understood components of the T3SS.  Translocon proteins 
SipB and SipC assemble the translocon of Salmonella and translocon proteins IpaB and IpaC 
assemble the translocon in Shigella (32).  Salmonella SipB and Shigella IpaB are ~ 62 kD in size 
and contain two transmembrane helices.  These are known as the major translocon proteins (94).  
The minor translocon proteins Salmonella SipC and Shigella IpaC are ~ 40 kD in size and 
contain one transmembrane helix (95).  Nonpolar knockouts of the translocon proteins in 
Salmonella prevent bacterial entry and the translocation of effectors into the host cell (32).  
Deletion of the Shigella translocon proteins also produces a similar phenotype (71).  In addition, 
deletion of Shigella IpaB also causes increased secretion of effectors (71).  This suggests that 
Shigella IpaB plays the additional role of blocking premature effector secretion along with the tip 
protein IpaD.  Not only are the translocon proteins crucial for the formation of the translocation 
pore [Figure 1-4] within the host cell membrane, but they are themselves translocated into the 
host cell cytoplasm where they act as effectors and interact with the actin cytoskeleton (96-99).  
Their role as effectors is key for bacterial entry into the host cells because latex beads coated 
with IpaB and IpaC can be internalized by Shigella (100).  Further, IpaB and IpaC along with 
IpaD are required for the contact-dependent hemolytic activity of Shigella (12).  Deletion of 
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SipB and SipC also affected contact-mediated lysis of RBC by Salmonella (34).  In both cases 
RBC lysis occurred due to the formation of ~25-35 Å wide pores within the cell membrane.  
Thus, the translocon punctures holes in the host cell membrane.  These translocation pores then 
act as a gateway for the entry of the translocon proteins and other effectors that induce 
cytoskeletal rearrangements and lead to internalization of Shigella and Salmonella.   
The translocon is critical for initiation of infection by Salmonella, Shigella, and other T3SS –
harboring pathogens.  Therefore lack of structural and functional information regarding the 
translocon hinders the full understanding of how the T3SS functions.  Immunofluorescence 
microscopy of Salmonella showed that SipB and SipC colocalize with the tip protein SipD on the 
bacterial surface after contact with the host cell (33).  Moreover, in both Shigella and Salmonella 
the tip protein is necessary for the formation of the translocation pore (12, 34, 73).  In Shigella, 
IpaB was shown to dock at the needle tip along with IpaD (90).  Therefore, the tip complex 
might act as a platform for the assembly of the translocon and its correct insertion into the host 
cell membrane (101).  However, because of the transient nature of the translocon and the rapid 
internalization of Salmonella into the host cells structural information on the translocon has been 
scarce (33, 71).  NMR and CD spectroscopy were used to perform preliminary structural analysis 
of a hydrophilic, folded domain at the N-terminus of the Salmonella translocon protein SipB.  In 
order to assemble on the tip complex platform, the translocon needs to attach itself on the tip 
complex.  However, it is not known how the translocon attaches to the tip complex.  The tip 
complex is hydrophilic in nature while, the translocon contains hydrophobic helices.  Therefore, 
a hydrophilic domain at one end of SipB would be a suitable target to bind to the tip complex.  In 
order to test this hypothesis, NMR spectroscopy and PRE were used to analyze the binding 
between the Salmonella tip protein SipD and the translocon protein SipB.  This dissertation 
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includes the first description of how a tip protein binds to a translocon protein.  Structural studies 
on SipB are described in chapter 5, while the interaction between SipD and SipB is described in 
chapter 6.   
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CHAPTER 2: Materials and methods 
2.1.  Protein expression and purification 
The construction of the SipD39-343 expression plasmid was described (1).  The SipD39-343 
expression plasmid was used as the PCR template for subcloning of the SipD39-338, SipDΔ116-124, 
SipDΔ186-189, SipDΔ187-188, and SipD131-343 contructs.  Expression plasmids for IpaD38-332 and 
IpaD130-332 were constructed by Dalian Zhong.  To generate the IpaD38-332 and IpaD130-332 
constructs, DNA segments coding for the respective polypeptides were PCR amplified from S. 
flexneri using suitable oligonucleotide primers and subcloned into pET-21A expression vector 
using restriction sites Nde1 and Sal1.  The pET-21A expression vector was modified previously 
to append a His6-GB1 tag followed by a Tobacco etch virus (TEV) protease cleavage site at the 
N-terminus of the polypeptide.  The B1 immunoglobulin domain of streptococcal protein G 
(GB1) (2) was used as the GB1 tag to enhance the solubility of the recombinant protein (GB1 
expression plasmid was obtained from Peter E. Wright, Scripps Research Institute, La Jolla, 
California).  The TEV protease cleavage site was used for proteolytic removal of the His6-GB1 
tag after recombinant protein expression and purification.  DNA segments coding for SipB 
residues 82 to 312 (SipB82-312), 340 to 404 (SipB340-404), 436 to 518 (SipB436-518), and 521 to 593 
(SipB521-593) were PCR amplified from S. typhimurium strain SL1344 (ATCC) and subcloned 
into pET-22B expression vector using restriction sites Nde1 and Xho1, with the addition of 
amino acids LEH6 at the C-terminus.  SipB82-267, SipB82-240, and SipB82-226 were generated using 
the SipB82-312 construct as the template.  A list of the oligonucleotide primers used in contruction 
of expression plasmids is provided in Table 3.  
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Table 3:  Sequence of the oligonucleotide primers used to generate various expression 
constructs.   
Plasmid name Primer sequence 
SipD131-343 F:  GACGAGAGACATATGGAGATTTGGGATATG 
R:  ACGCGTCGACTTATCCTTGCAGGAAGCTTTTGGC 
SipD39-338 F:  GACGAGAGACATATGATGCTTAATATTCAA 
R:  ACGCGTCGACTTATTTGGCGGTTTCCAG 
SipDΔ116-124 F:  CCGACGTCGGCCCCGAGAACAACC 
R:  GGTTGTTCTCGGGGCCGACGTCGG 
SipDΔ186-189 F:  GGTAAGGACGGTAATGATGTTACCTCACTC 
R:  GAGTGAGGTAACATCATTACCGTCCTTACC 
SipDΔ187-188 F:  GACGGTAATACCCTAGATGTTACC 
R:  GGTAACATCTAGGGTATTACCGTC 
SipB82-312 F:  GACCAGGTCCATATGGAAGGGCAATTGACATTACTGCTTGGCAAGTTAATG 
R:  GGTGGTGGTGGTGGTGCTCGAGCGGTTCGTTTCCTCGGCTTTG 
SipB82-267 F: GACCAGGTCCATATGGAAGGGCAATTGACATTACTGCTTGGCAAGTTAATG 
R: GGTGGTGGTGGTGCTCGAGCACAATCTCAATAAACATGGCCAT 
SipB82-240 F: GACCAGGTCCATATGGAAGGGCAATTGACATTACTGCTTGGCAAGTTAATG 
R: TCAGTGGTGGTGGTGGTGGTGCTCGAGATTCTGAGAGGC 
SipB82-226 F: GACCAGGTCCATATGGAAGGGCAATTGACATTACTGCTTGGCAAGTTAATG 
R: TCAGTGGTGGTGGTGGTGGTGCTCGAGAATGTTATCCGCTTT 
SipB340-404 F: GAGAGAGAGCATATGAGTCTGGCGCTGGCTGCGGTGGGA 
R: CCGCTCGAGCTCTGCCGTTTTCTTATCG 
SipB436-518 F: GAGAGAGAGCATATGAAACTGGGTAACGCGCTGAGCAAA 
R: CGCGGGATCCTTATGACTGGGCTGCGGTATTCGTG 
SipB521-593 F: GAGAGAGAGCATATGGGTGTTGCCGAGGGCGTATTTA 
R: CGCGGGATCCTTATGCGCGACTCTGGC 
IpaD38-332 F:  GAGAGAGAG CAT TCTCATCCTGTAAGT 
R:  CGCGGGATCCGAAATGGAGAAAAAGTTTATCTG 
IpaD130-332 F:  GAGAGAGAGCATATGTCTCATAGAGAACTGTGGGC 
R:  CGCGGGATCCGAAATGGAGAAAAAGTTTATCTG 
All sequences are from 5’ to 3’ direction.   
F stands for the forward primer and R stands for reverse primer.  
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Site-directed mutants, including truncations of SipD (SipDΔ116-124, SipDCΔ5, SipDΔ186-189, and 
SipDΔ187-188), were generated using the Stratagene QuickChange kit and confirmed by DNA 
sequencing.   
For protein expression, plasmids were transformed in E. coli BL21 (DE3) DNAY cells and 
grown at 37 oC until mid-log phase in 1 L LB broth (to obtain unlabeled proteins) or M9 minimal 
media (to obtain 15N or 15N, 13C-labeled proteins).  Recombinant protein expression was induced 
with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and bacterial growth was continued 
overnight at 15 oC in incubator with aeration at 200 rpm.  The bacterial cells were harvested by 
centrifugation for 15 minutes at 4000 rpm (2704 xg) and 4 oC and resuspended in ~ 30 ml 
binding buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl, and 5 mM imidazole) and lysed by 
sonication in a Branson Digital Sonifier for 5 minutes of 2 seconds long pulses at 30% power 
and 6 seconds of gap.  Cellular debris was removed by centrifugation at 13000 rpm (18254.3 xg) 
at 4 oC for 15 minutes and recombinant protein was purified from the supernatant using Ni+2-
affinity chromatography as described (1).  Proteins containing the His6-GB1 tag were digested 
with TEV protease and subjected to a second Ni+2-column purification as described (1).  The 
purified recombinant proteins were dialyzed in buffer and concentrated in centrifugal filters units 
(Millipore) for further use.  The buffer conditions and protein concentration for each 
experimental approach are denoted under the appropriate sections. 
2.1.1.  Amino acid specific labeling of SipD39-343 – SipD39-343 was separately labeled with 
[15N]Ala, Ile, Lys, and Met and [15N]Leu to generate 15N-AIKM-SipD and 15N-Leu-SipD 
respectively.  E. coli BL21 (DE3) DNAY cells expressing SipD39-343 were grown overnight in 1 
L LB-broth at 37 oC.  Cells from the overnight culture were harvested and resuspended in two 
flasks containing 500 ml M9 minimal media supplemented with 125 mg/L of 15N-labeled amino 
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acids, 300-450 mg/L of unlabeled amino acids until an OD600 of  ~ 0.6 - 0.8 was reached.  Cells 
were grown at 37 oC for 10 minutes and a final concentration of 1 mM IPTG was added to 
induce recombinant protein expression.  Cell growth was continued at 37 oC until the OD600 was 
~ 2.5 – 3.0 (~ 4hrs.).  Cells were harvested and the recombinant protein was purified as described 
(1). 
2.1.2.  13C-ILV labeling of SipD39-343 - The methyl groups of isoleucine, leucine, and valine 
residues of SipD39-343 were 13C-specifically labeled as described (3).  Briefly, E. coli BL21 (DE3) 
DNAY cells expressing SipD39-343 were grown in 1 L M9 minimal media at 37 oC with aeration.  
At OD600 ~ 0.4, the growth medium was supplemented with 100 mg of 2-ketobutyric acid-4-13C 
sodium salt hydrate (δ methyl group of Ile) and 100 mg of 2-keto-2-(methyl-13C)-butyric acid-4-
13C sodium salt (γ1 and γ2 methyl group of Leu and Val) (Sigma Aldrich) dissolved in sterile 
water.  Recombinant protein expression was induced with 1 mM IPTG at OD600 ~ 0.6-0.8 and 
cell growth was continued overnight at 15 oC.    
2.2.  Protein crystallization & Data collection 
2.2.1.  Free SipD39-343 and SipD39-343 bound to bile salts - About 20 mg/ml of WT and C244S 
SipD39-343 in buffer (20 mM Tris-HCl pH 8.0, 196 mM NaCl) were screened for crystallization 
using Compact Jr (Emerald Biosystems) sitting drop plates with 0.75 µl of protein and 0.75 µl 
crystallization solution, equilibrated in 100 µl of crystallization solution (Hampton Research).  
WT SipD39-343 yielded crystals in Hampton Research index screen condition 69 (25% (w/v) PEG 
3350, 100 mM Tris-HCl pH 8.5, 200 mM (NH4)2SO4) and C244S SipD39-343 yielded crystals in 
Index screen condition 45 (25% (w/v) PEG 3350, 100 mM Tris-HCl pH 8.5).  Crystallization 
was observed in ~ 24 hours at 20 oC.  Single crystals were added to cryoprotectant solution (25% 
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(w/v) PEG 3350, 100 mM Tris-HCl pH 8.5 and 10% glycerol) and flash cooled in presence of 
15-20% glycerol.   
C244S SipD39-343 was co-crystallized with bile salt deoxycholate by mixing 1 µl of 400 mM 
sodium deoxycholate (Amresco) dissolved in buffer (20 mM Tris-HCl pH 8.0, 196 mM NaCl) 
with 100 µl of 0.3 mM C244S SipD39-343 and incubating on ice for ~ 30 minutes.  The C244S 
SipD39-343-deoxycholate mixture was screened for crystallization in hanging drops containing 1.5 
µl C244S SipD39-343-deoxycholate and 1.5 µl of crystallization solution in presence of 600 µl of 
reservoir volume at 25 oC.  Initial crystals grew in 12 days in 0.2 M magnesium formate 
dihydrate and 20% (w/v) PEG 3350.  Diffraction quality crystals were obtained in 8 days in an 
optimized crystallization solution containing 0.2 M magnesium formate dihydrate and 15% PEG 
3350.  Crystals of WT SipD39-343 bound to bile salt chenodeoxycholate were obtained by soaking 
crystals of WT SipD39-343 in 4 mM chenodeoxycholate (Sigma) dissolved in crystallization 
solution.  Crystals were soaked in 80% crystallization solution and 20% glycerol and flash 
cooled in liquid nitrogen before x-ray diffraction.     
2.2.2.  SipD131-343 - SipD131-343 was purified and crystallized by Anindita Basu (Graduate 
student) as part of her rotation project.  SipD131-343 concentrated to 40 mg/ml in buffer (196 mM 
NaCl, 20 mM Tris-HCl pH 8.0) was screened for crystallization at 20 oC in Compact Clover 
(Emerald BioSystems) sitting drop vapor diffusion plates using 0.75 µl of protein and 0.75 µl of 
crystallization solution equilibrated against 75 µl of the latter.  Prismatic crystals were obtained 
in approximately 4 days from the Salt Rx screen condition B3 (Hampton Research, 1.0 M 
ammonium citrate, 100 mM sodium acetate pH 4.6).  Single crystals were transferred to a fresh 
drop of cryoprotectant solution containing 80% crystallization solution and 20% glycerol.   
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2.3.  Crystal structure determination 
2.3.1.  Free SipD39-343 and SipD39-343 bound to bile salts - X-ray diffraction data were 
collected by Kevin Battaile (Argonne National Laboratory) and the crystal structure was solved 
by Scott Lovell (Director, Protein structure Laboratory at the University of Kansas).  Diffraction 
data were collected at the Advanced Photon Source (APS) beamline 17BM (IMCA-CAT) to 1.9 
Å using an ADSC Q210 CCD detector.  Diffraction data were integrated and scaled with the 
HKL2000 package (4).  A C-centered orthorhombic or a C-centered monoclinic lattice with a β-
angle  ~ 90o, was obtained for the SipD39-343-deoxycholate crystals.  The correct space group 
(C2) was determined by checking the Laue class using POINTLESS (5).  The asymmetric unit 
contained two molecules of SipD39-343 having a solvent content of 46.2% and Vm of 2.3 Å3/Da.  
The self-rotation function was calculated with POLARRFN (6) using data from 15 Å – 3.5 Å 
resolution and an integration radius of 20 Å resulting in a peak on the κ = 180o section at ω = 
49.1o, and ϕ = 180o corresponding to a 2-fold non-crystallographic axis.  Structure solution was 
achieved by molecular replacement using the program Phaser (7).  The pathogenicity island 1 
effector protein from Chromobacterium violaceum (PDB id: 2P7N), sharing 50% sequence 
identity with SipD, was used as the search model and the program Chainsaw (6) was used to 
generate the homology model.  Rotation and translation searches were performed to obtain a 
clear solution for two molecules in the asymmetric unit.  Initial refinement converged at R = 
42% and Rfree = 46%.  Automated model building using ARP/wARP (8) and successive rounds 
manual model building followed by refinement with Coot (9) and REFMAC (10) were 
performed to further improve the structure.  A cloning artifact of residues Gly-36, His-37, and 
Met-38 was fitted into the residual electron density.  Further, a Ni+2 ion, possibly acquired during 
protein purification, was coordinated in a square planar arrangement to residues Gly-36 and His-
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37 of molecule A, and His-40 of another molecule A related by crystallographic 2-fold 
symmetry.  The structures of WT SipD39-343, C244S SipD39-343, and SipD39-343 bound to 
chenodeoxycholate were solved by molecular replacement using MOLREP (11) and the protein 
portion of the refined structure of SipD-deoxycholate as the homology model.  MolProbity (12) 
and PyMOL (13) were used to validate and analyze the structures.   
2.3.2.  SipD131-343 - Data collection and structure solution was performed by Scott Lovell.  X-
ray diffraction data were collected at 93K using a Rigaku RU-H3R rotating anode generator (Cu-
Kα) equipped with Osmic Blue focusing mirrors and a Rigaku R-axis IV++ image plate detector.  
Diffraction data were integrated and scaled with XDS (14) and Scala (5) respectively.  The Laue 
class was checked with POINTLESS (5), which indicated that 6/mmm was most probable and 
the possible space groups were P6122 or P6522.  Based on the calculated molecular weight of 
23,434 Da, the Matthew’s coefficient (15) was 2.86 with a solvent content of 57% and one 
molecule in the asymmetric unit.  Structure solution was carried out by molecular replacement 
with Phaser (7) using the free WT SipD39-343 structure as the search model (PDB: 3NZZ) (16) 
with N-terminal residues up to Glu-133 removed.  All possible chiral space groups in the Laue 
class 6/mmm were tested and the highest score was obtained for P6122.  Automated model 
building was conducted with ARP/wARP (8) followed by manual model building and refinement 
with Coot (9) and PHENIX (17) respectively.  Disordered side chain residues were truncated to 
the point to which electron density could be observed.   Structure validation was conducted with 
MolProbity (12).   
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2.4.  CD spectroscopy and thermal Denaturation      
CD spectra were acquired using a JASCO J-815 Spectropolarimeter.  Typical CD samples 
were prepared with 1 – 2 µM of protein in either distilled water or buffer (5 mM sodium 
phosphate pH 7.0, 5 mM NaCl).  Initially, the CD of a blank sample containing only buffer or 
distilled water was measured and subtracted from the protein spectrum.  Subtraction of the blank 
did not have any effect on the CD spectrum of the protein and therefore, this step was omitted in 
later experiments.  CD spectra were acquired in triplicate at 20 oC with a scan rate of 50 
nm/minute.  Thermal denaturation scans were performed by measuring the ellipticity at 222 nm 
over a temperature range of 20 oC to   80 oC and a temperature ramp rate of 2 oC/minute.  CD 
values in ellipticity (mdeg) were converted to molar ellipticity (θ = degcm2/dmole) by using the 
formula θ = {mdeg ✕ molecular weight (daltons)} / {concentration (mg/ml) ✕ 10}.  The melting 
temperature (Tm) was calculated using the JASCO CD software.   
2.5.  NMR Spectroscopy 
2.5.1.  Two dimensional NMR spectra of SipD - Two-dimensional 1H-15N-TROSY (18) 
spectra of SipD39-343, SipD39-338, SipDΔ186-189, and SipDΔ187-188 were acquired using 0.8 mM of 
protein dissolved in buffer (10 mM sodium phosphate pH 7.0, 10 mM NaCl, 5% D20).  All NMR 
data were collected at 25 oC in a Bruker Avance 800 MHz spectrometer equipped with a 
cryogenic triple resonance probe (unless otherwise mentioned).  Typical acquisition parameters 
were 40 scans, 30 ppm 15N sweep width centered at 118 ppm, 2048 1H complex points, and 160 
15N complex points.  NMR data were processed using NMRpipe (19) and analyzed using 
NMRview (20). 
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2.5.2.  NMR titrations of 15N-SipD39-343 with unlabeled SipB82-312 - 15N-SipD39-343 was titrated 
with unlabeled SipB82-312 using 0.2 mM 15N-SipD39-343 dissolved in buffer (10 mM sodium 
phosphate pH 7.0, 100 mM NaCl, 10% D20).   Five molar ratios of SipD to SipB of 1:0, 1:0.5, 
1:1, 1:2, and 1:3 were used to acquire 1H-15N-TROSY (18) spectra at 30 oC with 48 scans, 30 
ppm 15N sweep width centered at 118 ppm, 2048 1H complex points, and 260 15N complex 
points.  Previously reported backbone assignments (1) were used to calculate the intensity ratios 
for 182 non-overlapping peaks of SipD39-343.  
2.5.3.  Dilution experiments and NMR titrations of 15N-MxiHV68A-V70A with unlabeled IpaD - 
MxiHV68A-V70A was titrated with IpaD38-332 and IpaD130-332 using 0.4 mM 15N-MxiHV68A-V70A 
dissolved in NMR buffer (10 mM sodium phosphate pH 7.0, 10 mM NaCl, 10% D20).  Molar 
ratios of 15N-MxiHV68A-V70A to IpaD of 1:0, 1:0.25, 1:0.5, 1:1, and 1:2 were used to acquire five 
1H-15N-HSQC (21) spectra.  The dilution experiments were acquired with progressively 
decreasing concentrations (1.8 mM, 0.9 mM, 0.6 mM, 0.3 mM, and 0.125 mM) of 15N-
MxiHV68A-V70A dissolved in NMR buffer.  1H-15N-HSQC (21) spectra were acquired at 25 oC 
with 12 scans, 20 ppm 15N sweep width centered at 118 ppm, 2048 1H complex points, and 128 
15N complex points.  The backbone resonances of MxiH-V68A-V70A were assigned in order to 
analyze the results of NMR titrations and dilution experiments.  The backbone resonances of 
MxiHV68A-V70A were completed using 3D-HNCA (22), and 3D-CBCA(CO)NH (22) datasets 
acquired on 1.5 mM 15N,13C-MxiHV68A-V70A dissolved in NMR buffer.   
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2.6.  Paramagnetic relaxation enhancement 
2.6.1.  Spin labeling of SipB82-312, IpaD38-332, and IpaD130-332 – Specific residues on SipB82-
312, IpaD38-332, and IpaD130-332 were mutated to cysteine in order to attach a (1-Oxyl-2,2,5,5-
tetramethyl-∆3-pyrroline-3-methyl) methanethiosulfonate  (MTSL) as the spin label.  Proteins to 
be spin labeled were dialyzed in PRE buffer (20 mM sodium phosphate pH 7.0, 20 mM NaCl) 
along with 5 mM DTT to inhibit the formation of intermolecular disulfide bonds.  Prior to 
addition of MTSL, the DTT was removed by passing 500 µl of the protein solution through a 
NAP5 column (GE Healthcare) equilibrated with PRE buffer and eluted with 1000 µl PRE 
buffer.  The MTSL (10 mg) was dissolved in 250 µl acetone to make a 150 mM stock solution.  
50 µl of the MTSL stock solution was added to 1 ml of ~ 0.6 mM protein (~ 10✕ molar excess of 
MTSL).  The protein-MTSL solution was incubated overnight in the dark at room temperature.  
Excess MTSL was removed by passing the protein-MTSL solution through another NAP5 
column.  The resultant spin-labeled protein was concentrated when needed and Electrospray 
ionization mass spectroscopy (ESI-MS) was used to confirm the successful attachment of the 
spin-label to the protein. 
2.6.2.  Single time point PRE using 15N-specifically labeled SipD39-343 and SipB82-312 - PRE 
was determined by using the single time point method (23).  Identical 2D-NMR spectra were 
collected for a diamagnetic (protein without the spin-label) and a paramagnetic (protein labeled 
with MTSL) sample and PRE was determined from the intensity ratio Ipara/Idia for each non-
overlapping peak.  2D-1H-15N-HSQC (21) (AIKM SipD39-343) or 2D-1H-15N-TROSY (18) (Leu-
SipD39-343) datasets were acquired with 0.8 mM 15N-specifically labeled SipD39-343 and 0.4 mM 
unlabeled (Diamagnetic) or spin-labeled (paramagnetic) SipB82-312.  Protein concentration, buffer 
conditions, and acquisition parameters were identical for the diamagnetic and paramagnetic 
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datasets.  The backbone resonances of AIKM-SipD39-343 and Leu-SipD39-343 were derived from 
the published backbone resonances of 15N-SipD39-343 (1).  The 1H-15N-HSQC (21) spectra were 
acquired at 25 oC with 24 scans, 18 ppm 15N sweep width centered at 124 ppm, 2048 1H complex 
points, and 160 15N complex points.  1H-15N-TROSY (18) spectra were acquired at 30 oC with 32 
scans, 17 ppm 15N sweep width centered at 121.5 ppm, 2048 1H complex points, and 120 15N 
complex points.   
2.6.3.  Single time point PRE using 15N-MxiHCΔ5 and IpaD38-332 or IpaD131-332 - NMR spectra 
was acquired at 25 oC with a Bruker Avance 600 MHz spectrometer equipped with an inverse 
triple resonance probe.  Initially, PRE experiments were conducted with 0.4 mM of 15N-
MxiHV68A-V70A and 0.4 mM of IpaD.  However, full-length MxiH, equimolar protein ratios, and 
high protein concentrations produced a non-specific PRE effect due to protein oligomerization 
on MxiH residues irrespective of the position of the spin label on IpaD.  Therefore, for later 
experiments, 0.1 mM 15N-MxiH1-78 and 0.05 mM IpaD39-332 or IpaD130-332 were used. 
2.7.  HADDOCK modeling of the SipD39-343– SipB82-226 complex 
Results from NMR titrations of 15N-SipD39-343 with SipB82-312 and paramagnetic relaxation 
enhancement were used to generate a structural model of the SipD39-343 and SipB82-226 complex 
using the HADDOCK webserver (24).  The HADDOCK webserver required a list of active and 
passive residues for both SipD39-343 and SipB82-226.  Active residues are directly involved in 
binding and passive residues are adjacent to the active residues and are indirectly involved in 
binding.  The surface exposed residues showing the largest decrease in peak intensity upon 
titration with SipB82-312 were defined as the active residues for SipD39-343.  Spin labels on helices 
α3 and α4 of SipB82-312 produced the strongest PRE effect on SipD39-343.  However, because helix 
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α4 was absent in the crystal structure of SipB82-226, surface exposed residues on helix α3 were 
defined as active residues for SipB82-226.  Active residues for SipD39-343 and SipB82-226 are listed 
in Table 4.  The docking was performed according to default parameters and 200 models of the 
SipD39-343-SipB82-226 complex were generated.      
2.8.  Salmonella invasion assay 
2.8.1.  Construction of knockout strains of S. tyhphimurium - The lambda Red recombinase 
method (25) was used to generate sipD (sipD-) and sipB (sipB-) nonpolar knockout strains of S. 
typhimurium.  Knockout strains of S. typhimurium were made by Dalian Zhong.  A linear DNA 
segment containing a chloramphenicol resistance gene sandwiched between the regions flanking 
sipD/sipB was added to S. typhimurium in the presence of lambda Red recombinase.  
Homologous recombination between the sipD/sipB flanking sequences in the linear segment and 
the bacterial genome causes the replacement of sipD/sipB with the chloramphicol resistance gene 
creating a sipD-/sipB- S. typhimurium strain, which is resistant to chloramphenicol.  Plasmids 
pKD3 (containing chloramphenicol resistance gene) and pKD46 (containing genes for lambda 
Red-mediated recombination) were sourced from the E. coli Genetic Stock Center (Yale 
University) and the WT S. typhimurium SL1344 strain was a kind gift from Dr. Bradley Jones 
(University of Iowa).  The linear DNA segment was PCR amplified from pKD3 using primers 
containing sequences complementary to the chloramphenicol resistance gene and the sipD/sipB 
flanking regions.  Meanwhile, the temperature-sensitive plasmid pKD46 was electroporated into 
WT S. typhimurium SL1344 strain and grown at 30 oC.  The linear DNA segment was then 
electroporated into the SL1344/pKD46 strain and grown at 37 oC to expel the pKD46 plasmid.  
Successfully transformed colonies with the null mutation were selected against chloramphenicol 
resistance and confirmed by PCR and DNA sequencing.  WT or point mutants of sipD/sipB were 
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subcloned into the rescue plasmid pRK2 using Nde1 and Sal1 restriction sites and electroporated 
into sipD-/sipB- strains of S. typhimurium.  Bacterials strains (sipD- and sipB-) stably expressing 
WT or mutant sipD/sipB were stored at -80 oC in 10% glycerol. 
2.8.2.  Salmonella invasion assay - The Salmonella invasion assay was used to test whether 
mutations in sipD/sipB affected the ability of S. typhimurium to invade intestinal epithelial cells.  
Single colonies of the bacterial strains were grown overnight in 10 ml LB-broth containing 25 
mg/L Trimethoprim, 50 mg/L Ampicillin, and 25 mg/L Chloramphenicol, and grown overnight 
without aeration at 37 oC.  The overnight culture was diluted 1:10 in LB containing 1 mM IPTG 
and grown until OD600 was ~ 0.4.  For the Salmonella invasion assays with bile salts, increasing 
concentrations of deoxycholate or chenodeoxycholate were added to the growth medium at this 
stage.  Henle-407 cells (American Type Culture Collection CCL-6) were grown in 24 well plates 
in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum at 37 oC and 5% 
CO2.  A 1:4 dilution (15 ml to 60 ml) of a confluent 75 cm2 flask was used to seed the 24 well 
plates.  Prior to addition of bacterial cultures, each well was washed with 500 µl of DMEM.  
Bacterial cultures (10 µl/well) were added to Henle-407 cells in 300 µl DMEM and incubated at 
37 oC for 1 hour.  After 1 hour, wells were washed three times with 500 µl DMEM containing 
5% fetal bovine serum and 100 mg/L Gentamicin and incubated for 1.5 hours in the same 
medium to kill any extracellular bacteria.  Intracellular bacteria were protected from the 
antibiotic, as it could not be permeabilized.  Following antibiotic treatment, wells were rinsed 
with 500 µl fresh DMEM and cells were lysed in 200 µl 1% Triton X-100 dissolved in 1Χ PBS.  
The cell lysate was serially diluted (1:10) and 100 µl of the third dilution was spread on an LB-
agar plate and incubated overnight at 37 oC.  Percent invasiveness was calculated by counting the 
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number of colonies on each plate.  The sipD-/sipB- strain with WT sipD/sipB (in pRK2) was 
considered the positive control and denoted 100% invasiveness.    
2.9.  Immunoblotting 
2.9.1.  Affinity purification of antibodies - The expression of SipD and SipB (carrying point 
mutations) was tested by immublotting of proteins secreted by various strains of S. typhimurium 
with anti-SipD and anti-SipB antibodies.  Antisera against purified recombinant SipD39-343 (rat) 
and SipB82-312 (rabbit) were obtained from the Proteintech Group Inc. (Chicago, USA).  The 
AminoLink kit (Thermo scientific) was used to purify polyclonal anti-rat SipD39-343 and anti-
rabbit SipB82-312 antibodies from the antisera.  Purified antibodies were dialyzed in 1✕ PBS with 
0.05% sodium azide and 50% glycerol (v/v) was added after dialysis.  Aliquots containing 50 µl 
of purified antibodies were stored at  -20 oC and concentration was estimated by measuring 
absorbance at 280 nm (MW ~ 150 kD and molar extinction coefficient ~ 210,000 M-1 cm-1). 
2.9.2.  Extraction of T3SS proteins secreted into the growth medium - LB-agar plates with 
appropriate antibiotics (chloramphenicol for sipD-/sipB-, trimethoprim for strains containing 
pRK2) were streaked with S. typhimurium strains from a glycerol stock and incubated overnight 
at 37 oC.  A single colony was used to inoculate 10 ml LB containing 0.3 M NaCl (1 LB: 10 gm 
tryptone, 5 gm yeast extract, 17.53 gm NaCl, pH 7.0) and grown overnight at 37 oC with shaking 
at <150 rpm.  Overnight cultures were diluted 1:10 in fresh LB (0.3 M NaCl) containing a final 
concentration of 1 mM IPTG and bacteria were grown until OD600 ~ 1.0 was reached.  Cell 
pellets were collected by centrifugation at 4000 rpm (3220 xg) at 4 oC for 40 minutes.  Proteins 
extracted from the growth medium and the intact cell pellets were subjected to SDS-PAGE and 
immunoblotting.  Cell pellets were resuspended in 1 ml of 1Χ PBS and transferred to a 1.7 ml 
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eppendorf tube and centrifuged at 13,000 rpm (16060 xg) at 20 oC for 15 minutes.  The 
supernatant was discarded and pellets were resuspended in ~ 20 µl 1Χ PBS.   
The growth medium was passed through a 0.45 µ filter and treated with 1 ml of 10% 
Trichloroacetic acid (TCA) and incubated on ice for 1 hour.  Precipitated proteins were pelleted 
by centrifugation at 4000 rpm (3220 xg) at 4 oC for 40 minutes.  The supernatant was discarded 
and pellets were resuspended in 200 µl of 2% SDS solution and the volume was made up to 10 
ml with acetone. The acetone solution was incubated overnight at -20 oC.  The following day the 
acetone solution was centrifuged for 40 minutes at 4000 rpm (3220 xg) at 4 oC.  The supernatant 
was discarded and the pellets were air-dried.  Samples for SDS-PAGE were prepared by adding 
8M Urea (100 µl) and 2Χ SDS sample buffer (100 µl) to the pellets.  The remaining 5 µl of 
untreated cell pellets in 1Χ PBS was mixed with 50 µl 2Χ SDS sample buffer and all the samples 
were subjected to SDS-PAGE.   
2.9.3.  Extraction of T3SS proteins from bacterial cytoplasm - Cytoplasmic proteins were 
extracted by treating the bacterial cells with lysis buffer (20 mM Tris-HCl pH 8.0, 100 mM 
NaCl, 1 mM EDTA, 0.5 mg/ml Lysozyme, 1 mM PMSF, and 0.1% TritonX).  A portion (15 µl) 
of the cell pellets in 1Χ PBS was resuspended in 1ml Lysis buffer and incubated on ice for 30 
minutes followed by centrifugation at 13,000 rpm (16060 xg) at 20 oC for 10 minutes.  The 
supernatant was treated with 100 µl of 10% TCA and incubated on ice for 1 hour followed by 
centrifugation at 13,000 rpm (16060 xg) for 15 minutes at 20 oC.  The pelleted cytoplasmic 
proteins were resuspended in 15 µl of 2% SDS and the volume was made up to 1 ml with 
acetone.  The acetone solution was centrifuged for 15 minutes at 13,000 rpm (16060 xg) at 20 oC 
and treated similar to that obtained from the growth medium.  
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2.9.4.  Transfer of proteins to a nitrocellulose membrane - A semi-dry blotter (Amersham) 
was used to transfer proteins from the polyacrylamide gel to a nitrocellulose membrane.  The 
gels were removed from the cast, trimmed and stored in transfer buffer (25 mM Tris-HCl pH 8.0, 
192 mM glycine, 7.5 % methanol, 0.1% SDS).  Nitrocellulose membranes were trimmed 
according to size of the gels and soaked in methanol for 15 seconds, followed by a rinse in 
distilled water and then soaked in transfer buffer.  A sandwich of blotting papers-gel-
nitrocellulose membrane-blotting paper was prepared and placed on the blotter.  A small quantity 
of transfer buffer was placed on the sandwich and blotting was conducted at 70 mA for 1.15 
hours.   
2.9.5.  Membrane blocking and protein detection - Once the transfer was complete, the 
nitrocellulose membranes were incubated in 5% non-fat dry milk dissolved in water for 1 hour.  
Blots were incubated overnight in the primary antibodies (50 µl polyclonal anti-rat SipD39-343 and 
17 µl anti-rabbit SipB82-312) dissolved in 50 ml buffer (1% non-fat dry milk, 0.1% Tween-20, 1Χ 
TBS) at 4 oC.  The following day, the blots were subjected to three consecutive 30 minutes 
washes in wash buffer (0.1% Tween-20, 1Χ TBS).  The blots were incubated in 5 µl anti-rat IgG 
(1: 10,000 dilution of IrDye 680LT) and 2.5 µl anti-rabbit IgG (1:20,000 dilution of IRDye 
800CW) dissolved in 50 ml wash buffer for 1 hour at room temperature.  After incubation in the 
secondary antibodies, blots were rinsed in wash buffer again for three consecutive 30-minute 
periods.  Finally, the blots were placed in 1Χ PBS and visualized with Licor Odyssey imaging 
system.          
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CHAPTER 3: The crystal structure of the Salmonella tip protein SipD 
3.1.  Introduction  
Salmonella typhimurium causes Salmonellosis, one of the most common food-borne illnesses 
in humans worldwide.  The pathogenesis of Salmonella is dependent on the T3SSs encoded 
within the SPI-1 & SPI-2, which manipulate the host cellular machinery by delivering bacterial 
effectors directly into the host cell cytoplasm (1).  The SPI-1 T3SS is required for bacterial entry 
into non-phagocytotic cells of the human intestinal epithelium (2), while the SPI-2 T3SS is 
required for intracellular survival and replication of Salmonella (3).  Bacterial effectors delivered 
by the SPI-1 T3SS induce host actin cytoskeletal rearrangement, which in turn leads to 
membrane ruffling and bacterial uptake (2).  The T3SS is critical for the infectivity of 
Salmonella because non-functional mutations in the genes coding for T3SS proteins abolish the 
ability of Salmonella to invade eukaryotic cells (4).    
The structural component of the T3SS known as the needle apparatus consists of a basal 
complex that spans the inner and outer bacterial membranes, a needle, a tip complex, and a 
translocon [Figure 3-1].  The base, the needle, and the tip complex are assembled sequentially 
(5).  However, secretion of the translocon and effectors is blocked by the tip complex until 
specific environmental signals are received (5).  Specific cues including contact with the host 
cell (6) trigger the secretion of the translocon proteins, which assemble on the tip complex to 
form a functional translocon (6).  The translocon forms a pore in the host cell membrane through 
which the effectors are translocated into the host cell cytoplasm (7).  The tip complex is therefore 
multifunctional; it receives environmental stimuli and regulates the secretion of   
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Figure 3-1: A cartoon model showing the structural and functional components of the type III 
secretion system (T3SS).  The structural component is the needle apparatus, which consists of 
the base, needle, tip complex, and the translocon.  The functional components include the 
effectors and their cognate chaperones 
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translocon proteins and effectors.  The tip complex  also acts as a structural platform for the 
assembly of the translocon.  The tip complex is composed of several copies of the tip protein 
SipD (6) in Salmonella typhimurium, IpaD (8) in Shigella flexneri, BipD (9) in Burkholderia 
pseudomallei, LcrV (10) in Yersinia pestis, and PcrV (11) in Pseudomonas aeruginosa.  
  The tip proteins are highly α-helical and range from 32-37 kD in size.  IpaD and BipD have 
elliptical shapes and they contain a central coiled coil, a C-terminal domain of mixed α-helices 
and β-sheets, and an N-terminal α-helical hairpin [Figures 3-10B and C].  LcrV also contains 
the central coiled coil but lacks the N-terminal α-helical hairpin and adopts a dumbbell-like 
shape due to the globular domains on either side of the coiled coil [Figure 3-10A].  Moreover, 
LcrV and PcrV are chaperoned by the small cytoplasmic proteins LcrG and PcrG respectively 
(12).  The presence of the N-terminal α-helical hairpin domain and the absence of cognate 
chaperones has led to the hypothesis that IpaD and BipD are self-chaperoned by the N-terminal 
α-helical hairpin (13).  
The T3SSs of Salmonella, Shigella, and Burkholderia belong to the SPI-1 family of injectisomes 
(1) and the amino acid sequence of SipD is 36% identical and 50% similar to IpaD, and 22% 
identical and 36% similar to BipD.  Therefore, SipD is expected to share a closer resemblance to 
IpaD and BipD rather than LcrV and PcrV, which belong to the Ysc family of injectisome (1).  
The structure of SipD however was unknown.  Here the crystal structures of SipD in the 
presence and absence of the N-terminal α-helical hairpin domain are reported.  The atomic 
structures of SipD are useful in understanding the molecular mechanisms underlying the 
assembly of the tip complex and the translocon as well as the regulation of the T3SS of 
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Salmonella.  This knowledge will ultimately advance the development of novel therapeutics to 
target the T3SS.   
3.2.  Results 
3.2.1.  Protein expression and purification - The N-terminal 30-38 residues were disordered in 
the crystal structures of IpaD and BipD.  Therefore, the first 38 residues of SipD were truncated 
to generate SipD39-343.  IpaD and BipD also shared the N-terminal α-helical hairpin, which is 
hypothesized to be a self-chaperone for the tip proteins (13).  In order to test the effect of 
deletion of the self-chaperoning domain on the three-dimensional structure of SipD, residues 1- 
130 were truncated to yield SipD131-343.  The single cysteine residue in SipD was mutated to 
serine (C244S) to reduce the formation of intermolecular disulfide bonds.  Wild-type and C244S 
SipD39-343 and SipD131-343 were expressed in E. coli BL21 (DE3) DNAY cells with a GB1 tag 
fused to the N-terminus to enhance the expression levels and solubility of the recombinant 
protein.  The GB1 tag also contained His6 residues at the N-terminus to aid in protein 
purification by Ni+2-affinity chromatography [Figure 3-2].  A tobacco etch virus (TEV) protease 
site was placed after the His6-GB1 tag to obtain purified SipD after digestion with TEV protease.   
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Figure 3-2. SDS-PAGE showing the purification of SipD39-343 by Ni+2-affinity chromatography.  
Lane 1 shows the E. coli cell pellet.  Lane 2 shows E. coli supernatant before purification.  Lane 
3 shows purified SipD39-343 fused to His6-GB1 tag.  Lane 4 shows purified SipD39-343 after TEV 
digestion and without the His6-GB1 tag.  
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3.2.2.  Crystal structure of SipD39-343 - Crystals of WT and C244S SipD39-343, belonging to C2 
space group, grew within a day in sitting drop vapor diffusion plates [Figure 3-3].  Diffraction 
data was processed and refined to 1.7 Å for WT SipD39-343 and 1.9 Å for C244S SipD39-343 
[Table 4].  The asymmetric unit contained two molecules (A and B) in both WT and C244S 
SipD39-343.  Molecule A contained residues 36 to 342 and molecule B contained residues 47 to 
336 (WT) or 47 to 334 (C244S).  Residues Gly-36, His-37, and Met-39 were part of the cloning 
artifact.  A Ni+2 ion was coordinated within residues Gly-36 and His-37 of molecule A and His-
40 from a symmetry mate of molecule A.  This interaction might be important in crystal packing.  
The three-dimensional structure of SipD39-343 was highly α-helical with 62% of residues within 
eight α-helices (α1- α8) while, 6% of the residues formed five β-strands (β1- β5) and the 
remaining residues made up the random coils or disordered regions.  The overall structure of 
SipD39-343 could be divided into an N-terminal α-helical hairpin (α1 & α2), followed by a short α-
helix (α3), a long coiled coil (α4 & α8), and a C-terminal region containing three α-helices (α5, 
α6, and α7) and two β-strands (β3 & β4) [Figure 3-4].  A three-stranded antiparallel β-sheet (β1, 
β2, & β5) was present at the arbitrary “top” of SipD39-343 as depicted in Figure 3-4.  A loop 
region (residues 110 to 132) connecting the short helix α3 to helix α4 was disordered in both the 
molecules of WT and C244S SipD39-343 [Figure 3-4].  Additionally, C244S SipD39-343 was 
missing electron density for residues 219 to 221 (molecule B), which were part of the mixed α/β 
region.  The coiled coil divided SipD into a concave face and a convex face.  The concave face 
of the coiled coil was in contact with the N-terminal α-helical hairpin, at the arbitrary “bottom” 
of SipD39-343 (α1 & α2).  The convex face of the coiled coil was in contact with helix α3 and the 
disordered loop region (residues 110-132) [Figure 3-4].   
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Figure 3-3: Crystals of WT SipD39-343 (A), C244S SipD39-343 (B), and SipD131-343 (C) grew in 
sitting drop plates in Hampton research index screen condition 69, index screen condition 45, 
and Salt Rx screen condition B3 respectively. 
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Table 4. Crystallographic statistics for WT and C244S SipD39-343 and SipD131-343 
 WT SipD39-343 C244S SipD39-343 SipD131-343 
PDB ID 3NZZ 3O00 - 
Data collection 
   Unit-cell parameters (Å,o) 
       
 
 
    Space group 
Resolution rangea 
 
Wavelength (Å) 
Temperature (K) 
Observed reflections 
Unique reflections 
Mean <I/σ(I)>a 
Completeness 
Redundancya 
Rmerge (%)a,b 
 
a = 203.06 
b = 52.25 
c = 57.52 
β = 90.05 
C2 (No. 5) 
50.0-1.65  
(1.71-1.65) 
1.0000 
100 
256,708 
69,282 
39.2 (1.9) 
95.5 (76.1) 
3.7 (3.0) 
4.4 (49.6) 
 
a = 203.35 
b = 52.15 
c = 57.56 
β = 90.45 
C2 (No. 5) 
50.0-1.85  
(1.92-1.85) 
1.0000 
100 
195,676 
50,006 
36.1 (3.5) 
97.0 (81.6) 
3.9 (3.3) 
5.3 (32.4) 
 
a = 76.54 
c = 158.57 
 
 
P6122 
28.61-2.10  
(2.21-2.10) 
1.5418 
93 
229,573 
16,824 
22.5 (4.5) 
100.0 (100.0) 
13.6 (13.7) 
12.0 (67.6) 
Refinement 
Resolution (Å) 
Reflections (working/test) 
Rfactor/Rfree (%)c 
No. of atoms (protein  
A:B)/Ni2+/ligand/water) 
 
25.35 – 1.65 
62,042/3,296 
19.7/23.7 
2,190:2,018/1/348 
 
32.07 – 1.85 
46,099/2,477 
19.5/24.6 
2,186:2,019/1/297 
 
28.61-2.10 
15,906 / 850 
19.7 / 23.2 
1,156 / 12 / 92 
Model quality 
R.m.s deviations 
Bond lengths (Å) 
Bond angles (o) 
Average B factor (Å2) 
All atoms 
Protein (chain A/B) 
Ni2+ 
Glycerol 
Water 
Coordinate error based on  
maximum likelihood (Å) 
Ramachandran plot 
Most favored (%) 
Additionally allowed (%) 
 
 
0.014 
1.478 
 
29.6 
29.0 / 29.2 
22.0 
- 
35.4 
0.25 
 
 
99.1 
0.9 
 
 
0.015 
1.461 
 
29.7 
28.6 / 30.3 
21.3 
- 
34.0 
0.26 
 
 
98.9 
1.1 
 
 
0.013 
1.286 
 
28.0 
29.4 
- 
45.3 
32.6 
0.17 
 
 
99.0 
1.0 
a Values in parentheses are for highest resolution shell 
b Rmerge = ShklSi |Ii(hkl) - <I(hkl)>| / ShklSi Ii(hkl), where Ii(hkl) is the intensity measured for the ith 
reflection and <Ii(hkl)> is the average intensity of all reflections with indices hkl. 
c Rfactor = Shkl ||Fobs (hkl) | - |Fcalc (hkl) || / Shkl |Fobs (hkl)|; Rfree is calculated in an identical manner using 
5% of randomly selected reflections that were not included in the refinement 
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Figure 3-4: Structure of SipD39-343 showing the two molecules in the asymmetric unit.  The N-
terminal α-helical hairpin is colored yellow, the coiled coil is colored gray, and the mixed α/β 
region is colored cyan.  The location of the C244S point mutation is shown as a red sphere. 
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The two molecules of SipD39-343 were held together by intermolecular interactions between helix 
α1 of molecule A, which packs on top of helix α3 of molecule B.  Hydrogen bonding between 
residues in the N-terminal α-helical hairpin of molecule A and the mixed α/β region of molecule 
B may also be important for the dimerization of SipD39-343.            
3.2.3.  Crystal structure of SipD131-343 - The structure of WT SipD39-343 (residues 133 to 343) 
was used as a search model to solve the structure of SipD131-343 by molecular replacement.  The 
2.1 Å resolution crystal structure of SipD131-343 contained one molecule in the asymmetric unit 
[Table 4].  The predominantly α-helical secondary structure and overall architecture of     
SipD39-343 was maintained even after the removal of the N-terminal α-helical hairpin [Figure 3-
5].  The molecule contained five α-helices (α4 - α8) and five β-strands (β1 - β5) divided into the 
central coiled coil, the three-stranded antiparallel β-sheet on the “top”, and the C-terminal mixed 
α/β region [Figure 3-5].  The electron densities for several regions were missing in the crystal 
structure of SipD131-343.  Notably, the C-terminal region following Ser-328 could not be 
visualized except for a three-residue (333-336) loop [Figure 3-5].  In addition, Nδ2 of Asn-141 
and the backbone NH group of Ser-247 coordinated two molecules of glycerol possibly obtained 
from the cryoprotectant solution.  
3.2.4.  Functional characterization of truncated forms of SipD - In order to determine which 
regions of the tip protein are important for T3SS function, the effect of four truncated forms of 
SipD on the ability of Salmonella to invade cultured human epithelial cells was tested.  Deletions 
were made in loop α3-α4, which is the loop region connecting helices α3 and α4 (SipDΔ116-124),  
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Figure 3-5: Structure of SipD131-343 showing the coiled coil (gray) and mixed α/β region in cyan.  
The N-terminal α-helical hairpin domain, which is lacking in the SipD131-343 construct, is shown 
as a transparent contour to show its relative position in SipD131-343.  
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the β-strand β2 (SipDΔ186-189 and SipDΔ187-188), and five residues from the C-terminus (SipDCΔ5) 
of SipD [Figure 3-7].  The 25-residue loop α3-α4 was disordered in the crystal structure of 
SipD39-343 but not in the homologous protein Shigella IpaD.  A flexible loop might be important 
in protein-protein interactions or in regulating the opening of the needle channel.  Thus, a nine-
residue deletion Δ116-124 was generated in order to test the importance of loop α3-α4 in the 
function of the T3SS.  The β-strand β2 is part of an antiparallel β-sheet that is conserved in tip 
proteins Shigella IpaD, Burkholderia BipD, and Yersinia LcrV.  Conserved structural motifs 
might play important functional roles [Figure 3-10].  Thus the β-strand β2 was selected for 
mutagenesis.   The extreme C-termini of the needle proteins Salmonella PrgI (14) and Shigella 
MxiH (15) are critical for the polymerization of the needle.  To test if the same principle applies 
to the tip proteins, five residues were deleted from the C-terminus of SipD.  In order to test the 
effect of these deletions on the invasiveness of Salmonella, an invasion assay was performed 
with a strain of Salmonella lacking SipD (sipD-), which was complemented with the rescue 
plasmid (pRK2) expressing either full length (sipD+) or truncated SipD.  The invasiveness of 
Salmonella expressing SipDΔ116-124 was comparable to that expressing full length SipD or the 
WT strain SL1344 [Figure 3-6].  In contrast, SipDΔ186-189, SipDΔ187-188, and SipDCΔ5 resulted in a 
drastic reduction in the invasiveness of Salmonella suggesting that these regions are important 
for the function of SipD [Figure 3-6].   
3.2.5.  Structural characterization of truncated forms of SipD - CD spectroscopy was used to 
assess the folding of the truncated forms of SipD.  WT and truncated SipD yielded CD spectra 
characteristic of proteins with highly α-helical secondary structures with minima at 208 nm and 
222 nm and a ratio of molar ellipticity at 222 nm and 208 nm (θ222/θ208) of ~ 1.0 [Figure 3-8A].  
However, thermal denaturation of SipDΔ186-189 and SipDΔ187-188 monitored by CD spectroscopy at  
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Figure 3-6: Results of Salmonella invasion assay performed with a WT Salmonella strain or that 
containing a non-polar knockout sipD- or sipD- harboring a rescue plasmid pRK2 coding for WT 
(sipD+) or mutant SipD.  C244S SipD and SipDΔ116-124 did not affect the invasiveness of 
Salmonella.  However, SipDCΔ5, SipDΔ186-189, and SipDΔ187-188 produced non-invasive 
phenotypes.  
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Figure 3-7: (A) Molecule A from the crystal structure of SipD39-343 shows the deletion CΔ5.  (B) 
Molecule B from the crystal structure of SipD39-343 shows the deletions Δ116-124, Δ186-189, 
and Δ187-188.  The four tryptophan residues W135, W177, W234, and W290 shown in (A) and 
(B) were used for structural characterization of the non-invasive SipD deletion mutants.    
77	  
	  
222 nm showed a single transition temperature of 63.4o as opposed to the two transition 
temperatures (47o and 70o) observed for WT SipD.  The different melting behavior of SipDΔ186-
189 and SipDΔ187-188 suggested conformational changes in the folding of these mutants [Figure 3-
8B]. 
The folding of the non-invasive mutants SipDΔ186-189, SipDΔ187-188, and SipDCΔ5 was further 
characterized using NMR spectroscopy.  All three forms of SipD showed 1H-15N-TROSY 
spectra characteristic of a folded protein and were comparable to that of WT SipD [Figure 3-9].  
Additionally, the side chain NMR resonances of the four tryptophan residues were used to assess 
the conformational changes in truncated SipD [Figure 3-9].  SipD contained four tryptophan 
residues located at different regions of the protein as depicted in Figure 3-7.  W135 was buried 
in a pocket at the bottom of the coiled coil formed by α-helices α1-3, α4, and α8.  W177 was 
located in between the C-terminal end of helix α4 and the N-terminal end of helix α5 and directly 
below the β-strand β2.  W234 was located at the middle of helix α6 and W290 was located at the 
N-terminal end of helix α8 and facing the mixed α/β region.  SipDΔ186-189 showed the most 
drastic deviation in the side chain resonance of W177 and W290 but the NMR resonances of the 
other two tryptophan side chains were unaffected suggesting local conformational changes in the 
chemical environment of around β2 [Figure 3-9B].   
3.3.  Discussion 
3.3.1.  Comparison with the structures of other tip proteins - The tip proteins assemble on the 
T3SS needle to form a tip complex, which functions to sense environmental stimuli and regulate 
the assembly of the translocon.  The structure of SipD was unknown prior to this work.  The 
crystal structure of the Salmonella tip protein SipD was determined at 1.9 Å resolution.   
78	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-8: (A) CD spectra of WT and deletion mutants of SipD.  The inset shows θ222/θ208 
ratios, which are close to 1.0 indicating extensive inter-helical contacts.  (B) Thermal 
denaturation curves of WT or deletion mutants of SipD over a temperature range of 20 oC to 90 
oC, monitored by measuring CD at 222 nm.  Inset shows the estimated transition temperatures 
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Figure 3-9:  1H-15N-TROSY spectra of SipD39-343 (A), SipDΔ186-189 (B), SipDCΔ5 (C), and 
SipDΔ187-188 (D).  The boxed regions show the tryptophan side chain resonances, which were 
reported previously (16).  SipDΔ186-189 showed a change in the side chain NMR resonance of 
W177. 
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Figure 3-10: Comparison of the structures of the T3SS tip proteins: Yersinia LcrV (10) (A), 
Burkholderia BipD (17) (B), Shigella IpaD (13) (C), Salmonella SipD (D), and the SipD 
homolog from Chromobacterium violaceum .  The N-terminal region was composed of the α-
helical hairpin (yellow) and short α-helices (green) in B-E but formed a globular domain (green) 
in A.  The coiled coil (gray) and the mixed α/β region (blue) were common to all the tip proteins.  
The antiparallel β-sheet at the top is colored red.  This region was disordered in E.  This figure 
was generated using PDB codes 1R6F (LcrV), 2IXR (BipD), 2J0O (IpaD), 3NZZ (SipD), and 
2P7N (Pathogenicity island-1 effector protein).   
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Figure 3-11: Differences in the packing of the helices α1-3 in SipD and IpaD.  In IpaD (red) the 
longitudinal axis of helices α1 and α2 was rotated 18o counter-clockwise (A) and that of helix α3 
was rotated 26o clockwise (B) in comparison to SipD (blue). 
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SipD was oblong in shape and retained the coiled coil motif of all tip proteins and closely 
resembled Shigella IpaD, Burkholderia BipD, and the SipD homolog from Gram-negative soil 
bacterium Chromobacterium violaceum [Figure 3-10].  The closest structural similarity of SipD 
was with the Shigella IpaD and the two tip proteins shared a backbone Cα rmsd of 1.4 Å (for 186 
Cα atoms).  There were however, subtle differences in how the helices of the N-terminal hairpin 
domain of the two tip proteins packed against their respective coiled coils [Figure 3-11].  For 
example, the longitudinal axis made by helices α1 and α2 was rotated 18o counter clockwise 
[Figure 3-11A] and the helix α3 was rotated 26o clockwise [Figure 3-11B] in IpaD as compared 
to SipD.  These differences might be significant in the overall structure of the assembled tip 
complex of Shigella and Salmonella.  
Lunelli et al. (18) recently reported the crystal structure of full length SipD containing four 
molecules (A to D) in the asymmetric unit.  Similar to the SipD structure reported herein, about 
30 to 40 residues from the N-terminus were disordered in their SipD structure, and molecules A 
and B in both structures aligned with a backbone Cα rmsd ~ 1 Å.  However, unlike the SipD 
structures reported herein, Thr-128 to Asp-147 of molecules C and D in their SipD structure 
packed against each other as bent α-helices and were oriented almost perpendicular to the 
longitudinal axis of helix α4 (18).  Furthermore, the electron densities for the N-terminal hairpin 
of molecules C and D were absent, and this was probably because this domain moved away to 
avoid steric clash with the bent helices at the bottom of helix α4 (18).  A similar feature was 
noted in the structure of SipD131-343 reported herein, where the disordered C-terminus (residues 
333-336) was bent compared to the longitudinal axis of helix α8 [Figure 3-5].  Although their 
functional significance is yet to be established, these observations highlight the conformational 
flexibility of the coiled coil of SipD.    
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3.3.2.  Significance of the N-terminal α-helical hairpin - A common feature in Salmonella SipD 
and Shigella IpaD but absent in Yersinia LcrV is the N-terminal α-helical hairpin made up of 
helices α1 and α2 on the concave side of the coiled coil and a short helix α3 on the convex side 
of the coiled coil [Figure 3-10A, C, D, and E].  The Burkholderia BipD also contains the 
hairpin domain but helix α1 is very short and helices α2 and α3 are much longer with the turn 
region reaching up to the three-stranded β-sheet at the top of the molecule [Figure 3-10B].  A 
thermal melting scan of IpaD shows two transition temperatures at 40 oC and 70 oC but deletion 
of the N-terminal hairpin (residues 1 – 131) resulted in the loss of the 40 oC transition 
temperature suggesting that the hairpin folds independently of the rest of the tip protein (19).  
Removal of the hairpin also induces self-oligomerization of IpaD (13) suggesting that this 
domain might be responsible for preventing self-oligomerization of the tip protein.  Further, a 
Shigella strain lacking the hairpin domain of IpaD is still able to invade intestinal epithelial cells 
suggesting that this region is dispensable for T3SS function (20).  Lastly, ITC could detect a 
direct binding between SipD132-343 that lacked the hairpin domain and the Salmonella needle 
protein PrgI but not between full length SipD and PrgI suggesting that the hairpin might also 
hinder needle-tip interactions (18).  All these observations support the hypothesis that the N-
terminal α-helical hairpin acts as a self-chaperone for the tip proteins IpaD and SipD and 
prevents premature tip-tip or needle tip-interactions.   
How the assembly of SipD on the PrgI needle is regulated by self-chaperoning is poorly 
understood.  In order to gain more insight into the structure of SipD in the absence of the hairpin 
domain, we solved the crystal structure of SipD131-343 that lacks helices α1- α3.  Removal of the 
hairpin domain induced conformational flexibility in the tip protein resulting in several 
disordered regions in the crystal structure of SipD131-343 [Figure 3-5].  Nevertheless, the coiled 
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coil and the mixed α/β region in SipD131-343 maintain the overall conformation observed in 
SipD39-343 and the two molecules share a Cα rmsd of 1.3 Å.  The folding of SipD131-343 was also 
corroborated by the recently reported structures of SipD132-343 (18) and IpaD122-319 (21).  Our 
structure of SipD131-343 will be useful in further studies such as constrained modeling of the tip 
complex.  
3.3.3.  Deletion mutants of SipD - Deletion of residues 186 to 189 (SipDΔ186-189), 187 to 188 
(SipDΔ187-188), and the terminal five residues 339 to 343 (SipDCΔ5) of SipD negatively affected 
the ability of Salmonella to invade human intestinal epithelial cells [Figure 3-6].  The non-
invasiveness of Salmonella strains with sipDΔ186-189 and sipDΔ187-188 could be attributed to local 
conformation changes around the β-strand β2 of SipDΔ186-189 and SipDΔ187-188.  This highlights 
the significance of the antiparallel β-sheet motif in the folding of SipD [Figures 3-8B, 3-9B, and 
3-9D].  SipDCΔ5 also showed a non-invasive phenotype even though it was folded similarly to 
WT SipD.  Interestingly, deletion of the terminal five residues of IpaD disrupts the invasiveness 
of Shigella as well as the presentation of IpaD on the bacterial surface (20).  A plausible 
explanation of these observations is that the C-terminus of the tip proteins is involved in the 
assembly of the tip complex either by facilitating interactions with needle proteins or other tip 
proteins.  In contrast, deletion of SipD residues 116-124 did not affect the invasiveness [Figure 
3-6] of Salmonella suggesting that either this region is not important for T3SS function or the 
deletion of nine residues does not have an appreciable effect on the structure or function of the 
assembled tip complex. 
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CHAPTER 4: Characterization of the interaction between the Salmonella tip protein SipD 
and bile salts 
4.1.  Introduction 
The liver secretes bile to aid in the digestion of lipids.  Bile contains bile acids, which are 
amphipathic molecules derived from cholesterol.  Bile acids can react with sodium to form bile 
salts (1).  The concentration of bile acids ranges from ~8% in the gall bladder to ~2% in the 
small intestine (1).  Bile acids produced in the liver are known as primary bile acids.  Resident 
bacteria in the gut can convert the primary bile acids into secondary bile acids (2).  Cholic acid 
and chenodeoxycholic acid are the most abundant primary bile acids and deoxycholic acid and 
taurodeoxycholic acid are the most abundant secondary bile acids (2).   
Bile acids have antimicrobial properties, therefore enteric pathogens like Salmonella and 
Shigella alter the expression of a variety of genes to escape the harmful effects of bile acids (1).  
These pathogens modulate the expression of genes governing the lipopolysaccharide, toll 
proteins, efflux pumps, as well as virulence factors like the (T3SS) in response to bile acids (1).  
In the presence of bile, Salmonella represses the transcription of genes that regulate the T3SS 
and the ability of Salmonella to invade epithelial cells is reduced by a factor of 96% (3).  In 
contrast, the bile salt deoxycholate increased the invasiveness of Shigella and enhanced the 
secretion of Ipa proteins (4).  In addition, growth in deoxycholate induced the surface 
presentation of the Shigella translocon protein IpaB (5).  Electron microscopy of T3SS needles 
from Shigella showed that the surface exposed IpaB was bound at the tip of the needles, in the 
presence of deoxycholate (5).  Further, deoxycholate could directly bind to the Shigella tip 
protein IpaD (6).  Computational docking predicted that deoxycholate bound to a pocket between 
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the coiled coil and the N-terminal α-helical hairpin domain of IpaD (6).  Deoxycholate also 
bound to the Salmonella tip protein SipD (6).  In order to determine how bile salts interact with 
SipD, the tip protein was crystallized with bile salts deoxycholate and chenodeoxycholate.  The 
crystal structures of SipD39-343 bound to bile salts provide insights in understanding why 
Salmonella and Shigella show contrasting responses to bile. 
4.2.  Results 
4.2.1.  Crystal structure of the SipD39-343-deoxycholate and SipD39-343-chenodeoxycholate 
complexes - Crystals of the SipD39-343-deoxycholate complex were obtained by co-crystallization 
of SipD39-343 C244S with sodium deoxycholate.  Crystals of the SipD39-343-chenodeoxycholate 
complex were obtained by soaking the crystals of WT SipD39-343 in a solution of sodium 
chenodeoxycholate.  Crystals of WT SipD39-343 were also soaked in taurodeoxycholate and 
cholate hydrate.  However, these bile salts failed to form co-crystals with SipD39-343.  The co-
crystal structures of SipD39-343-deoxycholate and SipD39-343-chenodeoxycholate complexes were 
solved by molecular replacement and refined to a resolution of 1.9 Å.  The crystallographic 
statistics are listed in Table 5.  Both structures contained two molecules of SipD39-343 in the 
asymmetric unit and the bile salts were bound in identical hydrophobic pockets [Figure 4-1].  
These pockets had a surface area of ~520 Å2 and were formed at the interface of three molecules 
of SipD39-343.  The bile salt binding pocket was formed by the C-terminus and N-terminus of 
molecule A, helix α3 and the C-terminus of helix α8 of molecule B, and a loop from the mixed 
α/β region joining α-helix α5 to α6 (loop α5-α6) of molecule A2, which was related to molecule 
A by a crystallographic (011) translation.  The three molecules of SipD forming the bile salt 
binding pocket are shown in Figures 4-2 and 4-3.  The bile salt binding pocket was lined by the 
following residues:  R41, I45, K338, and F340 of molecule A, N104, S107, A108, L318, L322,  
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Figure 4-1: An overlay of the structures of SipD39-343 bound to deoxycholate and 
chenodeoxycholate showing the bile salt binding site (red box).  The bile salt binding site was 
formed by the N-terminus of α1 and the C-terminus of α8 from molecule A along the C-terminus 
of α8 and α3 from molecule B.  The structure of SipD-deoxycholate complex is colored in darker 
shades.  
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Figure 4-2:  (A) Side view of the structures of SipD-deoxycholate and SipD-chenodeoxycholate 
complexes showing the asymmetric unit containing two molecules (A and B) of SipD.  Molecule 
A2 was related to molecule A by a crystallographic (011) translation.  A loop within the mixed 
α/β region of molecule A2 (loop α5-α6) was in contact with the bile salt.  (B) Top view of the 
three molecules of SipD bound to one molecule of deoxycholate or chenodeoxycholate.  The C-
terminus of molecule A formed a parallel β-sheet with molecule A2 (see chapter 8 section 8.1.4).  
The structure of SipD-deoxycholate complex is colored in darker shades.  
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Figure 4-3:  (A) Expanded view of the deoxycholate-binding pocket in SipD39-343.  The residues 
lining the binding pocket are shown as sticks.  The structure of apo SipD39-343 is colored green 
and the three molecules (A, B, and A2) of SipD39-343-deoxycholate complex are colored in shades 
of blue.  The conformational changes in residues F340 and N104 upon binding bile salts are 
marked with black arrows.  The hydrogen bonding between the carboxyl group of deoxycholate 
and residues K338 and N104 of SipD39-343 are marked with red arrows.  The structure of 
chenodeoxycholate-bound SipD39-343 showed identical conformational changes in F340 and 
N104.  (B) Superposition of deoxycholate and chenodeoxycholate showing the relative 
orientation of chenodeoxycholate with respect to deoxycholate in A.   
 
 
 
93	  
	  
N321, V325, and T329 of molecule B, and S221 and G222 of molecule A2.  The interaction 
between SipD39-343 and bile salts was predominantly hydrophobic in nature but was stabilized by 
hydrogen bonds between the carboxyl groups of the bile salts and residues K338 (molecule A) 
and N321 (molecule B) of SipD39-343.  No large scale conformational changes were seen in 
SipD39-343 upon binding to bile salts and each of the complex structures could be aligned with the 
WT SipD39-343 structure with a backbone Cα rmsd of > 0.2 Å.  However, residue N104 was 
shifted 83o downwards and residue F340 was shifted 102o outwards in order to accommodate the 
bile salts [Figure 4-3].   
4.2.2.  Effect of deoxycholate on the invasiveness of Salmonella - The ability of Salmonella to 
invade eukaryotic cells is repressed by bile (3).  Salmonella invasion assays were done to 
determine if deoxycholate or chenodeoxycholate alone had similar effects on the invasiveness of 
Salmonella.  Increasing concentrations (0 mM, 1 mM, 2 mM, 3 mM, and 4 mM) of deoxycholate 
or chenodeoxycholate were added to the growth medium of different strains of Salmonella, 
which were then allowed to invade human intestinal epithelial cells (the protocol for the 
Salmonella invasion assay was described in chapter 2, section 2.8.2).  Addition of 
chenodeoxycholate yielded highly viscous bacterial cultures, which were unsuitable for the 
Salmonella invasion assays.  A sipD- strain complemented with the WT sipD gene (sipD+) 
showed a gradual decrease in invasiveness with increasing concentrations of deoxcyholate 
[Figure 4-4].  However, decrease in the invasiveness of WT S. typhimurium strain SL1344 was 
less pronounced as compared to the sipD+ strain.  The sipD- strain containing a nonpolar 
knockout in the sipD gene was considered as the negative control for the Salmonella invasion 
assays. 
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Table 5. Crystallographic statistics for SipD39-343-deoxycholate and SipD39-343-
chenodeoxycholate complex structures  
 C244S SipD39-343-
deoxycholate 
WT SipD39-343-
chenodeoxycholate 
PDB ID 3O01 3O02 
Data collection 
   Unit-cell parameters (Å,o) 
       
 
 
Space group 
Resolution rangea 
 
Wavelength (Å) 
Temperature (K) 
Observed reflections 
Unique reflections 
Mean <I/σ(I)>a 
Completeness 
Redundancya 
Rmerge (%)a,b 
 
a = 201.93 
b = 52.33 
c = 57.31 
β = 90.3 
C2 (No. 5) 
50.0-1.9  
(1.97-1.90) 
1.0000 
100 
170,803 
46,924 
20.3 (1.9) 
98.5 (88.1) 
3.6 (3.1) 
5.3 (38.1) 
 
a = 202.22 
b = 52.37 
c = 57.32 
β = 90.20 
C2 (No. 5) 
50.0-1.9  
(1.97-1.90) 
1.0000 
100 
169,943 
46,661 
27.9 (3.7) 
97.9 (83.5) 
3.69 (2.8) 
5.3 (23.0) 
Refinement 
Resolution (Å) 
Reflections (working/test) 
Rfactor/Rfree (%)c 
No. of atoms (protein  
A:B)/Ni2+/ligand/water) 
 
27.98 – 1.90 
45,527/2,249 
19.6/25.8 
2,184:2,053/1/28/25
2 
 
24.97 – 1.90 
43,463/2,308 
18.5/23.6 
2,177:2,032/1/28/330 
Model quality 
R.m.s deviations 
Bond lengths (Å) 
Bond angles (o) 
Average B factor (Å2) 
All atoms 
Protein (chain A/B) 
Ni2+ 
Deoxycholate or  
Chenodeoxycholate 
Water 
Coordinate error based on  
maximum likelihood (Å) 
Ramachandran plot 
       Most favored (%) 
Additionally allowed (%) 
 
 
0.017 
1.556 
 
32.0 
31.5 / 32.3 
26.6 
28.6 
 
34.0 
0.26 
 
 
98.9 
1.1 
 
 
0.018 
1.614 
 
28.2 
27.6 / 27.9 
21.8 
26.2 
 
33.5 
0.26 
 
 
98.9 
1.1 
a Values in parentheses are for highest resolution shell 
b Rmerge = ShklSi |Ii(hkl) - <I(hkl)>| / ShklSi Ii(hkl), where Ii(hkl) is the intensity measured for the ith 
reflection and <Ii(hkl)> is the average intensity of all reflections with indices hkl. 
c Rfactor = Shkl ||Fobs (hkl) | - |Fcalc (hkl) || / Shkl |Fobs (hkl)|; Rfree is calculated in an identical manner using 
5% of randomly selected reflections that were not included in the refinement 
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   4.2.3.  Effect of mutagenesis around bile salt binding site - SipD residues surrounding the 
bile salt binding pocket were mutated and the mutations were introduced into the sipD- knockout 
strain using the rescue plasmid pRK2.  The rationale behind each of the SipD point mutations are 
listed in Table 6.  The resultant Salmonella strains containing point mutations in SipD were used 
to perform Salmonella invasion assays and their invasiveness was compared to the sipD+ strain.  
Addition of deoxycholate diminished the invasiveness of the sipD+ strain.  Therefore, SipD 
mutants unable to bind deoxycholate were expected to show percent invasion values similar to or 
higher than the sipD+ strain.  A standard concentration of 2.5 mM deoxycholate was used for the 
Salmonella invasion assays.  However, all SipD mutants showed a phenotype similar to WT and 
sipD+ strains, where addition of deoxycholate reduced their invasiveness.  Results of the 
Salmonella invasion assays using point mutants of SipD are shown in Figure 4-6.    
4.2.4.  Effect of deoxycholate on the secretion of SipD and SipB - The effect of deoxycholate 
on the secretion of SipD and SipB was determined in order to test the hypothesis that 
deoxycholate represses invasion of Salmonella by downregulating the secretion of SipD or SipB.  
The proteins secreted by WT S. typhimurium in the presence and absence of deoxycholate was 
immunoblotted using anti-SipD and anti-SipB antibodies.  Initially, Salmonella was grown with 
2.5 mM deoxycholate and the secreted proteins were probed with anti-GroEL (loading control) 
and anti-SipD antibodies.  However, 2.5 mM deoxycholate produced more intense bands for both 
GroEL and SipD suggesting non-specific extraction of proteins.  Therefore, a concentration of 1 
mM deoxycholate was used for later experiments.   
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Figure 4-4:  Plots showing the effect of increasing concentrations of deoxycholate on the 
invasiveness of WT S. typhimrium and the sipD- strain expressing a plasmid-encoded WT sipD 
gene (sipD+).  Percent invasiveness for each strain was calculated relative to the invasiveness in 
the absence of deoxycholate (0 mM).  The sipD- was used as the negative control and assayed 
with 0 mM deoxycholate (data point was 0% invasion and was not included). 
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Table 6.  Rationales behind the design of point mutations around the bile salt binding site of 
SipD39-343 
WT residue Mutation Rationale  
F340H Smaller five-membered imidazole ring. 
F340L Hydrophobic residue lacking an aromatic ring. 
F340V Short hydrophobic residue. 
F340Y Similar aromatic ring structure. 
F340G Higher flexibility. 
F340P Higher rigidity. 
F340 
F340W Larger (indole) ring. 
K338E Oppositely charged.  
K338L Shorter in length and hydrophobic in nature.  
K338 
K338M Shorter in length and hydrophobic in nature. 
N321Q Polar but longer in length. 
N321D Similar in length but negatively charged. 
N321 
N321L Hydrophobic in nature. 
N104 N104D Negatively charged.  Cannot hydrogen bond with the carboxyl 
group of bile salt. 
S107A Hydrophobic in nature.  Cannot hydrogen bond with R41 
(Figure 4-4). 
S107 
S107T Similar in nature.  Can form a hydrogen bond with R41. 
S110A Hydrophobic in nature.  Cannot hydrogen bond with G42. S110 
S110T Similar in nature.  Can hydrogen bond with G42. 
S107A 
S110A 
Cannot hydrogen bond with R41 and G42. 
S107G 
S110G 
Cannot hydrogen bond with R41 and G42.  Higher flexibility. 
S107 
S110 
S107T 
S110T 
Hydrogen bonding with R41 and G42 will be retained. 
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Figure 4-5: The structure of SipD39-343 showing the interaction between the two molecules in the 
asymmetric unit.  Residues S107 and S110 of molecule B formed hydrogen bonds with the 
backbone amide groups of residues R41 and G42.    
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Figure 4-6:  Plots showing the invasiveness of Salmonella strains containing mutations in SipD 
with (+) or without (-) 2.5 mM deoxycholate.  Percent invasion was calculated relative to that of 
the invasiveness for the sipD+ strain in the absence of deoxycholate.   
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Figure 4-7: An immunoblot showing the degradation of SipB in Salmonella upon addition of 1 
mM deoxycholate (DOC).  The band corresponding to the degradation product of SipB is boxed.  
The sipB- strain was used as a negative control and the expression of SipD was unaffected by 1 
mM DOC.  
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The amount of SipD and SipB secreted into the growth medium or associated with the cell pellet 
was unaltered in presence of deoxycholate.  However, the anti-SipB antibody bound to a 55 kD 
band in addition to the band for full length SipB (62 kD) in the deoxycholate containing cultures 
of Salmonella [Figure 4-7].  This suggested that the bile salt was causing the degradation of 
SipB into a 55 kD product which still retained the epitope against the anti-SipB antibody (details 
of the protocol used for immunoblotting are described in chapter 2, section 2.9.1).   
4.3.  Discussion 
 Enteric pathogens such as Salmonella and Shigella are sensitive to bile salts present in the 
human intestine (1).  The bile salt deoxycholate was reported to bind to the T3SS tip proteins of 
Salmonella (SipD) and Shigella (IpaD) (6).  Interestingly, bile repressed the ability of Salmonella 
to invade cultured eukaryotic cells while stimulating the invasiveness of Shigella (3, 4).  In order 
to gain insight into how bile salts interact with the tip protein of Salmonella, the crystal 
structures of SipD39-343 bound to bile salts deoxycholate and chenodeoxycholate were solved and 
are reported herein.  In these structures, deoxycholate and chenodeoxycholate were bound in an 
identical manner at a hydrophobic pocket formed at the interface of three molecules of SipD39-
343.  Further, the carboxyl groups of the bile salts were within hydrogen bonding distance of the 
side chain amide group of N321 and the amine group of K338 of SipD39-343.  Site-directed 
mutagenesis aimed at disrupting the SipD-deoxycholate interaction failed to affect the 
invasiveness of Salmonella.  This phenotype suggested that the substitution of one or two amino 
acids might be insufficient to disrupt the interaction between SipD and deoxycholate.   
Growth of Shigella in presence of deoxycholate results in the recruitment of the Shigella 
translocon protein IpaB on the T3SS tip complex (5).  This suggests that the tip complex of 
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Shigella might be using bile salts as a sensor to trigger the next step in the formation of the 
translocon and this might explain why deoxycholate upregulates the invasiveness of Shigella.  
The secretion levels of Salmonella SipD and the Salmonella translocon protein SipB in presence 
or absence of deoxycholate were compared to test if deoxycholate represses the invasiveness of 
Salmonella by affecting the secretion of these two proteins.  Although deoxycholate did not 
affect the secretion of SipD, SipB underwent degradation into a ~55 kD product when 
Salmonella was grown in presence of 1 mM deoxycholate.  A possibility is that the binding of 
bile salts to SipD at the tip complex interferes with the assembly of the translocon, and as a result 
SipB is destabilized and is degraded by proteases.  Further studies on the interaction between 
SipD and SipB in the presence of bile salts will shed light on this problem.  
  4.3.1.  Heterogeneity of the bile salt binding sites - In total, four crystal structures of tip proteins 
bound to bile salts have been reported.  The first two structures are those of SipD39-343-
deoxycholate and SipD39-343-chenodeoxycholate complexes reported herein.  The third structure 
corresponds to Shigella IpaD121-319 bound to deoxycholate (7).  IpaD121-319 lacked the N-terminal 
α-helical hairpin.  The asymmetric unit of the IpaD121-319-deoxycholate complex consists of two 
molecules of IpaD121-319 (chain A and chain B) bound to two molecules of deoxycholate (DOC A 
and DOC B) at two slightly overlapping sites [Figure 4-8].  DOC A was bound to chain A on the 
same side as the mixed α/β region whereas DOC B was bound to chain B on the opposite side as 
the mixed α/β region.  The binding site of DOC B is closer to the bile salt binding site in the 
SipD-deoxycholate complex reported herein.  Nonetheless, the multiple structures of tip-bile salt 
complexes show that multiple regions of the tip protein can interact with deoxycholate.   
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Figure 4-8:  Crystal structure of IpaD121-319 bound to deoxycholate (7).  The two chains of 
IpaD121-319 are labeled and the two bile salt binding sites are circled.  DOC A and DOC B stand 
for the two molecules of deoxycholate.  DOC A was bound on the same side as the mixed α/β 
region (colored cyan) of chain A.  DOC B was on the opposite side as the mixed α/β region of 
chain B.  This figure was prepared using PDB ID 3R9V.   
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Figure 4-9:  Cartoon showing the structure of a SipD127-343-PrgI fusion molecule bound to 
deoxycholate (8).  The deoxycholate molecule is shown as sticks.  Deoxycholate was bound at 
the interface of PrgI from chain A and helix α6 of SipD and the central portion of PrgI of chain 
B.  This figure was prepared using PDB ID 3ZQB. 
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Finally, deoxycholate was crystallized with a fusion molecule composed of the Salmonella 
needle protein PrgI connected to SipD residues 127 to 343 by means of a 5-residue Gly-Gly-Ser-
Gly-Gly linker (8).  Figure 4-9 shows the structure of the SipD127-343-PrgI fusion molecule 
bound to deoxycholate.  SipD127-343 lacks the N-terminal α-helical hairpin domain.  The SipD127-
343-PrgI-deoxycholate complex contains two molecules of SipD127-343 (chain A and chain B) 
dimerized along their coiled coils.  PrgI folded against the convex side of the coiled coil, 
immediately below the mixed α/β region of each of the SipD127-343 molecules.  Deoxycholate 
bound at a pocket formed by the P-S-D-P turn motif of PrgI from chain A along with PrgI and 
helix α6 of SipD127-343 from chain B.  
The interaction between bile salts and tip proteins was also studied by NMR (9, 10) and 
fluorescence spectroscopy (6, 10).  NMR titration of 15N-labeled SipD39-343 (9) or 15N-labeled 
IpaD38-321 (10) with bile salts perturbed several residues that were globally distributed on the tip 
proteins.  Additionally, two Förster resonance energy transfer (FRET)-based assays were used to 
study the interaction between full length IpaD and deoxycholate (6, 10).  Using FRET between a 
fluorescein molecule attached to the carboxyl group of deoxycholate and a coumarin molecule 
attached to full length IpaD (6), deoxycholate was predicted to bind at a pocket formed by the N-
terminal helices and the coiled coil of full length IpaD.  A separate study determined how bile 
salt binding changed FRET between FlAsH tags placed at four tetracysteine (TC) pockets on 
different locations of IpaD (10) and concluded that deoxycholate binding induces large-scale 
conformational changes throughout the tip protein.   
Taken together, the heterogeneity in the mode of interaction between the tip proteins SipD 
and IpaD and bile salts could be attributed to the use of different constructs of SipD and IpaD 
with or without the N-terminal α-helical hairpin domain, the use of different techniques (X-ray 
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crystallography, NMR, and Fluorescence), or the absence of a distinct bile salt binding pocket on 
the tip proteins.  Nevertheless, a common feature seen in the crystal structures is that bile salts 
bound at the interface of two or more protein molecules.  Moreover, both NMR and 
fluorescence-based studies concluded that bile salt binding induced global conformational 
changes in the tip proteins.  Thus, it is possible that bile salts bind at the interface of the needle 
and tip proteins or two tip proteins and influence the packing of the tip complex, which in turn 
affects the regulation of the T3SS of Salmonella and Shigella in a contrasting manner.  Such 
conformational changes might prevent the binding of SipB to the tip complex in Salmonella 
leading to the degradation of SipB while, in Shigella, they promote the attachment of IpaB on the 
tip complex.  Bile-mediated repression might be how Salmonella exploits the concentration of 
bile to sense its local environment and prevents premature activation of the T3SS thereby 
conserving valuable resources. 
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CHAPTER 5: Expression of the Salmonella translocon protein SipB for NMR studies 
5.1.  Introduction 
The T3SS translocon sits on the tip complex and associates with the host cell membrane to 
form the translocation pore.  The pore is ~ 30-35 Å in diameter and allows the passage of 
effectors directly into the host cell cytoplasm (1).  The translocon is composed of the membrane 
proteins SipB and SipC in Salmonella (2).  In the bacterial cytoplasm SipB and SipC are 
partitioned and stabilized by the chaperone SicA (3).  Following contact with host cell the 
translocon proteins assemble on the tip complex to form the functional translocon (4).   
The secondary structure prediction for SipB is shown in Figure 5-1.  SipB contains an N-
terminal hydrophilic domain, two transmembrane helices, and a C-terminal amphipathic region 
predicted to be α-helical (5) [Figures 5-1 to 5-3].  The signal for T3SS-mediated secretion was 
reported to be within residues 3 to 8 of SipB while residues 80 to 100 were important for binding 
to SicA (6).  The transmembrane helices within residues 313 to 333 and 399 to 419 are 
connected by a hydrophilic loop (residues 333 to 399) (5) [Figure 5-3].  The transmembrane 
helices could intimately associate with model bilayers thereby positioning the loop region within 
the lumen of liposomes (5).  The C-terminal amphipathic region although peripherally associated 
with membranes, was reported necessary for the insertion of SipB into bilayers (5) [Figure 5-3].  
A peptide derived from the C-terminal region could inhibit membrane fusion of SipB and the 
entry of Salmonella into HeLa cells (7).   
How the translocon assembles on the tip complex is poorly understood.  Constructs 
corresponding to the N-terminal hydrophilic domain, the hydrophilic loop region, and the C-
terminal amphipathic region of SipB were expressed in E. coli in order to determine their 
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structure and molecular interactions with other components of the needle apparatus like SipD 
and SipC.  Structural characterization of the different regions of SipB was useful in designing an 
ideal construct for use in NMR studies. 
 5.2.  Results 
5.2.1.  Expression and purification of SipB - Residues 1 to 16 and 50 to 72 in SipB were 
predicted (8) to form random coils [Figure 5-1].  Further, residues 51-72 of the SipB homolog 
IpaB was reported to bind its chaperone IpgC, which is homologous to the Salmonella chaperone 
SicA (9).  Flexible regions that need to be stabilized by a chaperone could lead to a poor NMR 
spectrum.  Therefore, 81 residues from the N-terminus were not included in the construct 
representing the N-terminal hydrophilic domain of SipB.  The hydrophobic transmembrane 
helices were also not included in the expression constructs of SipB.  The “DAS” Transmembrane 
Prediction server (10) was used to localize the two transmembrane helices in SipB within 
residues 313 to 333 and 399 to 419 [Figures 5-2 & 5-3].  Finally, the C-terminus of SipB, was 
predicted to form an α-helix with an amphipathic region within residues 526 to 593 (5) [Figure 
5-3].  Accordingly, DNA segments coding for SipB residues 82 to 312 (SipB82-312), 340 to 404 
(SipB340-404), 436 to 518 (SipB436-593), and 521 to 593 (SipB521-493) were subcloned into pET22B, 
which appended a C-terminal hexahistidine tag (LEH6) to the recombinant protein.  These 
regions of SipB were also subcloned into pET21A, which appended an N-terminal His-GB1 tag 
to enhance the solubility of the recombinant proteins.  The constructs of SipB were expressed in 
E. coli BL21 (DE3) DNAY cells.   
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Figure 5-1:  The predicted secondary structure of SipB.  The secondary structure of SipB was 
predicted using four algorithms: DPM (11), DSC (12), MLRC (13), and PHD (14).  SEC. CONS. 
stands for secondary consensus, which is a combined representation of the four prediction 
algorithms.  Residues having high α-helical propensity are marked as “H” in blue, random coil 
regions are represented by “C” in yellow, regions likely to form extended β-strands are shown as 
“E” in red, and residues forming turns are labeled as “T” in green.  
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Figure 5-2:  A hydropathy plot showing the location of the hydrophobic transmembrane helices 
in SipB.  Regions within SipB residues 313-333 and 399-419 were predicted to contain 
transmembrane helices.  The “DAS” Transmembrane Prediction server (10) was used to generate 
the hydropathy plot.     
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Figure 5-3:  A schematic representation of the different regions of SipB based on the predicted 
transmembrane regions (shown in Figure 5-2) and membrane-binding studies with purified SipB 
(5).  The diagram is based on the topology of SipB in phospholipid bilayers and vesicles (5).  
The N-terminal hydrophilic domain is colored blue, the transmembrane helices associated with a 
lipid membrane is colored green, and the amphipathic region is colored yellow.  The expression 
constructs corresponding to each region within SipB are also labeled.   
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SipB82-312 within both pET22B and pET21A afforded high levels of recombinant protein 
expression [Figure 5-4A].  The pET21A expression vector was used for later experiments owing 
to ease in purification (protocol used for the purification of SipB82-312 is described in chapter 2, 
section 2.1).  SipB340-404 showed very low protein expression from both the expression vectors.  
SipB436-518 could be expressed only as a fusion protein containing the His6-GB1 solubility tag 
and the recombinant protein was unstable in solution upon removal of the solubility tag [Figures 
5-4B & 5-4C].  Moreover, SipB436-518 retaining the His6-GB1 tag (SipB436-518_GB1) produced CD 
and NMR spectra closely resembling that of free GB1.  Thus, this construct was not used for 
NMR studies.  Expression of SipB436-593 led to the death of bacterial cells suggesting that this 
region was toxic to E. coli.  SipB82-312 was further characterized using CD and NMR 
spectroscopy and used for NMR titrations with SipD (NMR titrations of SipB and SipD are 
described in chapter 6, section 6.2 ).      
5.2.2.  CD Spectroscopy - The secondary structure of SipB82-312 was examined using CD 
spectroscopy.  The resultant spectrum had well defined minima at 208 nm and 222 nm, 
indicating a highly α-helical fold [Figure 5-5A].  The thermal melting profile of SipB82-312 at 222 
nm showed a distinct unfolding event with a Tm of 54 oC.  To further localize the boundaries of 
the folded regions, we generated truncations SipB82-267, SipB82-240, and SipB82-226.  All three 
truncations were α-helical, with Tm values similar to that of SipB82-312.  SipB82-267, SipB82-240, and 
SipB82-226 had Tm values of 53.8 oC, 59.8 oC, and 50.2 oC respectively [Figure 5-5B].  NMR 
spectroscopy was employed for further characterization of the SipB truncations. 
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Figure 5-4:  (A) SDS-PAGE showing the purification of SipB82-312.  Lane 1 shows the bacterial 
supernatant before induction of protein expression, lane 2 shows bacterial supernatant after 
induction of protein expression, lane 3 shows the bacterial cell pellet after induction of protein 
expression, lane 4 shows      SipB82-312 after purification using Ni+2-affinity chromatography, and 
lane 5 shows SipB82-312 after dialysis into a low salt buffer and concentration (purification of 
SipB82-312 is described in chapter 2, section 2.1).  (B) SDS-PAGE showing the purification of 
SipB436-518 containing the His6-GB1 tag (SipB436-518_GB1).  Lanes 1 and 2 contain the flow 
through and wash respectively.  Lanes 3 through 12 contain fractions eluted from the Ni+2-
affinity column containing increasing amounts of SipB436-518_GB1.  (C) SDS-PAGE showing the 
separation of SipB436-518 from the His-GB1 tag after digestion with Tobacco Etch Virus protease.  
Removal of the His-GB1 solubility tag (lane 14) destabilized SipB436-518 and the recombinant 
protein was degraded in solution.  Extremely low amounts of SipB436-518 (boxed) were detected 
in the flow through and wash fractions (lanes 1-13)   
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Figure 5-5:  (A) CD spectra of the truncations SipB82-312, SipB82-267, SipB82-240, and SipB82-226 
showing a highly α-helical secondary structure indicated by the negative ellipticity at 208 nm 
and 222 nm.  (B) Thermal denaturation of SipB82-312 showed a distinct unfolding event with a Tm 
of 54 oC suggesting the presence of a folded domain.  The truncations SipB82-267, SipB82-240, and 
SipB82-226 showed thermal denaturation profiles similar to SipB82-312.  
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5.2.3.  1H-15N-TROSY spectra of SipB constructs - A 1H-15N-TROSY (15) spectrum of 
SipB82-312 showed less than 3% of the backbone amide groups and the remaining peaks were 
broadened [Figure 5-6A].  Protein concentrations as low as 200 µM, high acquisition 
temperatures, and high salt containing buffer did not improve the NMR spectrum of SipB82-312, 
suggesting that its poor quality was due to highly dynamic regions within the protein rather than 
protein oligomerization.  The truncations SipB82-267, SipB82-240, and SipB82-226 were designed in 
order to optimize the NMR construct for the N-terminal domain of SipB.  Deletion of residues 
312 to 266 (SipB82-267) did not have any effect on the 1H-15N-TROSY spectrum [Figure 5-6B].  
However, deletion of residues 312 to 239 (SipB82-240), or 312 to 225 (SipB82-226) yielded much 
improved spectra showing > 80% of the backbone amide groups [Figures 5-6C & 5-6D].  The 
recently solved crystal structure of SipB82-226 showed that this region forms a trimeric coiled coil 
(16).  Further, NMR titrations of 15N-SipD39-343 with unlabeled SipB82-226 detected an interaction 
between these two proteins (NMR titrations of 15N-SipD39-343 with SipB82-226 is described in 
chapter 6, section 6.2).  Thus, attempts were made to assign the backbone NMR resonances of 
15N-SipB82-226 in order to determine which residues of SipB82-226 are affected on titration with 
unlabled SipD39-343.  
5.2.4.  3D-HNCA experiments with SipB82-226 - Initially, a 3D-HNCA (17) dataset was 
collected using 1 mM of 15N-13C-SipB82-226 and the first free induction decay (FID) was analyzed 
to determine the optimal experiment parameters.  However, the FID showed poor signal-to-noise 
ratio, which did not improve upon increasing the number of scans from 16 to 32 [Figures 5-7A 
& 5-7B].  A fresh sample was prepared using 0.4 mM 15N-13C-SipB82-226 to avoid protein 
oligomerization, which can lead to poor NMR signal.  The first FIDs from three 3D-HNCA (17) 
datasets collected with  
117	  
	  
 
 
   
 
 
 
 
 
 
 
 
 
 
 
Figure 5-6:  (A) & (B) 1H-15N-TROSY spectra of SipB82-312 and SipB82-267 respectively showing 
poorly resolved peaks.  (C) & (D) 1H-15N-TROSY spectra of SipB82-226 and SipB82-240 showing 
well resolved backbone NMR peak resonances.   
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56, 64, and 84 scans showed no increase in the signal-to-noise ratio [Figures 5-7C to 5-7E] and 
thus the complete 3D-HNCA (17) spectra were not collected.           
5.2.5.  Size exclusion chromatography of SipB – Size exclusion chromatography (SEC) was 
used to determine the oligomeric states of SipB82-312, SipB82-240, and SipB82-226.  Purified SipB 
truncations were chromatographed through a Superdex 75 SEC column that was previously 
calibrated with proteins of known molecular weights.  SipB82-312 eluted at 107.18 ml, which is 
very close to the elution volume of Blue Dextran (107.51 ml) [Figure 5-8A].  Blue Dextran has a 
molecular weight of 200 kD and was used as a marker for the void volume of the SEC column.  
Monomeric SipB82-312 is   26.2 kD in size and thus was estimated to form a heptameric complex 
to elute similar to a 200 kD protein.  SipB82-240 had a molecular weight of 18 kD and eluted at 
106.34 ml and 135.46 ml [Figure 5-8B].  This indicated the presence of a large oligomeric 
population that travels through the void volume of the SEC column and a smaller trimeric 
population (~ 49 kD).  The 17 kD SipB82-226 also showed a biphasic elution and two elutions 
were seen at 104.52 ml and 141.63 ml [Figure 5-8C].  The smaller species corresponded to a 
dimer while, the larger population eluted in the void volume.   
5.3.  Discussion 
In Salmonella the tip protein SipD assembles the T3SS tip complex and the translocon 
proteins SipB and SipC assemble the translocon.  SipD, SipB, and SipC are critical for the 
attachment of Salmonella to cultured human intestinal epithelial cells and for the delivery of 
effectors directly into the cytoplasm of the host cells (4).  Initial contact with the host cell 
membrane triggers the colocalization of SipB and SipC on SipD (4).   
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Figure 5-7:  The first free induction decay (FID) from 3D-HNCA (15) experiments using 15N-
13C-SipB82-226.  Panels A and B were collected using 1 mM protein while, the panels C, D, and E 
correspond to a protein concentration of 0.4 mM.  The number of scans used for the acquisition 
of each experiment is labeled on the respective panels.    
 
 
120	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-8:  Size exclusion chromatography (SEC) of the truncations of SipB.  (A) SEC of 
SipB82-312 shows a single oligomeric population that flows through the void volume and elutes at 
107.18 ml.  (B) SEC of SipB82-240 shows a small trimeric population (Ve = 135.46 ml) and a large 
oligomeric population (Ve = 106.34 ml).  (C) SEC of SipB82-226 shows a small dimeric 
population (Ve = 141.63 ml) and a large oligomeric population (Ve = 104.52 ml).   
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The delivery of effectors through the translocon is a poorly understood process and the structure 
of the translocon is unknown.  Constructs corresponding to different regions of SipB were 
expressed in E. coli for further study.   
Initial tests for expression showed that SipB340-404 corresponding to the hydrophilic loop 
region had extremely low levels of protein expression in E. coli.  The C-terminus of SipB is 
needed for integration into lipid membranes (5).  This region is predicted to form an α-helix, 
which can peripherally associate with the lipid membrane.  SipB436-518 and SipB521-593 were 
designed to contain the proximal and distal portion of the C-terminal amphipathic region.  
SipB436-518 was unstable without the GB1 solubility tag and SipB521-593 was toxic to E. coli 
[Figures 5-4B & 5-4C].  Previously others were able to purify SipB428-593 (5), which is similar to 
the SipB436-518 and SipB521-593 constructs combined.  Therefore, a SipB436-593 construct was also 
generated.  However, SipB436-593 also had very low level of protein expression.  This discrepancy 
could be attributed to the slightly different constructs, or use of a higher amount of IPTG (0.1 
mM versus 1 mM) and a different growth medium (Tryptic soy broth versus LB broth) (5, 18).  It 
is also noteworthy, that the reported purification protocol for SipB428-593 involved the extraction 
of the protein from cell pellets using GuHCL followed by refolding in Tris-HCL buffer (5, 18).    
Only SipB82-312 containing the N-terminal hydrophilic region could be over-expressed and 
purified to yield high quantities of recombinant protein that was stable in solution [Figure 5-4A].  
CD and thermal denaturation of SipB82-312 revealed a highly α-helical secondary structure 
containing a folded domain, which underwent a distinct unfolding event with a Tm of 54 oC 
[Figures 5-5A & 5-5B].  These results are in agreement with previous reports of the presence of 
protease-resistant domain within residues 26 to 309 of SipB (19).  SipB82-312 produced a narrow 
1H-15N-TROSY (15) spectrum with unresolved peaks and less than 3% of the backbone amide 
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groups visible.  The poor quality of NMR data might be due to oligomerization or highly 
dynamic regions within the protein molecule.  Thus low protein concentration (0.2 mM) and high 
acquisition temperatures (upto 42 oC) were used to rule out protein oligomerization.  However, 
these conditions did not improve the quality of the NMR spectrum suggesting the presence of 
flexible regions within SipB82-312.   
SipB contained three regions within residues 82 to 312 that were predicted to form random 
coils.  These regions were located within residues 173-182, 231-250, and 268-271 [Figure 5-1].  
In order to obtain an ideal NMR spectrum corresponding to the N-terminal domain of SipB the 
flexible regions had to be removed.  However, removal of residues 173-182 from the central 
portion of SipB82-312 might destabilize the tertiary structure of the remaining polypeptide.  
Therefore, predicted random coil regions from the C-terminal end of SipB82-312 were truncated to 
generate SipB82-226, SipB82-240, and SipB82-267.  Removal of the region within residues 268-271 in 
SipB82-267 did not affect the NMR spectrum [Figure 5-6B].  In contrast, removal of both the 
predicted flexible patches within residues 231-271 in SipB82-240 and SipB82-226 produced 1H-15N-
TROSY (15) spectra showing > 80% of the backbone amide groups [Figures 5-6C & 5-6D].  
The crystal structure of SipB82-226 was recently determined and shown to form a three-helix 
bundle (16).  The structure of SipB82-226 agrees with the predicted secondary structure of SipB in 
Figure 5-1.  In the secondary structure prediction residues 95-98 and 175-180 were predicted to 
adopt a random coil conformation.  In SipB82-226 these regions were disordered.  One difference 
however, was that residues 124 and 125 were predicted to have α-helical character but in SipB82-
226 these residues form a helical turn and are disordered as well.  NMR titrations of SipB82-226 
with unlabeled SipD39-343 showed that this region of SipB could interact with the tip protein (see 
chapter 6).  Hence, attempts were made to assign the backbone NMR resonances of SipB82-226.  
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Despite a well-dispersed 2D-NMR spectrum, 15N-13C-SipB82-226 yielded poor signal-to-noise 
ratio in a 3D-HNCA spectrum [Figures 5-7A & 5-7B] and low protein concentration and 
increased number of scans did not make any difference to the NMR signal [Figures 5-7C to 5-
7E].    
Purified full length SipB was reported to form homohexamers using its N-terminal domain 
(19).  Although SipB82-240 and SipB82-226 were designed to lack predicted flexible regions these 
constructs might still retain the oligomerization motif within the N-terminal domain.  Size 
exclusion chromatography of SipB82-226 revealed the presence of a major population of > 200 kD 
oligomer similar to SipB82-312 [Figures 5-8A & 5-8C].  SipB82-226 also formed a minor 
population roughly corresponding to a dimeric species [Figure 5-8C].  Similarly, SipB82-240 
yielded a large oligomeric species and a smaller trimeric species [Figure 5-8B].  Thus, SEC 
suggested that removal of their respective flexible regions shifted the equilibrium of SipB82-226 
and SipB82-240 to a heterogenous oligomer population.  Therefore, the poor signal in a 3D-HNCA 
(17) experiment using 15N-13C-SipB82-226 could be due to a small monomeric population at 25 oC, 
which was forming independent of the concentration of protein molecules.  The significance of 
the oligomerization of SipB using its N-terminal domain is unknown.  
In summary, SipB82-312 could be easily expressed and maintained in solution.  The presence 
of flexible regions in addition to a folded domain within SipB82-312 resulted in a poor NMR 
signal.  These flexible regions were located within residues 231-271 and their truncation resulted 
in improved 2D-NMR spectra.  However, even though SipB82-240 and SipB82-226 had well 
dispersed 2D-NMR spectra they produced low signals in a 3D-HNCA experiment probably due 
to a small monomeric population.  One way to counter this problem would be to design point 
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mutations that introduce surface charges on Sipb, thereby preventing oligomer formation while 
still retaining the function of the translocon protein. 
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Chapter 6:  The interaction between the Salmonella tip protein SipD and the N-terminal 
hydrophilic domain of the translocon protein SipB  
6.1.  Introduction 
The Salmonella translocon protein SipB was required for bacterial entry into cultured human 
intestinal epithelial cells (1).  SipB along with SipC assemble on the tip complex to form the 
T3SS translocon, which allows Salmonella to attach to the host cell membrane and to deliver 
effectors through the translocation pore (1-3).  The molecular interactions responsible for the 
attachment of the translocon to the tip complex are unknown.  Purified SipB could associate with 
liposomes using two centrally located hydrophobic regions predicted to form transmembrane α-
helices (4).  SipB also contained a C-terminal amphipathic region and an N-terminal hydrophilic 
region.  The C-terminal amphipathic region helped in the binding of SipB to lipid membranes 
(4).  However, the role of the N-terminal domain of SipB in the assembly of the translocon is the 
least understood.   
The N-terminal region of SipB formed a protease-resistant domain that was responsible for 
the homo-oligomerization of SipB into hexamers (5).  The tip complex is assembled from the 
hydrophilic tip protein SipD.  Hence, the N-terminal hydrophilic domain of SipB could be 
responsible for the attachment of the translocon to the tip complex.  SipB residues 82 to 312 
were purified from E. coli and NMR spectroscopy was used to detect a weak interaction between 
this region of SipB and the tip protein SipD.  Paramagnetic relaxation enhancement (PRE) was 
used to determine the surfaces involved in the interaction between SipB82-312 and SipD.  The 
interaction between SipB82-312 and SipD was helpful to understand how the translocon might be 
anchored to the tip complex.   
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6.2.  Results 
6.2.1.  NMR titrations of SipD39-343 with the N-terminal hydrophilic region of SipB - 15N-
SipD39-343 was titrated with increasing concentrations of unlabeled SipB82-312.  The backbone 
assignments for SipD39-343 published previously (6) were used to identify the residues affected on 
interaction with SipB82-312.  Progressive decrease in the intensity of several peaks denoted an 
interaction in the intermediate-exchange NMR timescale [Figure 6-1].  Intermediate exchange 
implies that chemical exchange between the free and bound states occurs on an intermediate 
timescale.  In other words, the peaks are broadened due to interference from chemical exchange 
during the detection period of the NMR experiment (7).  The peak intensities of 182 residues in 
the 1:1 dataset over that of the 1:0 dataset were plotted to find the residues of SipD39-343 most 
affected on interaction with SipB82-312 [Figure 6-2A].  Residues showing the strongest decrease 
in peak intensity upon interaction with SipB82-312 were distributed over a wide region of SipD39-
343, and are shown in Figures 6-2B & 6-2C.  The affected peaks represent residues that are 
located at the binding interface as well as those that undergo conformational change due to 
binding.  Hence, the wide distribution of the affected peaks might suggest that SipD39-343 
undergoes global conformational changes upon binding to SipB82-312.    
SipB82-312 produced a poor 1H-15N-TROSY spectrum (2D-NMR spectra of 15N-SipB82-312 is 
shown in chapter 5, section 5.2.3), thus preventing complementary NMR titrations using 15N-
labeled SipB82-312.  Recently, the crystal structure of a shorter fragment containing SipB residues 
82 to 226 was reported (8).  This construct (SipB82-226) produced a higher quality 1H-15N-TROSY 
spectrum with over 80% of the backbone amide groups well dispersed.  13C-ILV-labeled SipB82-
226 was titrated with unlabeled SipD39-343 in order to determine if SipB82-226 retains binding with 
SipD39-343.   
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Figure 6-1:  NMR titration of 15N-SipD39-343 with unlabeled SipB82-312 at different molar ratios.  
SipB82-312 interacted with SipD39-343 in the intermediate exchange NMR timescale.  The SipD39-
343 residues showing the strongest decrease in peak intensities are boxed and labeled.   
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Figure 6-2:  (A) Plot showing the ratio of peak intensities of 15N-SipD39-343 residues mixed with 
an equimolar amount of unlabeled SipB82-312 (1:1) to that with no SipB82-312 (1:0).  (B) & (C) 
Two views of the structure of SipD showing the residues (red sticks) that were most affected 
upon titration with SipB.  
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Figure 6-3:  (A) 1H-13C-HSQC spectra of 13C-ILV-SipB82-226 titrated with unlabeled SipD39-343 at 
different molar ratios.  The four peaks with 13C chemical shift within 12-16 ppm represent the 
methyl groups of the four Ile residues in SipB82-226.  The methyl groups of Leu and Val residues 
are represented by two peaks per residue and have a 13C chemical shift within 19-28 ppm.  The 
asterisks mark the SipB82-226 peaks that showed the strongest decrease in intensity upon addition 
of SipD39-343.  (B) Panels showing the appearance of two new peaks corresponding to Leu or 
Valine methyl groups of SipB82-226 upon progressive addition of SipD39-343. 
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SipB82-226 also showed an interaction in the intermediate exchange regime with SipD39-343 with 
the reduction in the intensities of several peaks representing the side chain methyl groups of Ile, 
Leu, and Val residues of SipB82-226 [Figure 6-3].  
6.2.2.  Paramagnetic Relaxation Enhancement (PRE) - Single time point PRE (9) was used 
to determine which region of SipB82-312 interacts with SipD39-343.  MTSL was used as the spin 
label and attached to specific sites on SipB82-312 using cysteine point mutants (Ala-109, Lys-127, 
Asp-207, Lys-211, Asn-283, and Glu-303) [Figure 6-4].  CD was used to ensure that SipB82-312 
with cysteine substitutions and spin labeled SipB82-312 were folded natively [Figure 6-5].  
Further, SipD was 15N-amino acid specifically labeled in order to reduce the complexity of the 
NMR datasets (15N-amino acid specific labeling of SipD39-343 is described in Chapter 2, section 
2.1.1).  A molar ratio of SipD to SipB82-312 of 1:0.5 was chosen for the PRE experiments.  A 
higher ratio yielded lower data quality due to excessive peak broadening.  Residues in SipD 
within ~ 20 Å of the spin label on SipB82-312 would experience a high PRE effect, and show 
reduced peak intensities in the paramagnetic spectrum compared to the diamagnetic spectrum.  
Therefore, no PRE effect on SipD residues would be observed if the spin label on SipB82-312 is 
farther away from the surface of interaction.  Representative 2D-NMR spectra used for PRE 
experiments are shown in Figures 6-6 & 6-7. 
Spin labels on SipB82-312 at positions Ala-109, Lys-127, and Glu-303 produced weak or 
moderate PRE effect on SipD and all peaks had an Ipara/ Idia ratio above 0.6 [Figures 6-6 to 6-9].  
On the other hand, spin labels at positions Asp-207, Lys-211, and Asn-283 induced the strongest 
PRE effect on certain SipD residues.  In the crystal structure of SipB82-226, Asp-207 and Lys-211 
are close to each other, while the position of Asn-283 is unknown, but can be expected to lie on 
helix α4 modeled over the crystal structure of SipB82-226 [Figures 6-4].   
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Figure 6-4:  Two views of the model of SipB82-312 showing the structure of SipB82-226 with the 
addition of residues that were missing in the crystal structure.  The region within residues 227 to 
312 is represented as helix α4 based on their predicted α-helical propensities.  The spheres 
represent the positions of the spin labels that were attached on SipB82-312 in order to determine 
their PRE effect on SipD39-343.  Yellow spheres represent spin labels, which did not produce a 
high PRE effect on SipD39-343.  Red spheres represent spin labels that produced a high PRE effect 
on the residues of SipD39-343.  The residues shown as pink sticks denote the position of the 
mutations in SipB that yielded non-invasive strains of Salmonella.  
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Figure 6-5:  CD spectra of WT SipB82-312 compared to the cysteine mutants before (Dia) and 
after attachment of the spin label (Para).  (A) through (F) shows CD spectra of SipB82-312 
containing cysteine mutants A109C, K127C, D207C, K211C, N283C, and E303C respectively.  
The θ222/θ208 ratio denoting interhelical contacts within each form of SipB82-312 are mentioned. 
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Figure 6-6:  (A) 1H-15N-HSQC spectra of SipD39-343 15N-amino acid specifically labeled at Ala, 
Lys, Ile, and Met (AIKM) mixed with diamagnetic (without spin label) D207C SipB82-312.  (B) 
1H-15N-HSQC spectra of 15N-AIKM-SipD39-343 mixed with paramagnetic (with spin label MTSL) 
D207C SipB82-312.  Arrows represent the SipD39-343 residues that showed decreased peak intensity 
in presence of the spin label at D207C of SipB82-312. 
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Figure 6-7:  (A) 1H-15N-TROSY spectra of SipD39-343 15N-amino acid specifically labeled at Leu 
residues (Leu) mixed with diamagnetic (without spin label) D207C SipB82-312.  (B) 1H-15N-
TROSY spectra of 15N-Leu-SipD39-343 mixed with paramagnetic (with spin label MTSL) D207C 
SipB82-312.  Arrows represent the SipD39-343 residues that showed decreased peak intensity in 
presence of the spin label at D207C of SipB82-312. 
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Residues on SipD experiencing the strongest PRE effect were Ala-115, Leu-116, Ala-123, Leu-
214, Ala-217, and Leu-280 [Figures 6-6 to 6-10]. These residues had an Ipara/Idia ratio below 0.6, 
and mapped around the mixed α/β region of SipD39-343.  The results of PRE studies, summarized 
in Figure 6-10, show that the mixed α/β domain of SipD interacts with a surface along helix α3 
and α4 of SipB82-312.  
6.2.3.  HADDOCK modeling of the SipD39-343-SipB82-226 complex - Results of NMR titrations 
and PRE experiments were used to generate a structural model of the SipD-SipB82-226 complex 
using HADDOCK (10).  The active residues on SipD39-343 and SipB82-226 used for the docking are 
listed in Table 7.  Figure 6-11 shows the highest scoring model out of the 200 structures 
generated by a HADDOCK run using default parameters.  HADDOCK scores the models based 
on a weighted sum of four energy terms.  These include electrostatic, van der Waals, desolvation, 
and restraints violation energies.  The model with the smallest weighted sum is ranked first (10).  
In the model depicted in Figure 6-11, SipB82-226 binds close to the mixed α/β region of SipD39-343 
along helix α4 and the complex is stabilized predominantly by electrostatic interactions between 
polar and charged residues, which are conserved among Salmonella species.  HADDOCK 
predicted a total buried surface area of ~ 2024.4 Å2.  Such a large buried surface area might 
indicate tight interaction.  Direct binding studies are required to estimate the affinity between 
SipD39-343 and SipB82-226.       
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Figure 6-8:  Results of PRE experiments with AIKM-SipD39-343 and four spin label positions on 
SipB82-312.  Each panel represents the Ipara/Idia ratio of SipD peaks for one spin label position, 
which is labeled on the top left.  The SipD39-343 residues are labeled at the x-axis.  The gray line 
represents a peak intensity ratio of 1, which suggests no PRE effect.   
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Figure 6-9:  Results of PRE experiments with Leu-SipD39-343 and six spin label positions on 
SipB82-312.  Each panel represents the Ipara/Idia ratio of SipD peaks for one spin label position, 
which is labeled on the bottom left.  The SipD39-343 residues are labeled at the x-axis.  The gray 
line represents a peak intensity ratio of 1, which suggests no PRE effect. 
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Figure 6-10:  Summary of the results of PRE experiments.  The SipD39-343 residues showing 
weak (yellow), moderate (orange), or strong (red) PRE effect are listed and mapped onto the 
crystal structure of SipD39-343.  In order to show the position of Ala-123, a loop region from 
residue Ser-118 to Ala-132 missing in the crystal structure of SipD39-343, was added using 
Molscript (11).  Each column corresponds to one spin label on SipB82-312.  The spin label at K127 
did not produce a PRE effect and all the residues of Leu-SipD39-343 had Ipara/Idia ratios higher than 
0.8.  Thus, the column for K127 was omitted. 
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6.2.4.  Salmonella invasion assay and Immunoblotting - Several single point mutations were 
made along helix α3 and α4 of SipB.  These mutations were tested for their effect on the ability 
of Salmonella to enter human intestinal epithelial cells in a Salmonella invasion assay.  However, 
most of the substitutions did not have any significant effect on the invasiveness of Salmonella 
[Figure 6-12].  In contrast Salmonella strains expressing SipB K211A, SipB D215A, and SipB 
A218D were completely non-invasive.  These three residues lie on consecutive turns of α3 in 
SipB82-226 [Figure 6-4].  To further investigate the cause of non-invasiveness the expression of 
SipB in the non-invasive strains of Salmonella was tested.  The LB growth medium, cell pellet 
and cytoplasm of Salmonella expressing SipB K211A, SipB D215A, and SipB A218D were 
probed with anti-SipB82-312 and anti-SipD antibodies.  Bands corresponding to smaller fragments 
of SipB, around 30kD in size, were seen in the non-invasive strains [Figure 6-13].  In contrast, 
the sipB+ strain of Salmonella contained a full length SipB around 60kD in size.  This suggests 
that the point mutations K211A, D215A and A218D were causing SipB to be degraded in 
Salmonella.  The expression profile of SipD was used as an internal control, and showed a 40kD 
band corresponding to full length SipD.  
6.3.  Discussion 
The Salmonella translocators SipB and SipC are homologous to IpaB, IpaC (Shigella sp), 
BipB, BipC (Burkholderia sp), YopB, YopD (Yersinia sp), and PopB, PopD (Pseudomonas) 
among others (12).  Although structural information exists for only the N-terminal domain of 
SipB and IpaB, membrane binding and pore formation by the translocators, have been studied 
extensively (13-18).  Purified translocon proteins can integrate into lipid membranes, but they 
need to assemble on the needle tip for delivery of effectors and T3SS-mediated bacterial entry 
into host cells (1, 3, 5, 19).  Therefore, the assembly of the translocon on the tip plays an 
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important role in the function of the T3SS.  Currently, the mechanism of this assembly process is 
unknown.  The N-terminal hydrophilic domain of SipB was proposed to bind to the tip protein 
and thereby attach the translocon to the tip complex.    
Initial CD spectroscopy and thermal scanning experiments showed the presence of a folded 
domain within residues 82 to 312 of SipB (CD spectra of SipB constructs are shown in chapter 
5, section 5.2.2).  Others have also reported a protease-resistant domain at the N-terminus of 
SipB (5).  This was confirmed by the recent crystal structure showing that the N-terminal domain 
was made up of three antiparallel α-helices.  Interestingly, this region is also responsible for 
forming oligomers of SipB (5).  Hence, it was hypothesized that the N-terminal domain of SipB 
binds to SipD and helps in the assembly of the translocon using its oligomerization motif.  
Although the latter remains to be tested, evidence of interaction between SipB82-312 and SipD39-343 
is reported here.   
SipB82-312 did not produce an ideal NMR spectrum, whereas the backbone resonances of 
SipD39-343 were already assigned (6).  Owing to these reasons, 15N-SipD39-343 was used to 
perform NMR titrations with unlabeled SipB82-312.  Several peaks showed a decrease in intensity 
representing an interaction in the intermediate exchange NMR timescale, which is consistent 
with a weak interaction between SipD39-343 and SipB82-312.  The affected residues were globally 
distributed on SipD39-343.  Such a weak interaction may be needed to provide SipB with sufficient 
conformational flexibility, to sense the host environment and recruit SipC, or switch the 
translocon to an “actively secreting” state.  Owing to the absence of chemical shifts, the single 
time-point PRE method (9) was used to identify the residues in SipD39-343 that are interacting 
with SipB82-312.   
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Table 7:  List of residues defined as “active” for HADDOCK modeling of the SipD39-343-SipB82-
226 complex using HADDOCK.  Active residues are those that might be directly involved in 
interaction.   
 
 
 
 
 
 
 
 
 
 
 
 
SipD39-343 SipB82-226 
L78 Q183 
Q82 E185 
S85 A186 
K92 Q190 
S98 K193 
E100 T196 
S107 E197 
A144 K199 
S148 E200 
N196 D203 
N203 K204 
S210 D207 
N211 V210 
S236 K211 
D269 T214 
G270 K217 
N284 A218 
Q310 E221 
K324 K222 
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Figure 6-11:  (A) & (B) Two views of the highest scoring model of the complex of SipD39-343 
and SipB82-226 obtained by haddock modeling, using results of NMR titrations and PRE.  SipB82-
226, colored in rainbow spectrum, binds near the mixed α/β region of SipD39-343 (in green).  
Residues of SipD39-343 and SipB82-226 participating in electrostatic interactions (dotted lines) are 
represented as sticks and labeled.   
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Nuclear dipoles within ~ 20 Å from a paramagnetic spin label will undergo increased relaxation.  
In the single time point method (9), this phenomenon can be observed as a reduction in the peak 
intensity of the affected nuclei in the presence of the spin label.  Spin labels were attached to six 
positions on SipB82-312, and SipD39-343 was labeled with specific 15N-amino acids.  Results of 
PRE experiments showed that a region on SipB82-312 from residues Asp207 to Asn283 binds to 
the mixed α/β region of SipD39-343. 
In support of our results, deletion of the mixed α/β region (residues 192 to 267) of IpaD, the 
homolog of SipD, prevented the localization of IpaB on the Shigella needle tip (20).  
Furthermore, the Salmonella needle protein PrgI was shown to bind at the lower portion of the 
coiled coil in SipD (21).  Together with a cryo-EM model of the needle (22), this finding 
suggests that in the assembled tip complex the mixed α/β region of SipD faces outside.  
Additionally, Epler et al. reported similar observations on the assembled tip complex of Shigella 
(23).  These results complement our findings, because if the mixed α/β region is exposed on the 
needle tip, it will be free to bind to SipB.  Incorporating these results, a model was proposed 
where the N-terminal domain of SipB provides the anchor, which attaches the translocon to the 
needle tip [Figure 6-14].  
Single amino acid substitutions were made, along helix α3 and α4 of SipB, to disrupt its 
interaction with SipD.  However, these mutations did not have any negative impact on the 
invasiveness of Salmonella.  This can be explained by the nature of the residues lining the 
binding interface between SipD and SipB.  The surface of SipB82-226 interacting with SipD39-343 is 
rich in charged residues like Lys, Arg, Asp, and Glu.  Likewise, the surface of the mixed α/β 
region of SipD39-343 is composed of polar and charged residues.   
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Figure 6-12:  Results of Salmonella invasion assay done with strains of Salmonella expressing 
SipB with single point mutations.  Most substitutions did not affect the invasiveness of 
Salmonella.  However, strains sipB K211A, sipB D215A, and sipB A218D were non-invasive. 
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Figure 6-13:  An immunoblot showing the secretion profile of the non-invasive mutant sipB 
K211A compared to sipB+ strain of Salmonella at increasing time points (0-2 hours).  The 
numbers indicate hours at which cultures were harvested after adding IPTG.  SipD was seen as a 
gradually intensifying band at 40 kD.  In the sipB+ strain a band at 62 kD denotes full length 
SipB.  In the sipB K211A mutant strain the 62 kD band was absent but a 30 kD band (yellow 
box) corresponding to a degradation product of SipB was observed.   
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Therefore, the interaction between SipD39-343 and SipB82-312 is most probably mediated by a 
multitude of electrostatic interactions and a single point mutation might not be sufficient to 
disrupt this binding in Salmonella.  A sensitive patch was found within SipB residues Lys-211, 
Asp-215, and Ala-218, which upon mutagenesis, lead to the degradation of SipB in Salmonella.  
Why single point mutations on the surface of SipB would cause such an extreme response is 
unclear and several speculations can be put forward to explain this observation.  SipB has one 
known chaperone SicA, which binds to both SipB and SipC within the bacterial cytoplasm and 
partitions them to prevent their aggregation and degradation (24).  SicA is thought to bind to 
residues 80-160 of SipB (25).  Studies with S. flexneri IpgC have further narrowed the 
chaperone-binding site to residues 15 to 73 of IpaB (26).  This region is absent in the crystal 
structure of SipB82-226 or IpaB74-224, however, it is not unlikely that the sensitive patch on SipB 
packs against the chaperone-binding site and mutations which affect the local tertiary structure 
also affect chaperone binding and lead to reduced stability of SipB.  Alternatively, the mutations 
could affect the interaction of SipB with other proteins necessary to maintain it within the 
bacterial cytoplasm.  In this context, SipB is known to form complexes with proteins like InvE, a 
secretion regulator for the translocators (27), and the OrgABC sorting platform (28), which 
controls the secretion of various T3SS substrates in a spatiotemporal manner.  Further analysis of 
complex formation of T3SS proteins needs to be undertaken to answer these questions with 
certainty. 
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Figure 6-14:  A model explaining how the interaction between SipD and SipB could facilitate 
the attachment of the translocon on the tip complex. 
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In summary, the N-terminal hydrophilic domain of SipB interacts with the tip protein SipD.  
The surfaces involved in this interaction were located to the mixed α/β region of SipD39-343 and 
along helix α3 and α4 of SipB82-312.  These findings suggest a possible mechanism for the 
assembly of the translocon where the N-terminal domain of one molecule of SipB binds to the 
mixed α/β region of one molecule of SipD [Figure 6-14].  This interaction might help to anchor 
the translocon on the tip complex and correctly insert the transmembrane domains of SipB into 
the host cell membrane.  Further studies are required to fully understand how the translocon 
protein SipC binds to SipB and SipD in order to assemble the translocon in Salmonella.        
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Chapter 7:  The interaction between the Shigella needle protein MxiH and the tip protein 
IpaD  
7.1.  Introduction 
The tip complex of the Shigella T3SS is assembled from five copies of the tip protein IpaD.  
The IpaD monomers bind to the needle protein MxiH to form the tip complex (1).  The atomic 
structure of the tip complex of Shigella was recently determined using Cryo-EM (1).  However, 
the low resolution (20 Å) of the structure limited detailed analysis of the molecular interactions 
between the IpaD and MxiH.  The interaction between the tip proteins Salmonella SipD and 
Shigella IpaD with their respective needle proteins Salmonella PrgI and Shigella MxiH was 
reported to be in the intermediate exchange NMR timescale suggestive of a weak binding affinity 
(2, 3).  Further, PRE was used to locate the binding site of Salmonella PrgI on the coiled coil of 
Salmonella SipD (2). 
The structure of SipD and PrgI from Salmonella closely resembles the structures of IpaD and 
MxiH from Shigella (4-7).  Despite the structural and functional homology between the 
components of T3SS of Salmonella and Shigella, these two pathogens were reported to form 
needles with different structures (8, 9).  Particularly, upon polymerization into the needle, the 
Shigella MxiH was shown to develop a β-hairpin conformation at the C-terminus (8).  
Differences in the structures of the needles could lead to differences in how the tip protein 
interacts with the needle proteins in Salmonella and Shigella.  In order to answer this question, 
PRE was used to locate the binding site of Shigella MxiH on the tip protein IpaD.  The 
interaction between the needle protein and the tip protein in Shigella highlights the significance 
of the coiled coil of the tip protein in the assembly of the tip complex.        
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7.2.  Results 
7.2.1.  Backbone assignment of a full length, functional double mutant of MxiH - Full length 
WT MxiH polymerizes in solution and hence is unsuitable for biochemical assays.  MxiHCΔ5 was 
used previously for NMR titration with IpaD.  However, MxiHCΔ5 also prevents the formation of 
the needle in Shigella and is therefore non-functional in a Shigella invasion assay.  Substitution 
of MxiH residues Val68 and Val70 with Alanine was reported to prevent in vitro polymerization 
of full length MxiH (10).  Further, the MxiHV68AV70A variant was functional in a Shigella 
invasion assay (10).  A 1H-15N-HSQC spectrum of MxiHV68AV70A has several peak shifts and new 
peaks in comparison to 15N MxiHCΔ5 [Figure 7-1].  Backbone amides of MxiHV68AV70A were 
assigned using 3D-HNCA and 3D-CBCA(CO)NH datasets.  A portion of the 3D-HNCA dataset 
for 13C-15N-MxiHV68AV70A is shown in Figure 7-3.  The 83-residue MxiHV68AV70A yields 80 
peaks in the 1H-15N-HSQC spectrum [Figure 7-2].  The remaining 3 were proline residues, 
which lack a backbone amide group.  Assignments could be made for 78 out of the 80 peaks, 
which amounts to 98% of the backbone amide groups in MxiHV68AV70A.  The backbone amide 
peaks assignments of MxiHV68AV70A are shown in Figure 7-2.  Residues Trp10, Glu17, Leu26, 
Ala38, and Asn66 were overlapped with residues Glu29, Asp20, Leu15, Asp21, and Asp8 
respectively.  Residues Leu37 and Leu 47 could not be assigned possibly because of peak 
broadening or peak overlap.   
7.2.2.  NMR titration of 15N-MxiHV68AV70A with unlabeled IpaD38-332 and IpaD130-332 - 15N-
MxiHV68AV70A was titrated with IpaD38-332 at five molar ratios (1:0, 1:0.25, 1:0.5, 1:1, and 1:2).  
Several backbone amide peaks of MxiHV68AV70A showed a progressive decrease in peak intensity 
upon addition of IpaD38-332 indicating an interaction in the intermediate exchange NMR 
timescale [Figure 7-4A]. 
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Figure 7-1:  An overlay of the 1H-15N-HSQC spectra of MxiHCΔ5 (black) and MxiHV68AV70A 
(red).  Several backbone amide peaks were shifted and new peaks were observed in the 1H-15N-
HSQC spectrum of MxiHV68AV70A.   
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Figure 7-2:  The assigned 1H-15N-HSQC spectrum of MxiHV68AV70A.  Residues Trp10, Glu17, 
Leu26, Ala38, and Asn66 were hidden under the peaks for residues Glu29, Asp20, Leu15, 
Asp21, and Asp8 respectively.  These assignments were used for NMR titration of MxiHV68AV70A 
with IpaD38-332 and IpaD130-332.   
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Calculation of the peak intensity ratios of the 1:1 dataset over 1:0 dataset (I1:1/I1:0) showed that 
residues 21 to 64 were the most affected and the I1:1/I1:0 ratio was below the average intensity 
ratio of 0.5 [Figure 7-4B].  15N-MxiHV68AV70A was also titrated with IpaD130-332, which lacked 
the N-terminal α-helical hairpin.  IpaD130-332 induced decrease in the intensity of the same 
backbone peaks of 15N-MxiHV68AV70A as IpaD38-332 [Figure 7-5] suggesting that the N-terminal 
α-helical hairpin is dispensable for the interaction between MxiH with IpaD.  
7.2.3.  PRE experiments with 15N-MxiHV68AV70A and IpaD38-332 - Initially, PRE experiments 
(11) were performed using 15N-MxiHV68AV70A and IpaD38-332.  Cysteine substitutions were made 
on   IpaD38-332 in order to attach a spin label and MTSL was used as the spin label.  Unlabeled 
(diamagnetic) or spin labeled (paramagnetic) IpaD was mixed with 15N-MxiHV68AV70A and each 
sample was used to collect a 1H-15N-HSQC spectra.  Intensities of the backbone amide peaks of 
MxiHV68AV70A from the paramagnetic (Ipara) and diamagnetic (Idia) were compared to obtain the 
Ipara/Idia ratios.  However, a comparable PRE effect was observed irrespective of the position of 
the spin label on IpaD38-332 [Figure 7-6].  This suggested a non-specific effect of the spin label 
probably due to the oligomerization of MxiHV68AV70A or the MxiHV68AV70A-IpaD38-332 complex.  
Therefore, the   MxiHCΔ5 construct was used for later PRE experiments. 
7.2.4.  PRE experiments using 15N-MxiHCΔ5 and IpaD38-332 - In total 10 spin label positions 
on IpaD38-332 were tested for the PRE effect they induced on 15N-MxiHCΔ5 [Figure 7-7].  These 
spin labels were along the coiled coil of IpaD38-332 on helices α4 and α8.  An increased PRE 
effect on 15N-MxiHCΔ5 was observed when the spin label on IpaD38-332 was moved to the 
“bottom” of the coiled coil.  The results of the PRE experiments are shown in Figure 7-8.  The 
highest PRE effect on 15N-MxiHCΔ5 was induced by the spin labels at R132C and C322, denoting 
that MxiHCΔ5 were closest to these spin label positions.   
160	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7-3:  A portion of the 3D-HNCA strips of 13C-15N-MxiHV68AV70A showing the Cα and the 
1H-15N resonances of the current and preceeding residues.  The connectivity between the strips is 
shown as lines.  The 15N chemical shift is on the z-axis   
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Figure 7-4:  (A) NMR titration of 15N-MxiHV68AV70A with IpaD38-332 at five molar ratios.  The 
peaks marked with arrows showed a decrease in intensity upon addition of IpaD38-332.  (B) 
Quantification of the NMR titration of MxiHV68AV70A and IpaD38-332.  The ratio of peak 
intensities for each of the complex (1:0.25, 1:0.5, 1:1, 1:2) datasets over the free (1:0) dataset is 
plotted against the residues of MxiHV68AV70A.  Residues 21 to 64 in MxiHV68AV70A were the most 
affected by IpaD38-332. 
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Figure 7-5:  NMR titration of 15N-MxiHV68AV70A with IpaD130-332 that lacked the N-terminal α-
helical hairpin.  IpaD130-332 affected the same residues (marked by arrows) of MxiHV68AV70A as 
IpaD38-332.  This suggests that the N-terminal α-helical hairpin is not required for the interaction 
between MxiH and IpaD. 
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Figure 7-6:  Results of PRE experiments using 15N-MxiHV68AV70A and IpaD38-332, which was spin 
labeled at four positions.  Refer to figure 7-7 for the location of the spin labels on IpaD38-332.  A 
PRE effect was observed on MxiHV68AV70A irrespective of the position of the spin label 
suggesting a non-specific interaction possibly due to aggregation of the protein molecules in 
solution.  15N-MxiHCΔ5 was used instead of 15N-MxiHV68AV70A for later experiments.  
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The residues in MxiHCΔ5 that showed the highest PRE effect when the spin label was placed at 
R132C of IpaD38-332 are shown in Figure 7-9.  These residues mapped to the helix-turn-helix 
head domain of MxiHCΔ5. 
7.3.  Discussion 
The atomic structures of T3SS needle and tip proteins from Salmonella and Shigella have 
been determined (4-7, 10).  The needle proteins form an α-helical hairpin with flexible N- and C-
termini (6, 7).  The tip proteins are highly α-helical and adopt a roughly oblong shape with a long 
central coiled coil (4, 5, 12).  The coiled coil is positioned in between an N-terminal and a C-
terminal domain (4, 5, 12).  The tip proteins assemble at the needle tip to form the tip complex, 
which blocks premature secretion of effectors and acts as a platform for the assembly of the 
translocon (13).  It is not known where the Shigella needle protein MxiH binds on the tip protein 
IpaD.  In order to answer this question we analyzed the molecular interaction between MxiH and 
IpaD using NMR spectroscopy and PRE (11). 
Purified full length versions of the needle proteins Salmonella PrgI and Shigella MxiH 
undergo spontaneous polymerization (7).  In order to counter this problem truncated needle 
proteins lacking the last five residues (PrgICΔ5 and MxiHCΔ5) have been used for in vitro studies 
(7, 14).  However Poyraz et al. (10) reported that the MxiHV68AV70A double mutant is both 
functional and soluble.  Hence, this variant was initially used to conduct NMR titrations with 
IpaD38-332.  The interaction between 15N-MxiHV68AV70A and IpaD38-332 was found to be in the 
intermediate exchange NMR timescale and several backbone amide peaks of MxiHV68AV70A 
showed a decrease in peak intensity.  15N-MxiHCΔ5 was titrated with unlabeled IpaD38-332 
previously and both fast exchange and intermediate exchange interactions were observed (3).   
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Figure 7-7:  (A) & (B) Two views of the structure of IpaD38-332 showing the positions of the spin 
labels used for PRE experiments with 15N-MxiHCΔ5.  The N-terminal α-helical hairpin is shown 
in the background.  The spin labels are colored according to the PRE effect they induced in 
MxiHCΔ5.  Spin labels on the “bottom” of the coiled coil of IpaD38-332 induced high PRE effect on 
MxiHCΔ5 residues. 
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Figure 7-8:  Results of the PRE experiments using 15N-MxiHCΔ5 and spin labeled IpaD38-332.  
Each panel represents one spin label position on IpaD38-332. The positions of the spin labels on 
the structure of IpaD38-332 are shown in figure 7-7.  The data points in each panel represent the 
Ipara/Idia ratio of that residue of MxiHCΔ5.  Spin labels at R132 on helix α4 and C322 and S306 on 
helix α8 produced the strongest PRE effect on MxiHCΔ5. 
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Figure 7-9:  (A) & (B) Two views of MxiHCΔ5 showing the residues that were most affected by a 
spin label at residue R132 of IpaD38-332.  The MxiHCΔ5 residues are colored according to their 
Ipara/Idia ratio.  Yellow represents low PRE effect and an Ipara/Idia ratio of 0.80-0.70, orange 
represents moderate PRE effect and an Ipara/Idia ratio of 0.70-0.60, and red represents high PRE 
effect and an Ipara/Idia ratio < 0.60. 
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Figure 7-10:  Concentration-dependent chemical shifts in 15N-MxiHV68AV70A.  1H-15N-HSQC 
spectra from samples of 15N-MxiHV68AV70A having five different concentrations are overlaid.  
The backbone amide peaks that are labeled showed peak shifts in the fast exchange NMR 
timescale.  These shifts represent MxiH-MxiH interaction. 
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However, we did not observe any fast exchange peaks upon titration of MxiHV68AV70A with 
IpaD38-332.  15N-MxiHV68AV70A undergoes concentration-dependent peak shifts in the fast 
exchange NMR timescale [Figure 7-10].  These shifts represent interaction between two 
molecules of MxiH.   
In Shigella IpaD, Salmonella SipD, and Burkholderia BipD the N-terminal domain is 
composed of an α-helical hairpin (4, 5).  The N-terminal domain is thought to prevent premature 
polymerization of the tip proteins because its removal in IpaD and BipD led to the self-
oligomerization of the tip proteins (4).  Further evidence of a self-chaperoning function of the N-
terminal α-helical hairpin domain comes from the observation that IpaD lacking this domain can 
still facilitate the invasion of eukaryotic cells by Shigella (13).  Recently it was shown that the N-
terminal α-helical hairpin domain of SipD might actually hinder its interaction with the needle 
protein PrgI because its removal increased the affinity between the two proteins (15).  However, 
no studies had analyzed the direct interaction between MxiH and IpaD in the presence and 
absence of the N-terminal domain.  Therefore, 15N-MxiHV68AV70A was titrated with IpaD130-332 
that lacked the N-terminal α-helical hairpin and it was found that this domain was dispensable 
for the interaction between IpaD and MxiH.  This observation supports the hypothesis that the N-
terminal α-helical hairpin as a self-chaperone for IpaD and prevents premature oligomerization 
but is not necessary for interaction with the needle protein. 
PRE is a useful technique to locate binding interfaces involved in weak protein-protein 
interactions due to the ability of the paramagnetic spin label to affect NMR active nuclei within a 
large radius (~20 Å) (11).  Hence, to locate the binding site of MxiHV68AV70A on IpaD38-332, spin 
labels were attached to the latter.  PRE had been previously used to show that PrgI, the 
Salmonella homolog of MxiH binds along the coiled coil of SipD, the Salmonella homolog of 
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IpaD (2).  Following this observation, the spin labels on IpaD38-332 were attached along the coiled 
coil.  However, after the collection of a few datasets, it was found that the spin labels were 
producing a non-specific PRE effect on MxiHV68AV70A irrespective of their position on the coiled 
coil of IpaD38-332.  This indicated that either MxiHV68AV70A or the MxiHV68AV70A-IpaD38-332 
complex was aggregating in solution.  In order to rule out these experimental artifacts, much 
lower concentrations of both the proteins were used without any change in the pattern of the PRE 
effect on MxiHV68AV70A.  Finally, 15N-MxiHV68AV70A was substituted with 15N-MxiHCΔ5.   
After several trials a concentration of 0.1 mM 15N-MxiHCΔ5 and 0.05 mM IpaD38-332 was 
chosen for the PRE experiments to avoid aggregation of the proteins in solution.  Spin labels on 
the coiled coil of IpaD38-332 that were closer to the antiparallel β-sheet (top) did not produce any 
PRE effect on MxiHCΔ5.  In contrast, when spin labels were attached on helices α4 and α8 
towards the “bottom” of the coiled coil, a high PRE effect was observed in MxiHCΔ5 residues 
[Figure 7-7 & 7-8].  This suggested that MxiH binds to the bottom of the coiled coil of IpaD 
similar to the Salmonella PrgI interaction (2).  The needle proteins Salmonella PrgI and Shigella 
MxiH are oriented in opposite directions in the polymerized needles (8, 9).  The N-terminus of 
PrgI is on the surface of the Salmonella needle but the C-terminus of MxiH is on the surface of 
the Shigella needle.  Further, a β-hairpin forms at the C-terminus of MxiH upon polymerization 
of the needle (8).  These differences would lead to the assumption that the interaction between 
the needle and tip would be different between Salmonella and Shigella.  However, despite having 
completely opposite orientations in the Salmonella and Shigella needles, the needle proteins bind 
to the tip proteins at a similar location, which is the bottom of the coiled coil of the tip protein.  
The coiled coil is a common feature in the tip proteins Yersinia LcrV (12) and Burkholderia 
BipD (16), in addition to Salmonella SipD (5) and Shigella IpaD (4).  Our results highlight the 
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functional significance of the coiled coil because in both Salmonella and Shigella a common 
mode of interaction was used by the tip and the needle proteins.  It is thus tempting to speculate 
that the assembly of the tip complex of the T3SS might follow a common principle where the 
coiled coil of the tip protein binds to the needle proteins. 
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Chapter 8:  Summary and future directions 
Several Gram-negative bacteria that are pathogenic to humans are completely dependent on 
the function of the T3SS in order to invade host cells (1).  The bacterial species harboring the 
T3SS are responsible for several widespread illnesses that continue to have a negative impact on 
human health worldwide (1).  More than a decade of extensive research has been performed to 
understand the architecture, function, and regulation of the T3SS.  The needle apparatus of the 
T3SS is capped by a hydrophilic tip complex and a membrane bound translocon (2).  The 
structure and function of the tip complex and the translocon are poorly understood.  Work 
described in this dissertation was directed towards addressing some of the gaps in the current 
understanding of the tip complex and the translocon of the T3SS.    
8.1.  The structure of SipD 
8.1.1.  Comparison of SipD and IpaD - The tip complex is required for the insertion of the 
translocon into the plasma membrane of the target eukaryotic cell thereby enabling the 
translocation of effectors into the eukaryotic cell cytoplasm (3, 4).  The tip complex also 
regulates secretion through the needle by blocking premature secretion of effectors until contact 
with the target cell is established (5, 6).  Thus the tip complex is both an assembly platform and a 
sensor and its structure holds clues to how it fulfils these roles.  Intact tip complexes of Shigella 
(7) and Yersinia (8) have been visualized.  However, the structure of the tip complex of 
Salmonella is not known.  Several copies of a hydrophilic tip protein SipD assemble the tip 
complex in Salmonella (9, 10) .  The atomic structure of SipD was necessary to understand the 
structure of the intact tip complex of Salmonella.  Therefore, SipD39-343 was crystallized using 
sparse-matrix vapor diffusion screening.  Crystallization data was collected at the Advanced 
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Photon Source and the structure of SipD was solved at 1.9 Å resolution using molecular 
replacement with the SipD homolog from Chromobacterium as the search model.  The structure 
of SipD was compared to the tip proteins IpaD (11) from Shigella, BipD (12) from Burkholderia, 
and LcrV (13) from Yersinia.  IpaD and SipD showed almost identical domain architecture and 
aligned with a Cα rmsd of 1.4 Å (for 186 Cα atoms).  A long central coiled coil was the most 
distinct feature of both SipD and IpaD.  There was an α-helical hairpin followed by a short α-
helix on the N-terminal side, a mixed α/β region on the C-terminal side, and a three-stranded 
antiparallel β-sheet on one end of the coiled coil.  The mixed α/β region was made up of three α-
helices and two β-strands.  The first major difference between SipD and IpaD was that the loop 
connecting α-helices α3 to α4 (loop α3-α4) was disordered in SipD but not in IpaD.  The second 
difference was that the longitudinal axes of α-helices α1- α 3 were titled at different angles in 
SipD and IpaD.  These differences might correspond to different modes of function of the tip 
complexes of Salmonella and Shigella.  For instance, the higher flexibility of loop α3-α4 of SipD 
might form a more dynamic surface on the tip complex of SipD.  Subtle changes in the dynamic 
states of the tip complex could potentially allow Shigella and Salmonella to fine-tune their 
physiological responses to specific environmental cues.  Likewise, changes in the helical axes of 
SipD and IpaD might lead to the formation of tip complexes with different structures or with 
different surface properties.  As a matter of fact, SipD is unable to compliment a non invasive 
strain of Shigella that lacks IpaD (14).  This indicates that even though SipD and IpaD share 
close structural resemblance these two tip proteins function in a different manner.  High-
resolution structures are required for a thorough analysis of the physical and chemical properties 
of the intact tip complexes of Salmonella and Shigella in order to understand how they function.  
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8.1.2.  Implications of the crystal structure of SipD131-343 - The central coiled coil was a 
common feature of SipD, IpaD, BipD, as well as LcrV (15).  The N-terminal α-helical hairpin 
however, was absent in LcrV (13).  It was hypothesized that the N-terminal hairpin acts as a self-
chaperone for the tip proteins SipD, IpaD, and BipD (11).  A chaperone can assist in the folding 
of a protein or, in case of the T3SS, could prevent premature interactions with other proteins.  
The crystal structure of SipD131-343 lacking the N-terminal α-helical hairpin was determined to 
answer this question.  SipD131-343 could maintain the folding of the coiled coil and the mixed α/β 
region in the absence of the N-terminal hairpin.  This concluded that the N-terminal hairpin is 
not required for folding of SipD and suggested a possible role in how SipD interacts with other 
proteins.  In fact, isothermal titration calorimetry using PrgI and SipD with or without the N-
terminal hairpin indicated that the affinity between these two proteins increases in absence of the 
N-terminal hairpin of SipD (16).  Removal of this domain in Shigella IpaD induces self-
oligomerization of the tip protein (11).  Therefore, it is likely that the N-terminal hairpin folds 
against the coiled coil and masks the interfaces required for the formation of the tip complex 
within the bacterial cytoplasm.  Another interesting observation is that the N-terminal hairpin 
folds independent of the rest of SipD.  A completely folded form of the 37kD tip protein is too 
large to pass through the 25 Å channel of the needle.  Therefore, the tip protein must be 
transported through the needle in a partially folded or completely unfolded state.  Thus, it is 
possible that the N-terminal hairpin unfolds during the transport of SipD through the needle and 
once SipD reaches the needle tip this region moves away to expose the surfaces required for the 
assembly of the tip complex [Figures 8-1 & 8-2].              
8.1.3.  Potential applications of the crystal structures of SipD - The tip complexes of Shigella 
(7) and Yersinia (8) were determined using electron microscopy.  The atomic structures of the tip  
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Figure 8-1:  Proposed state of SipD before and during transport though the needle.  (A) 
Estimated diameter of the inner channel of the needle (17, 18).  (B) Schematic diagram of 
the folded state of SipD before transport through the needle.  (C) Proposed partially 
unfolded state of SipD during transport through the needle.    
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Figure 8-2: Proposed state of SipD at the needle tip in the assembled tip complex.  The tip 
proteins assemble along their coiled coils.  The N-terminal α-helical hairpin of SipD is 
splayed away to expose the surfaces required for the assembly of the tip complex.  Six SipD 
molecules are shown at the tip complex based on the three-dimensional model of the 
Salmonella needle (19) and experimental restraints derived using PRE (20).  
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proteins Shigella IpaD (11) and Yersinia LcrV (13, 21) were then modeled into the three-
dimensional reconstructions of their tip complexes.  Although the low resolution of the resultant 
models prevented analysis of the molecular interfaces it was found that five molecules of IpaD 
and LcrV polymerize to form the needle complexes of Shigella and Yersinia respectively.  There 
is however, a lack of consensus regarding the stoichiometry of the Salmonella tip complex.  
Galkin et al.(19) determined the structure of the Salmonella needle using cryo-EM and reported 
6.3 molecules of the needle protein PrgI per turn of the needle.  This information was combined 
with experimental restraints derived using paramagnetic relaxation enhancement (PRE) to model 
six molecules of SipD at the tip complex (20).  In contrast, Loquet et al.(22) used solid state 
NMR (ssNMR) to report that the Salmonella needle contained 5.7 subunits of PrgI per turn of the 
needle.  This suggests that Salmonella needles might assemble with heterogeneous helical 
parameters and could potentially assemble tip complexes with varying stoichiometry.  The 
crystal structures of SipD reported herein in combination with other techniques like electron 
microscopy and computational modeling could be used to generate models of the Salmonella tip 
complex and thereby solve this puzzle.  The lack of high resolution structures of the intact tip 
complex might be due to several impediments.  First, the tip complex is probably loosely 
attached to the needle and is thus lost during purification.  Second, the tip complex might adopt 
heterogeneous conformations on each of the needles.  This property can reduce the quality of 
three-dimensional reconstructions of the tip complexes.  One way to circumvent these hurdles is 
to model the structure of the intact tip complexes from experimentally derived restraints.  The 
crystal structure reported herein might prove to be useful for such approaches for modeling of 
the tip complex.  In fact, PRE was used to characterize the interaction between SipD and PrgI 
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and obtain restraints for structure calculation of Salmonella tip complexes (20) using the crystal 
structure of SipD reported in this dissertation. 
 8.1.4. Mutagenesis of SipD - The tip complex blocks premature secretion of effectors, senses 
the presence of host cell, and also works as an assembly platform for the translocon (2).  This 
raises the question whether the different functional roles are played by the tip proteins as a whole 
or are assigned to the different domains.  Indeed, mutagenesis of the Shigella IpaD shows that 
each domain of the tip protein might play a different role (14).  Short deletions were made in 
SipD in order to test the function of its domains.  Deletion of only five residues (residues 338-
343) from the C-terminus of SipD yielded a non-invasive phenotype in Salmonella even though 
the folding of SipD was unaltered.  Interestingly, deletion of five residues from the C-terminus of 
the needle proteins Salmonella PrgI (23) and Shigella MxiH (24) prevents the polymerization of 
the needle.  Further, in Shigella IpaD a similar deletion prevents the localization of IpaD on the 
bacterial surface (9).  These results strongly suggest that the extreme C-terminus is required for 
the formation of the tip complex.  Thus, the needle and the tip proteins seem to follow a common 
mode of function where the C-terminus is required for the polymerization of the needle and the 
tip complex respectively.  It is possible that the C-terminus of each of the tip proteins are 
positioned close in space in the tip complex and takes part in extensive protein-protein 
interactions to stabilize the tip complex [Figure 8-3A].  The amino acid sequence of the deleted 
portion is Lys-Ser-Phe-Leu-Gln.  The Lys residue might form salt-bridges, Ser and Gln could be 
involved in H-bonds, while Phe from multiple copies of the tip proteins could form base-stacking 
interactions, and Gln and Leu might participate in van der Waals interactions.  Alternatively, it is 
possible that the C-terminus of the tip proteins binds to the needle proteins and thereby attaches  
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Figure 8-3:  Two proposed models showing the possible interactions mediated through the 
extreme C-terminus of SipD.  SipD is colored orange and the two α-helices of PrgI are colored 
light blue (C-terminal helix) and dark blue (N-terminal helix).  (A) Top-view of the tip complex 
where the C-termini of several SipD molecules could interact with each other to assemble the tip 
complex.  (B) An alternative model showing the side- view of the tip complex where the C-
terminus of SipD contacts the N-terminus of the needle proteins.  Both the C-terminus of SipD 
(chapter 4 figure 4-2) and N-terminus of PrgI (22) can adopt an extended β-strand conformation.   
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the tip complex on the needle.  In support of this model, residues Ser339, Phe340, and Leu341 
adopt a β-strand conformation and form a two-stranded parallel β-sheet along with residues 
Val223, Lys224, and Val225 within the mixed α/β region of another molecule of SipD (chapter 4 
section 4.2.1).  Incidentally, the N-terminal tails of PrgI molecules within the polymerized needle 
also adopts an extended conformation.  Thus it is tempting to speculate that in the assembled tip 
complex the C-terminus of SipD might form a β-sheet along with the N-terminus of PrgI [Figure 
8-3B].       
Residues 116 to 124 were deleted from the 25-residue loop α3-α4 of SipD.  Like the deletion 
of residues 338-343, this nine-residue deletion did not affect the structure of SipD.  However, 
more surprisingly, this deletion had no affect on the invasiveness of Salmonella.  Previous 
studies indicate that loop α3-α4 is most probably oriented on the outer surface of the tip complex 
(20).  If that case this region should be involved in formation of the translocon.  On the contrary, 
if loop α3-α4 is oriented towards the internal surface of the tip complex, it would probably make 
contacts with other tip proteins or needle proteins or might regulate the diameter of the needle 
channel.  In each of these cases, deletion of this loop should be expected to affect the function of 
SipD.  However, it is also possible that this flexible loop region is required for intermolecular 
motions, perhaps for adjusting the position of the N-terminal hairpin with respect to the core of 
SipD [Figure 8-4].  In that case deletion of just nine residues might not be sufficient to produce 
an easily identifiable phenotype using a Salmonella invasion assay.  
The tip proteins SipD, IpaD, BipD, and LcrV contain an antiparallel β-sheet on one end of 
the coiled coil.  This end was arbitrarily denoted as the “top” of the tip protein while, the 
opposite end was referred to as the “bottom” of the tip protein.   
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Figure 8-4: Schematic diagram of SipD showing a possible role of loop α3-α4 in controlling the 
orientation of the N-terminal α-helical hairpin with respect to the coiled coil of SipD.  
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Figure 8-5:  Structures of the tip complex of Shigella (7) and Yersinia (8, 21).  (A) Side-view of 
the three-dimensional reconstruction of tip complex formed by IpaD showing an elongated 
structure at the needle tip of Shigella (7).  (B) Top-view of the Shigella tip complex showing 
pentameric symmetry.  Five IpaD molecules were fitted into the Shigella tip complex.  (C) The 
Side-view of the Shigella tip complex with five IpaD molecules.  The mixed α/β region (marked 
by arrow) of IpaD was rotated by an angle of 160o in order to fit the electron density map of the 
Shigella tip complex.  (A), (B), and (C) from Epler CR, Dickenson NE, Bullitt E, Picking WL., 
Ultrastructural analysis of IpaD at the tip of the nascent MxiH type III secretion apparatus of Shigella 
flexneri, J Mol Biol. 2012; 420:29-39.  Published with permission © 2012 Elsevier Ltd. All rights 
reserved.  (D) Electron micrograph showing the tip complex of Yersinia (8).  Distinct head, neck, 
and base substructures were visible at the tips of the Yersinia needles.  From Mueller CA, Broz P, 
Müller SA, Ringler P, Erne-Brand F, Sorg I, Kuhn M, Engel A, Cornelis GR, The V-antigen of Yersinia 
forms a distinct structure at the tip of injectisome needles, Science. 2005; 310:674-6.  Reprinted with 
permission from AAAS.  (E) Five molecules of the Yersinia tip protein LcrV were fitted into the 
EM reconstruction of the Yersinia tip complex (21).  The N-terminus of LcrV formed the base 
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substructure and the C-terminus formed the head.  From Broz P, Mueller CA, Müller SA, Philippsen 
A, Sorg I, Engel A, Cornelis GR., Function and molecular architecture of the Yersinia injectisome tip 
complex, Mol Microbiol. 2007; 65:1311-20.  Reproduced with permission © Blackwell Publishing 
Limited.   
 
This antiparallel β-sheet is another conserved structural element in the tip proteins and might 
play an important role in the function of the T3SS.  Therefore, two or four residues were 
removed from β-strand β2, which is part of the three-stranded antiparallel β-sheet at the top of 
SipD.  These deletions rendered Salmonella unable to invade intestinal epithelial cells.  
However, this phenotype could be attributed to structural changes near the top of SipD.  
Nevertheless, these results implied that the antiparallel β-sheet is important to maintain the native 
folding of SipD.  Interestingly, this region was suggested to act like a hinge, which allows a 165o 
rotation of the mixed α/β region of IpaD to form the Shigella tip complex (7) [Figure 8-5].  
However, such a drastic rotation would require complete reorganization of the intramolecular 
interactions between the mixed α/β region and the coiled coil of IpaD.  The thermodynamic 
parameters driving such a large-scale conformational change are unclear.  Moreover, no such 
drastic rotation in LcrV was reported to occur during the formation of the Yersinia tip complex 
(21) [Figure 8-5].  However, it is not improbable for the same structural motif to play divergent 
roles in the assembly of the tip complexes in different bacterial species.  Therefore, the 
antiparallel β-sheet can potentially be crucial for the correct assembly of the tip complex.   
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8.2.  Implications of the interaction between SipD and bile salts 
The tip complex is exposed on the bacterial surface and can potentially interact with small 
molecules present within the host environment (10).  Salmonella and Shigella travel through the 
digestive system of humans in order to invade the epithelial cells of the small and large intestines 
respectively.  Therefore, it is not surprising that the tip proteins SipD and IpaD can bind to bile 
salts (25).  It is however, intriguing that Salmonella (26) and Shigella (27) react differently to 
bile salts.  The bile salt deoxycholate enhances invasion of host cells in Shigella possibly by 
triggering the recruitment of the translocon protein IpaB to the needle tip (27, 28).  The 
invasiveness of Salmonella, on the other hand, is repressed in presence of deoxycholate.  The 
crystal structures of SipD bound to bile salts deoxycholate and chenodeoxycholate showed that 
bile salts bind at a hydrophobic pocket at the interface of three molecules of SipD.  The effect of 
deoxycholate on the secretion of SipB was also tested and it was found that SipB was degraded 
into a smaller fragment when Salmonella was grown with deoxycholate.  Thus, it is possible that 
binding of SipD to deoxycholate affects its interaction with the translocon protein. 
Although bile affects T3SS function, the interaction between the Shigella IpaD (28) and 
deoxycholate is not a necessary for the invasiveness of Shigella (29, 30).  Likewise, in 
Salmonella deoxycholate does not completely abolish the invasiveness of Salmonella.  What 
then is the physiological significance of interaction between bile salts and tip proteins?  One 
possible theory is that Salmonella and Shigella use bile salts as a spatiotemporal probe.  In other 
words, the tip complex of these pathogens might be sensitive to the concentration of bile, which 
will be highest in the upper gastrointestinal tract and gradually decrease in the small and large 
intestines.  In case of Salmonella for example, it has been proposed that high concentration of 
bile salts prevent premature activation of effector secretion in the upper gut, perhaps by 
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interfering with the formation of the translocon, but when Salmonella reaches the small intestines 
and the amount of bile salts is lower this negative effect on translocon formation is relieved and 
the T3SS is fully activated (26).  However, this model cannot completely explain the effect of 
deoxycholate on the T3SS of Shigella.  The contrasting response to bile salts in Salmonella and 
Shigella could perhaps be attributed to the fact that Salmonella colonizes the small intestinal 
epithelium while, Shigella colonizes the large intestinal epithelium.  Another possibility is that 
the interaction between bile salts and isolated tip proteins is distinct from the interaction between 
bile salts and the assembled tip complex.  One approach to test this hypothesis could be to 
analyze the interaction between bile salts and tip proteins that have been chemically cross-linked 
to mimic the assembled tip complex. 
8.3.  The needle-tip interaction in Shigella 
How the tip complex is attached on the needle is not clearly understood.  NMR spectroscopy and 
PRE were used to show that the Shigella needle protein MxiH binds at the bottom of the coiled 
coil of the tip protein IpaD.  Similar results were reported for Salmonella where the needle 
protein PrgI also bound to the bottom of the coiled coil of the tip protein SipD (20).  However, 
the needles from Salmonella (22)and Shigella (31) reportedly had drastic differences.  In 
Salmonella needles, the N-terminus of PrgI was displayed on the outer surface of the needle 
whereas in the Shigella needles, the N-terminus of MxiH was reported to face the inner channel 
of the needle.  This discrepancy contradicts the conserved mode of interaction between the 
needle and tip proteins.  The structural models of the Shigella needles were generated by fitting 
the crystal structure of MxiH (32) into three-dimensional EM reconstructions of Shigella needles 
(31, 32).  The structure of the Salmonella needle on the other hand was determined by a 
combination of ssNMR, electron microscopy, and computational modeling.  Recently, ssNMR 
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was used to generate a homology model of the Shigella needles (33).  In complete contrast to the 
earlier models, this model showed that the conserved C-terminus of MxiH is oriented to the 
internal surface and the variable N-terminus of MxiH is oriented towards the exterior of the 
Shigella needle [Figure 8-6].  Further, the ssNMR-derived models of Salmonella (22) and 
Shigella (33) reported that the needle proteins within the polymerized needles adopt similar 
secondary structural features.  The N-terminus of both Salmonella PrgI and Shigella MxiH 
adopts an extended conformation followed by a proximal α-helix, a loop, and a distal C-terminal 
α-helix [Figure 8-6].  The ssNMR-based models are in agreement with the results of PRE 
experiments, which show that both Salmonella PrgI and Shigella MxiH bind to the bottom of the 
coiled coil of their respective tip proteins SipD and IpaD.  Given that the coiled coil is a common 
feature in all  tip proteins it can be speculated that this region plays an evolutionarily conserved 
role in the assembly of the tip complex.  As a matter of fact, coiled coils are a common structural 
motif observed among the components of the needle apparatus (32, 34).  It is likely that the 
coiled coil is used a building block in the architecture of the needle apparatus.  Characterization 
of the interaction within the tip proteins will further explain how they travel through the needle 
and assemble the tip complex.               
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Figure 8-6:  A homology model of the Shigella needle determined using solid state NMR (33).  
This models shows that the N-terminus of MxiH is displayed on the surface of the needle and the 
C-terminus lines the inner channel of the needle.  The agreement of the model with the cryo-EM 
map (31) reported earlier is shown.  An extended density labeled prot. was reported to fit a β-
hairpin in the C-terminus of MxiH.  In the above model this density was hypothesized to fit a 
rigid-extended N-terminal tail of MxiH.  Figure reproduced from PLoS Pathog. 2013; 9(3): e1003245.  
PLOS copyright policies allow anyone to download, reuse, reprint, modify, distribute, and/or copy 
articles in PLOS journals with proper citations.  No permission is required from the authors or the 
publishers. 
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8.4.  Interaction between SipD and SipB: implications for the assembly of the translocon 
The tip complex is followed by the translocon that connects the needle apparatus with the 
respective tip proteins SipD and IpaD.  Given that the coiled coil is a common feature in all tip 
proteins it host cell membrane and provides a passage for the effectors in form of a translocation 
pore.  Deletion of SipB affects the function of the translocon more drastically than deletion of 
SipC (4).  SipB is also larger in size and contains two transmembrane helices while SipC 
contains only one.  Thus, SipB is considered as the major translocon protein in Salmonella (34).  
SipB contains a hydrophilic protease-resistant domain at the N-terminus (35).  This N-terminal 
domain was hypothesized to bind to the hydrophilic tip protein SipD to anchor the translocon on 
the tip complex.  A combination of NMR spectroscopy and PRE was used to provide evidence of 
interaction between SipD and SipB and locate their binding interfaces.  It was found that a region 
of SipB within residues Asp207 to Asn283 binds to the mixed α/β region of SipD. 
The major translocon protein Salmonella SipB and its homolog IpaB from Shigella contain 
similar predicted secondary structural elements.  Further, SipB can complement for IpaB to 
restore invasion of HeLa cells and lysis of macrophages by Shigella (36).  SipB and IpaB are not 
only important for the formation of translocon but are also translocated into the target host cell 
(37, 38).  They can activate caspase-1 leading to the apoptosis of macrophages (39, 40).  The 
multiple roles of SipB and IpaB are segregated within distinct functional domains (35, 41).   
Previous studies have tested the importance of the N-terminal regions of SipB and IpaB (41-43).  
Like other T3SS substrates, their extreme N-termini were required for their secretion through the 
needle apparatus.  Up to residues 120 -160 were required for binding to the chaperone SicA in 
case of SipB and IpgC in case of IpaB.  Several deletions of ~ 10 amino acids were generated in 
IpaB (42).  It was found that deletions within residues 207 to 247 did not have any effect on the 
191	  
	  
function of IpaB.  However, deletion of residues 247-286 caused changes in the structure of IpaB 
(42).  These residues lie within the SipD-binding surface of SipB reported herein.  It is not clear 
why the IpaB mutations failed to produce a distinct phenotype in Shigella.  It is however, 
noteworthy that point mutations K211A, D215A, and A218D in SipB yielded non-invasive 
strains of Salmonella but deletion of residues 207-217 in IpaB did not affect the function of the 
T3SS of Shigella.  These results suggest that IpaB and SipB might have differences in how they 
function.  In fact, complete deletion of IpaB in Shigella (6) causes an increase in the secretion of 
late effectors but deletion of SipB in Salmonella does not have any appreciable effect on effector 
secretion (5).  In contrast to the mutagenesis of IpaB discussed above, Shen et al. (41) reported 
that deletions within residues 227-266 in IpaB produced a defect in regulation of effector 
secretion.  Given that the localization of IpaB at the needle tip is required to prevent premature 
secretion of effectors in Shigella, this result suggests that residues 227-266 of IpaB might be 
required for the interaction between IpaB and IpaD.  This observation therefore, agrees with our 
results that residues 207-283 within SipB bind to SipD.  The regions downstream of the N-
terminus of the major translocon proteins form two transmembrane helices which are required 
for their binding to the host cell membrane (34).  The extreme C-terminus is also required for the 
membrane-insertion of SipB into the lipid membrane (35).  The C-terminus of IpaB was also 
found to bind to IpaC (44).  Incidentally, the C-terminus of SipC was found to mediate its 
interaction with SipB (45). 
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The observations discussed above can be combined to propose a model for the assembly of 
the translocon in Salmonella.  In the bacterial cytoplasm SipB remains bound to the chaperone 
SicA.  SipB most probably exits the needle in a partially folded form probably still retaining 
some helical character.  At the needle tip, the hydrophilic N-terminal domain of SipB binds to 
the mixed α/β region of SipD displayed at the exterior surface of the tip complex.  This 
interaction could be important for correctly embedding the transmembrane helices of SipB into 
the host cell membrane.  When SipC is subsequently secreted, the C-termini of SipB and SipC 
might interact to form an active translocon.  However, it is also possible that other regions of 
SipB besides the N-terminal domain are involved in the interaction with SipD or perhaps there 
are regions of SipB, which bind both SipD and SipC at the same time.  Further, the molecular 
interactions responsible for polymerization of multiple copies of SipB at the translocon remain to 
be elucidated.  The N-terminus of SipB is also responsible for oligomerization of SipB in vitro 
(35).  Thus, it is plausible that the N-terminal domain of one molecule of SipB binds to one 
molecule of SipD and simultaneously contacts the N-terminal domain of an adjacent SipB 
molecule.  This proposed model is depicted in Figure 8-7.  Further studies need to be directed 
towards answering how full length SipB binds to itself and to SipD and SipC.     
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Figure 8-7:  Proposed model of the assembled translocon of Salmonella built using six-fold 
symmetry based on previous reports (19, 20).  SipD is represented as green ellipses.  The N-
terminal domain of one SipB binds to the mixed α/β region (not shown) of one SipD.  Two 
transmembrane helices of SipB are embedded within the host cell membrane and the C-terminal 
amphipathic helix is peripherally associated with the host cell membrane.  One SipC (blue) is 
bound to one molecule of SipB.  
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8.5.  Conclusions 
The T3SS is a macromolecular protein complex presenting multiple interfaces that can be 
targeted to disrupt its assembly.  However, detailed molecular characterization of the interfaces 
is required to understand the underlying mechanism of assembly and to develop strategies to 
disrupt such interactions.  Weak protein-protein interactions and structural heterogeneity are 
typical of large macromolecular complexes and they also pose challenges to obtain atomic 
resolution structures of such assemblies (46, 47).  NMR is well suited to study such weak 
interactions in solution and PRE has an advantage over other biochemical and biophysical tools 
because it is sensitive to long range interactions (46, 48).  Probing how protein components of 
the needle apparatus interact in vitro will generate useful data that can then be applied to 
understand the overall assembly of the T3SS.  The results of the experimental work described in 
this dissertation advance our understanding of the needle, tip, and translocon proteins and also 
forward mechanistic models of how these proteins interact with each other to form the different 
components of the needle apparatus.  This knowledge will ultimately lead to a better appreciation 
of the workings of the T3SS.    
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